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Abstract
Clusterin is a highly conserved protein that has been found in every mammalian species
examined and in two species of aves. Clusterin is distributed widely throughout the
mammalian body and interacts with a diverse array of proteins. These many binding

interactions have led to suggestions that clusterin is involved in an equally diverse arra

of functions. Clusterin is also widely reported to be dramatically upregulated in times of
stress and during apoptosis indicating that it may regulate cell death. However, no
genuine physiological function for clusterin has yet been established.

One of the two main goals of this project was to determine whether clusterin expression
was involved in regulating cell death. This was investigated by transfecting two
different expression systems containing human clusterin cDNA into L929 cells and
determining if the upregulated expression of clusterin altered the rate of cell death
induced by either TNFa, TNFa + actinomycin D, staurosporine, colchicine, or azide.
Cells transfected with an expression system containing a cytomegalovirus (CMV)
promotor were found to be resistant against TNFa-induced cell death. These transfected
cells were not protected from any other cytotoxic agent tested. The other expression
system (which resulted in lower levels of clusterin expression) did not provide cells
with protection against TNFa or any of the other cytotoxic agents. Further studies
suggested that clusterin, normally a secreted product, acted intracellularly to protect
L929 cells from TNFa-induced death. However, a control L929 cell line that
overexpressed green fluorescent protein was also shown to be protected from TNFainduced death. Therefore it is possible that the cytoprotection associated with
overexpression of clusterin is an artifact resulting from non-specific effects of high
levels of protein expression.

It has been deduced from the amino acid sequence of clusterin that it contains three
amphipathic helixes, which are required for hydrophobic interactions. It has also been
demonstrated that clusterin has a high affinity for hydrophobic surfaces as it can be
purified from ram rete testis fluid on the basis of it's strong hydrophobic interaction
with Affi-blue gel. Other reports have suggested that clusterin's association with
complement, apolipoprotein A-I and cell aggregation are due to hydrophobic
interactions. Thus, it appears likely that many of clusterin's binding interactions involve
binding to regions of exposed hydrophobicity, a similar property to that of chaperone
proteins which bind to regions of exposed hydrophobicity on other proteins. It was also
recently demonstrated that a conserved region in the clusterin promotor binds heat
shock factor 1, a transcriptional activator of the heat shock protein chaperones. This
element can also mediate heat-shock-induced transcription suggesting that expression of
clusterin and heat shock proteins may be co-regulated. The second main goal of this
project was to test the hypothesis that clusterin has chaperone-like activity.

Clusterin was shown to prevent catalase and GST from heat-induced precipitation as
well as preventing BSA and a-lactalbumin from reduction-induced precipitation. It was
demonstrated by ELISA that clusterin binds with higher affinity to the denatured form
of these proteins. Futhermore, gel filtration analyses of solutions containing any one of
these protein together with clusterin, following stress treatment, revealed that high
molecular weight complexes had formed between the two proteins. It is proposed that
clusterin protects proteins from stress-induced precipitation by binding to hydrophobic
regions that become exposed to the solvent to form solubilized high molecular weight
complexes. The ability of clusterin to non-specifically protect various proteins from
stress-induced precipitation confirms that clusterin has chaperone-like activity and
suggests that clusterin has a complementary role to heat shock proteins in vivo.
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CHAFFER 1
Introduction

Clusterin: a review of the existing
literature.

/./ THE GENERAL FEATURES OF CLUSTERIN
Clusterin is one of many names assigned to a glycoprotein which has been discovered

several times in diverse research areas and whose function is still to be elucidated. Ea
new discovery assigned a different name to this protein (Table 1.1). The name clusterin
arose from an early finding of Blaschuk et al. (1983) who reported that this protein was
capable of clustering Sertoli cells. Clusterin is now the internationally accepted name
for the protein (First clusterin workshop, 13th-16th September 1992, Cambridge UK).

Table 1.It-Alternative names of clusterin originating from different research areas.
(Modified from Table 1 in Rosenberg et al., 1993)
Name
Source
Site where clusterin was
Reference
found
Clusterin
Ram
Reproduction/ cell aggregating
Blaschuk etal., 1983
Sulphated glycoprotein 2

Rat

Sertoli cells/ reproduction

Collard and Griswold, 1987

Bovine

Adrenal Medulla/ Chromaffin

Fischer-Colbrie etal., 1984

granules

Palmer and Christie, 1990

Rat

Prostate/apoptosis

Legerefa/., 1987

Canine

Renal Cells/ Vectorial secretion

Hartmann etal., 1991

Human

Serum (liver)/complement

Kirszbaum et al., 1989

(SGP-2)
Glycoprotein-III
(GP-III)
Testosterone repressed
prostrate message-2
(TRPM-2)
Glycoprotein 80
(Gp80)
Serum protein-40,40

regulation

(SP-40,40)
Cytolysis inhibitor (CLI)

Human

Serum (Liver)/ complement

Jenne and Tschopp, 1989

regulation

T64

Quail

Neuroretinal cells/ cell

Michel etal., 1989

transformation
Apolipoprotein J

Human

Blood/ Lipid transport

James et al, 1991

(Apo J)

2

Clusterin has been detected in a variety of m a m m a l s and two non-mammalian species,
the quail (Rosenberg et al, 1993) and recently the chicken (Mahon et al, 1999).
Complete nucleotide sequencing of clusterin complementary DNA (cDNA) from these

different species has shown that human and dog clusterin products are the most sim

with 78% identity (Jenne and Tschopp, 1992; Hartmann et al, 1991). Clusterin from t
human and rat are also very homologous with 77% identity (May and Finch, 1992).

Human and quail clusterin are the least similar with 49% identity (Jenne and Tschop

1992). The most conserved region between clusterin molecules from different species
between residues lue 87 and met 150 (homology 98% (Jenne and Tschopp, 1992))

which contains five disulphide bonds. This high level of conservation suggests that
region is important in the function of clusterin.

Clusterin is widely distributed throughout the body and is transcribed from a sing

located on chromosome 8pl2-21 in humans (Purrello et al, 1991; Dietzsch et al, 1992

Fink et al, 1993) and chromosome 14 in the mouse (Bikenmeier et al, 1993). Clusteri

cDNA is comprised of 16,580 bp which is organised into nine exons and eight introns

(Wong et al, 1994 a). There are significant differences in the 5' untranslated seq

between clusterin sequences isolated from different human tissues, suggesting that

similar clusterin multigene family exists (Wong et al, 1994 a). Analysis of the pr

region of clusterin revealed API, AP2, SP1, and NF-2 motifs which are thought to be
essential for clusterin regulation (Wong et al, 1993). In addition cAMP response

elements, heat shock protein binding and growth hormone factor 1 binding motifs hav
also been identified within the promotor region (Wong et al, 1993).

Clusterin has been located in bodily fluids including h u m a n plasma (50-100 ug/ml) and
blood platelets (Murphy et al, 1988; Jenne and Tschopp, 1989), human breast milk (de

Silva et al, 1990a), urine (O'Bryan et al, 1990), spinal fluid (Hochstrasser et al, 1
on the surface of mature sperm and in seminal plasma (250-500 p.g/ml; Jenne and
Tschopp, 1989; de Silva et al, 1990a; O'Bryan et al., 1990). In humans, clusterin
mRNA has been detected in cells of most organs, although at different levels of

expression. The brain, ovary, testis, stomach and liver express clusterin at the hig

level while the kidney, heart, spleen, lung, and breast express clusterin mRNA at a m
lower level with no expression detected in T-cells (de Silva et al, 1990a). It has

generally been found that epithelial cells, especially those that border fluid fille

constitutively express higher levels of clusterin than other cell types (Jordan-Sta
al, 1992).

Early studies showed clusterin to be a heavily glycosylated protein which in its matu

secreted form has a molecular mass of 70-80 kDa and has low pi in the range of 4.9-5.

(Blaschuk et al, 1983; de Silva et al, 1990b and c). The size of unglycosylated clu
determined by an in vitro assay revealed a 50 kDa species (de Silva et al, 1990b),
however pulse chase studies in HepG2 cells only identified unprocessed clusterin to
have a size of 58 kDa (Burkey et al, 1991). Recently a report analysing purified

clusterin with matrix-assisted laser desorption ionization mass spectrometry reveal

that two molecular weight species of unglycosylated clusterin exist, and have sizes o
58,505 and 63,507 (Kapron et al, 1997).

4

Mature secreted clusterin exists as a heterodimer and is comprised of two subunits

which are similar in amino acid sequence but which are nevertherless distinct (de Silv

et al, 1990c). The subunits are referred to as a and p\ with glycosylated masses of 34
36 kDa and 36-39 kDa, respectively (de Silva et al, 1990b). The subunits are linked
together by 5 disulphide bonds which are distributed over a span of 29 amino acid
residues rich in cysteine (de Silva et al, 1990b, Choi-Miura et al, 1992b). The
disulphide bonds are inter-subunit linkages which are conserved between all clusterin
homologues indicating a possible importance in conformation (Choi-Miura et al,

1992b; figure 1.1). Both subunits of clusterin are translated from a single 1.9 kb mRN

transcript (de Silva et al, 1990a). Therefore clusterin originally exists as a single
polypeptide in which the predicted sequence contains 449 amino acids, including a 2122 N-terminal amino acid secretory sequence (de Silva et al, 1990a, de Silva et al,
1990b; Wong et al, 1994a). Ninety five percent of clusterin reaches the extracellular
environment as a heterodimer; sometime following translation and preceding secretion
the disulphide bonds form followed by cleavage of clusterin (Burkey et al, 1991). The
position of this cleavage is the same for all clusterin homologues and occurs between
amino acid residues 205 and 206 by an unknown enzyme (Jordan-Starck et al, 1992;
Jenne and Tschopp, 1992). The cleavage creates a 205 amino acid a subunit and a 222
amino acid (3 subunit.

A lot of information about putative structural features of clusterin has been deduced
from the amino acid sequence of the protein. Figure 1.1 displays the approximate
position of the four heparin binding domains, six glycosylation sites, numerous

phosphorylation sites, and three amphipathic helices that are predicted to exist on th

5

a SUBUNIT

P SUBUNIT
0

Protein kinase C phosphorylation site

0

Tyrosine kinase phosphorylation site

|

0

Casein kinase II phosphorylation site

cn

1 1 Clusterin signature

Cysteine
N-glycosylation site
Heparin binding domains

Number l = C-K-P-C-L-K-X-T-C
Number 2 = C-L-[R/K]-M-[R/K]-x-[E/Q]-C-[ED]-K-C

Predicted ampipathic helixes.

F i g u r e 1.1: Schematic representation of the structure of clusterin showing
the location of various k n o w n and predicted features (predicted features
highlighted in pink in legend). All predicted features (except ampipathic
helixes) were determined through software analysis performed at the following
w e b site: http://prowl.rockefeller.edu/cgi-bin/sequence. Ampipathic helixes
regions were determined by de Silva et al (1990a). Glycosylation sites have
been confirmed by Kapron et al, 1997.

6

clusterin subunits. The glycosylation sites in clusterin are asparagine linked (or Nlinked, i.e. have amino acid motifs of Asn-X-Ser/Thr, where X represents any amino
acid except for proline (Alberts, 1989)), as Burkey et al. (1991) showed that
carbohydrates associated with clusterin were removed by N-glycanase and not O-

glycanase. Recent studies have confirmed that (i) clusterin has six glycosylation site

which contain seven possible types of oligosaccharide structures, and (ii) clusterin i
heparin binding protein (Kapron et al, 1997; Hennessy et al, 1997; Pankhurst et al,
1998). The binding of heparin to clusterin is independent of cations and the affinity
increases at acidic pH (Pankhurst et al, 1998).

There are two sequences that are common between clusterin species and they have been
defined by the Prowl protein internet database (USA) as clusterin signatures (Figure
1.1). Using these electronic databases to compare protein sequences reveals that

clusterin is a truly unique protein as it has limited homology to any sequenced protein
The most similar protein is a newly found secretory protein expressed in human rod
photoreceptor cells (Shimizumatsumoto et al, 1997) and has a 17.8% homology
(identity) to clusterin. A sequence matrix plot comparing these two proteins shows a
scattered linear distribution of the homologous sequences (Figure 1.2). One of these
homologous regions aligns within the number one clusterin signature, which is the
region most conserved between different species of clusterin, and indicates that these
proteins are related.
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Figure 1.2: Scoring matrix comparing amino acid sequences of clusterin to the rod
receptor protein as determined by Mac Vector 4.1.4 software. The red line corresponds
amino acid sequences that are at least 60 % homologous between proteins. Note a perfe
match would be represented as a diagonal line from the top left hand corner to the bottom
right hand corner. Software settings were: hash value = 2; and minimum % score = 60.
Protein sequences were retrieved from the Entrez database (Rod photoreceptor protein
sequence ID 961457; clusterin sequence ID 4502905).

1.2 CLUSTERIN INTERACTIONS

One of the problems associated with identifying clusterin's function is the wide varie
of proteins to which it binds. Clusterin has been found associated with many proteins

and is expressed in a variety of different cell types. Studies have linked clusterin t
aggregation, reproduction, complement regulation, lipid transport, neurodegenerative
diseases of the brain (eg Alzheimer, scrapie and Pick disease), and cell death.
Unfortunately the function of clusterin in each of these areas has not been established. It
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remains to be shown whether clusterin has a specific role that is c o m m o n to each area of
research where it has been studied or whether it is a multifunctional protein.

1.2.1 Aggregation properties of clusterin.

The addition of purified clusterin to erythrocytes, white blood cells, spermatozoa, TM-

cells, Sertoli cells, renal epithelial and Staphylococcus aureus cells has been shown t
result in the aggregation of those cells (Fritz et al, 1983, Rosenberg and Silkensen,

1995; Blaschuk et al, 1983; Silkensen et al, 1995; Partridge et al, 1996). Clusterin is
most efficient in aggregating homogenous populations of cells as the addition of
clusterin to mixed populations of erythrocytes and TM-4 cells only resulted in loose
aggregation of those cells (Fritz et al, 1983). One study which examined the

aggregation of porcine renal epithelial cells demonstrated by electron microscopy that
the addition of clusterin enhanced the formation of cell junctions (Silkensen etal,
1995). This finding suggests that clusterin enhances homogenous cell interactions by
binding to surface ligand(s) that are present only on particular cell membranes.

There is also evidence which suggests that clusterin is involved in more complex cell
aggregation interactions. For example clusterin is upregulated in smooth muscle cells
that form nodules but not in smooth muscle cells that grow in a monolayer (Diemer et
al, 1992). Futhermore Schwochau et al. (1998) demonstrated that the aggregation of
cells due to the presence of clusterin in vitro enhanced their viability when exposed

H2O2 when compared to cells left in suspension. However it is likely that the increase

viability was not a direct effect of clusterin as the aggregation of cells into the sh

sphere resulted in inner cells becoming shielded from the cytotoxic agents by the oute
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cells. It is unlikely that clusterin aggregates cells into the shape of a sphere in vivo
because this shape is physiologically unfavourable as the inner cells would be starved of
nutrients.

Clusterin is the main protein component of ram rete testis fluid and it is likely to be the
factor in this fluid responsible for the aggregation of Sertoli cells in vitro (Fritz et al,
1983). It has not been reported whether other bodily fluids, which contain clusterin, are
also capable of aggregating cells in vitro. However, it appears that the aggregative

effects of clusterin on various cell types in vitro are likely to be non-specific as there ha
been no evidence for high affinity clusterin binding sites on these cells (Fritz, 1995).
Interestingly, the in vitro aggregating effect of clusterin has been shown (for one cell
type) to be inhibited by the addition of carnitine or chemically related compounds (Fritz
and Burdzy, 1989). Carnitine possibly interacts with clusterin or it could generally bind
to and mask cell membranes thereby inhibiting the aggregation of cells.

Clusterin is also capable of aggregating weakly with itself to form dimers and tetramers
(Blaschuk et al, 1983, Griswold et al, 1986). Gel filtration studies have shown that in
purified clusterin preparations the ratio of aggregated clusterin to monomer clusterin
increases with concentration (Figure 1.3a). This self-interaction is created by non-ionic
forces as aggregated clusterin dissociates into monomers in the presence of 6M urea
(Blaschuk et al, 1983). Electrostatic forces may be partly responsible for aggregation as
gel filtration studies demonstrate that aggregated clusterin is unstable at low pH (Figure
1.3b).
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Figure 1.3: (A) The elution profile of 100 uJ of immunoaffinity purified clusterin at 2
mg/ml (dark blue line), and 1 mg/ml (black line) in P B S (pH 7.4) when injected onto a
Superose 6 gel filtration column (0.5 ml/min) (B) Effect of p H on the
polymeric/monomeric ratio of immunoaffinity purified clusterin. 500 p.1 of clusterin at 1
mg/ml in MES/PBS (1:1) was adjusted to p H 5.5 (purple line), 6.5 (green line), or 7.5
(black line) and subjected to F P L C using a Superose 6 gel filtration column (0.5
ml/min). Experiments were performed by Tim Hochgrebe (manuscript submitted).
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7.2.2 Reproduction

Clusterin was first identified in studies aiming to find proteins that were involved i

somatic cell-germ cell interactions (Blaschuk et al, 1983). Through these early findin

it was found that clusterin was the major protein component of the testis fluid (18% o

total protein content is clusterin) and was the major secretory product of Sertoli cel

(epithelial cells of the seminiferous tubules of the testes) (Blaschuk et al, 1983). A

function of Sertoli cells is to support and nourish immature sperm cells, this indicat

that clusterin could be an important factor in the generation of mature sperm cells. M

recently clusterin has been detected in the acrosome and tail region of almost all mat
sperm cells (Sylvester et al, 1984; Sylvester et al, 1991). Different monoclonal
antibodies that recognise different variants of clusterin (presumably different
glycosylations) have been used to assess the morphology of human sperm (Obryan et
al, 1994). The association of clusterin with membranes of sperm cells have led to
proposals suggesting that clusterin is involved in the formation of cytoskeletal
components of sperm tails, complement defence, membrane remodelling and cell to cell
interactions (Jenne et al, 1989; Rosenberg and Silkensen, 1995; Blaschuk etal, 1983).

1.2.3 Complement regulation
Complement is part of the humoral immune system which destroys invading pathogen
cell membranes by forming, through a complex cascade of protein interactions, a
membrane attack complex (MAC). Complement is tightly regulated and the disruption

of any step in the cascade of protein interactions stops the formation of MAC. Cluster
has been shown to associate with complement complexes. In particular, clusterin binds
to the complement proteins C7, C8b, and C9 (Tschopp et al, 1993a). It has been
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suggested that clusterin m a y regulate the formation of the M A C as stepwise additions of
clusterin followed by complement proteins C5-6, C7, C8 and C9 (each at a

concentration of 1 p.g/ml) inhibited haemolysis of erythrocytes in vitro (Choi-Miura e
al, 1989; Murphy et al, 1989). McDonald and Nelsestuen (1997) also reported similar

findings. These studies are supported by an in situ experiment carried out on rat kidn
perfused with plasma that had or had not been depleted of clusterin. Complementinduced glomerular injury was increased in kidneys perfused with clusterin-depleted
plasma (Saunders et al, 1994). Clusterin has also been reported to localise with
complement in various affected tissues (French et al, 1994a; Vakeva et al, 1993;
Silkensen et al, 1998). These findings led to claims that clusterin was a complement

inhibitor in vivo, for example, it was proposed that clusterin on the surface of sperm
reduced the chance of complement attack in the female genital tract (Kirszbaum et al,
1989).

However, other studies strongly suggest that clusterin does not regulate complement in

vivo. Complement is activated in infarcted tissue (Weisman et al, 1990) and as cluster

colocalises at these sites (Vakeva et al, 1994), this suggests that clusterin is ineffi

at inhibiting the formation of the MAC. Similarly in a "physiological" assay containin
a 1:100 dilution of human serum to which clusterin was added to 200 lig/ml (twice its
physiological concentration), the rate of haemolysis of rabbit blood cells was not
affected (Hochgrebe et al, 1999). Futhermore, the extrapolation of this data set
estimated that clusterin concentrations two orders of magnitude greater than is found
serum would be required to protect cells from complement in physiological conditions.

In addition, the induction of cell surface human clusterin by transfected L929 cells d

not protect these cells from complement lysis in h u m a n serum (Hochgrebe et al, 1999).

1.2.4 Binding to immunoglobulins
The passage of human plasma over an immunoaffinity column bearing covalently

attached immunoglobulin G (IgG) suprisingly purified clusterin (Wilson et al, 1991). I
was found that clusterin specifically binds to the Fc and Fab regions of Ig by a
multivalent mechanism (Wilson et al, 1991; Wilson and Easterbrook-Smith, 1992).
Initial experiments demonstrated that purified clusterin could enhance the formation
antibody-antigen complexes (Wilson et al, 1991). However, this was later shown to be
the effect of the complement protein Clq which unknowingly copurified with clusterin
(Roeth and Easterbrook-Smith, 1996).

1.2.5 Lipid transport
Isolation of clusterin from human plasma by immunoaffinity chromatography led to the
finding that a 28 kDa protein co-purified with clusterin (Jenne et al, 1991). This 28

protein was identified as apolipoprotein A-I (apo A-I) and the interaction between it
clusterin was demonstrated to be hydrophobic as they dissociated in the presence of

non-ionic detergents (Jenne et al, 1991). However this interaction appears to be speci
as serum clusterin binds to immobilised apo A-I (Jenne et al, 1991; Kunutake et al,
1994) and the mole ratio of apo A-I copurifying with clusterin in serum remains
constant (Stuart et al, 1992). Apo A-I is the major protein component of high density

lipoprotein (HDL) complexes that are involved in the transport of lipids around the bo

(Stryer, 1988). Interestingly clusterin has also been purified from a subclass of seru

HDL particles that contain apo A-I and cholesteryl ester transfer protein activity (de

14

Silva et al, 1990c; Hennessy et al, 1997; James et al, 1988).

The association of clusterin with HDL particles suggests that clusterin could be invo

in reverse cholesterol transport. The reverse cholesterol transport mechanism, propose
by Glomset (1968), predicts that HDL particles are scavangers for cholesterol and once
they are loaded transport it via the circulatory system to the liver for excretion or
recycling. One study has shown that only 5% of the apo A-I-HDL species were

responsible for the transfer of cholesterol from fibroblasts to plasma (de Silva et al,
1990a). Wilson et al. (1995) suggests that this small subspecies of apo A-I-HDL could

be unique in that it contains clusterin (it is estimated that 2-4% of total apo A-I c
clusterin (Jenne et al, 1991)) which may be the essential ingredient allowing the HDL
particle to remove cholesterol. Clusterin's affinity for the various immune components
may (i) direct HDL complexes to cells that are to be removed, and (ii) link HDL

particles to cell membranes allowing transfer of cholesterol from the cell surface to
HDL particle (Figure 1.4).

Interestingly a distinct HDL subspecies has been reported to exist which not only
contains apo A-I and clusterin but a 44 kDa enzyme called paraoxonase (Blatter et al,
1993). Paraoxonase is one member of a poorly understood multigene family (PrimoParmo et al, 1997) and is classed as an "A"-esterase which catalyses the hydrolysis of
organophosphates, aromatic carboxylic acid esters, and carbamates (La Du, 1992). It is
unknown whether this HDL subspecies is capable of transporting cholesterol. However
a recent study indicates that it may be capable of tranporting cholesterol as this
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Figure 1.4: The lipid recycling hypothesis. Under non-stressed conditions cells
typically express low amounts of clusterin (A). Cells which are damaged, or are
about to be destroyed tend to upregulate clusterin production (B and C). It is
proposed that clusterin m a y interact with both Ig (or M A C ) and apolipoprotein
A-I/HDL. Such an interaction would allow H D L particles to be transported to
cells, which are to be broken down, and perhaps anchor the complex onto the
membrane surface. There the H D L complex could collect cholesterol from the
cell surface before taking it to be recycled. B y a similar mechanism clusterin
m a y also escort H D L particles to foreign cells, and aid in their removal by
collecting cholesterol from the membrane. Modified from figure 5.5 in Wilson et
al, 1995.
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subspecies of H D L was detected in artery walls atherosclerotic plaques (Mackness et al,
1997). Paraoxonase has also been reported to co-purify with clusterin from human
plasma by immunoaffinity chromatography. The association between paraoxonase and

clusterin was shown to be specific and saturable in vitro with a mole ratio of 8.2 ±2.
(clusterin:paraoxonase) (Kelso et al, 1994). Paraoxonase has been shown to protect
against chlorpyrifos toxicity in mice (Li et al, 1995) and can also modulate the
biological activity of mildly oxidized LDL (Watson et al, 1995). An interaction
between paraoxonase and clusterin is also apparent when oxidized LDL is introduced
into LDL receptor knockout mice. The introduction of oxidised LDL resulted in an

increase in the levels of serum clusterin and paraoxonase and suggests that this compl
may act as a "detoxifying unit" (rounding up and neutralising lipoperoxides) (James,
1995; Navab era/., 1997).

Evidence has accumulated showing that clusterin alone can enhance the efflux of
various lipids from cells. For example, in HepG2 cells, secreted clusterin exports
various lipids including triglycerides, unesterified cholesterol, phospholipids, and
cholesterol esters presumably from the cell membrane (Burkey et al, 1992). Similarly

clusterin assembles into lipoprotein particles when secreted from retinal Muller glial
cells (Shanmugaratnam et al, 1997). Furthermore clusterin has been shown to enhance
the efflux of cholesterol from macrophage foam cells (Gelissen et al, 1998). This

lipoprotein like activity of clusterin supports its possible involvement in cholestero
transport.

1.2.6 GP330 - clusterin receptor
Glycoprotein 330 (gp330, previously known as megalin) is a membrane associated
glycoprotein which is associated with the autoimmune disorder Heymann's nephritis,
which is the animal model of human membranous glomerulonephritis. This disease

initiates when circulating antibodies bind to antigens on the surface of epithelial c
glomeruli. The antigen-antibody complexes then shed and collect in the base membrane
causing nephritis (Alousi et al, 1969). gp330 is expressed in epithelial cells of the
kidney; it is an antigen which is recognised by antibodies circulating in affected
glomeruli (Kerjaschki and Farquhar, 1983).

gp330 is related to the low density lipoprotein (LDL) receptor and the LDL receptor
related protein (LRP) which all have the following common features:(i) cysteine-rich repeats,
(ii) YWTD repeats,
(iii) a single membrane spanning region and,
(iv) one or more NPXY internalization signals (Brown et al, 1991).

Several ligands have been shown to bind in vitro to gp330, some of these include
receptor associated protein (RAP), lipoprotein lipase, lactoferrin, Ca2+, albumin,
thyroglobulin and tissue/urokinase plasminogen activator : plasminogen activator

inhibitor -1 complexes (Willnow et al, 1992; Moestrup et al, 1993; Hjalm et al, 1996;
Cui et al, 1996; Zheng et al, 1998). While the interaction between gp330 and any one
of these ligands are specific they don't help identify the function of gp330 because
the distribution of these ligands throughout the body is different to gp330 and; (b)
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ligands are not specific for gp330 as they also have high affinity for the more widely
distributed LPR. Further studies attempting to find a specific ligand for gp330 and not
LPR successfully isolated a protein from milk that was identified as clusterin (Kounnas
et al, 1995). Following specific binding to gp330, clusterin is internalised and
subsequently degraded by F9 cells (Kounnas et al, 1995). Clusterin therefore appears to
be a specific gp330 ligand and further research is required to elucidate the purpose of
this interaction.

1.2.7 Neurodegenerative diseases and amyloid J3 peptide
Alzheimer's disease (AD), Pick's disease (PD) and Huntington disease (HD) are all
neurodegenerative diseases which affect neurons of the hippocampus. Clusterin has
been found to be upregulated in these damaged tissues and its specific role in these
diseases is unclear (Duguid et al, 1989). Most of the research to date has focused on
clusterin's association with AD.

In AD brain tissue clusterin has been detected interacting specifically with the affect
dystrophic neurites and associating in neuropil threads (McGeer et al, 1992). Another
classical pathological feature of AD is the formation of amyloid deposits, with which
clusterin also associates (McGeer et al, 1992). Little is known about the toxicity of
these plaques or how they form. The principle component of these deposits is amyloid P
(a^) peptide which is a product from the cleavage of amyloid precusor protein (Sisodia
and Price, 1995). Soluble ap1 has been found in plasma, cerebrospinal fluid and cell
supernatants and associates with clusterin (Ghiso et al, 1993). The interaction between

clusterin and a{3 is specific (dissociation constant = 2 x IO"9 M) and is not dissociat

the presence of other ap affinity ligands (Matsubara et al, 1995). Presumably ap is the
ligand to which clusterin binds in amyloid deposits.

It is unclear whether clusterin has any effect on the formation of amyloid deposits in
vivo. Clusterin has a higher affinity for soluble ap than the aggregated polymer form
(Matsubara et al, 1995). The origin of ap in the brain of AD patients is unknown.
Perfusion experiments have been performed to determine whether clusterin is capable of
transporting aP to the brain. In one perfusion experiment, aP-clusterin complexes were

demonstrated to be transported more efficiently across the blood brain barrier into the

brain than ap alone (Zlokovic et al, 1994). Further studies implicated that aP-clusterin
complexes were transferred across the blood brain barrier via the binding of clusterin
gp330 (Zlokovic et al, 1996). However, in another study where radiolabeled clusterin
was injected intravenously, no transfer of radiolabeled clusterin to the brain was

detected (Shayo et al, 1997). This suggests that clusterin does not cross the blood brai

barrier in vivo which therefore indicates that it is not capable of transporting aP int

brain. In addition, clusterin purified from the brain is 5 kDa smaller than clusterin fr
serum (Oda et al, 1994), which suggests that the clusterin associated with ap in the
brain is locally produced. Clusterin produced in the brain may also regulate the
formation of amyloid plaques as clusterin is capable of partially blocking the
aggregation of ap (Oda et al, 1995), however further research in this area is required.

aP has been shown to be neurotoxic to primary neuron cultures (Yankner et al, 1990;
May et al, 1992a), which implies that the presence of amyloid plaques in AD contribute
to cognitive decline. However, it is unclear whether clusterin can interfere with the

toxicity of ap. O n e study found that clusterin-aP complexes were more lethal (as
determined by an oxidative stress assay) than soluble ap to PC 12 cells (Oda et al,

1995), while another demonstrated clusterin protected rat hippocampal cultures from th
toxic effects of ap (Boggs et al, 1996).

Clusterin is also associated with other neuron diseases. For example clusterin

colocalises in apoptotic photoreceptor cells (Agarwal et al, 1996), and is also deposi

in senile plaques in brains of Down syndrome patients (Kida et al, 1995). Similarly th

expression of clusterin is increased in cells of the rodent brain after transient glo
ischemia (May et al, 1992b; Kida et al, 1995), neurons of wobbler mice (Popper et al,

1997), in retinitis pigmentosa (Jomary et al, 1993a and b; Jones et al, 1992; Smith et
al, 1995; Wong et al, 1994), and in the hippocampus following entorhinal cortex

lesioning (Lampert-Etchells et al, 1991). These reports suggest that clusterin plays a
important role in diseased or stress affected neurons.

1.2.8 TGF/3

TGFP has been shown to regulate clusterin gene expression in a cell dependent fashion.
In several fibroblast and epithelial cell lines TGFp has been shown to upregulate

clusterin expression (Jin and Howe, 1997) which in one case resulted in a truncated 43

kDa form of clusterin becoming localised to the nucleus (Reddy et al, 1996). Similarly
TGFP was shown to upregulate clusterin expression in neurons and astrocytes (Laping

et al, 1994). The upregulation of clusterin in cells treated with TGFP involves protei
kinase C signalling and requires the API binding site in the clusterin promotor (Jin
Howe, 1997). However TGFp has also been found to downregulate clusterin expression

(Thomas-Salgar and Millis, 1994). The different regulatory effects of T G F p indicate

that other unidentified factors are responsible for the control of clusterin expression
example, treatment of astrocyte cultures with TGFp results in the downregulation of
clusterin expression, however, when oligodendrocytes and microglia are present, TGFp

treatment results in the upregulation of clusterin expression in astrocytes (Morgan eta
1995).

Clusterin has also been shown to interact with the intracellular domains of both type

and type II TGFp receptors in vitro (Reddy et al, 1996). However it seems unlikely that
clusterin is directly involved in TGFP signaling, as clusterin is normally a secreted
protein and thus is not confined to the cytosol of the cell.

1.3 CLUSTERIN AND APOPTOSIS
Apoptosis is a form of programmed cell death which is initiated when cells are not
needed (e.g. self reactive thymocytes (Coleman, 1992)). Apoptosis is a selective event
and therefore must be tightly regulated. Clusterin may also be involved in regulating
apoptosis as clusterin mRNA was found to be one of the dominant upregulated mRNA

species in the rat ventral prostate following castration (which is associated with a h
level of programmed cell death) (Montpetit etal, 1986, Leger etal, 1987). Castration

results in the regression of the ventral prostate due to the ablation of androgens nor

required to maintain homeostasis. The regression of this tissue appears to require prot

synthesis, and as clusterin expression is upregulated specifically in these dying cells
(Buttyan et al, 1989), as well as in other apoptotic cells, it has been suggested that
plays a functional role in apoptotic cell death.
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Research performed by Akakura et al. (1996) suggest that clusterin plays a protective
role in the cell death of castrated rat prostate cells. This study created androgenindependent cell lines by repeatedly castrating and replanting tissue into other mice.
Cells which became androgen-independent by not dying after castration were found to
have more intracellular clusterin compared to androgen-dependent cells which die after
castration (Akakura et al, 1996). Clusterin in the androgen-independent cells localized
to the nucleus suggesting it may help regulate protein expression. However, it is

possible that the expression of clusterin in these cells may only be coincidental to cell
survival. Further research in this area is therefore required.

Other studies have also found clusterin upregulated in tissues/cells undergoing apoptosi
where it may also have a cytoprotective effect. For example, inducing status epilepticus
in rats results in apoptosis of brain nerve cells which upregulate clusterin expression
(Dragunow et al, 1995); rat mammary carcinoma cells treated with anti-estrogen
toremifene which inhibits growth and causes cell death results in those cells
upregulating clusterin (Huovinen et al, 1993); and numerous cell lines induced to
undergo apoptosis also upregulate clusterin expression (Kyprianou et al, 1991, SimboliCampbell et al, 1996). Similarly, it may explain the correlation between high clusterin
expression and tumour potency seen in glioma and prostate cells (Danik et al, 1991;
Steinberg et al, 1997). The possible cytoprotective capabilities of clusterin may also
explain its presence and upregulation in neurodegenerative diseases. However it is
unclear how clusterin could act as a cytoprotective agent. Because clusterin is normally
a secreted product, it may function locally outside the cell, perhaps on membranes of
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stressed cells. Immunofluoresence studies by Simboli-Campbell et al (1996) did detect
small amounts of clusterin localising to the cell membrane surface of early apoptotic

MCF-7 cells. Interestingly, they also detected a large amount of clusterin in apoptoti
bodies and secretory vesicles of late apoptotic MCF-7 cells, which could have been
accumulated from outside the cell or specifically produced by those cells.

A study carried out by Bursch et al. (1995) on rat liver demonstrated that clusterin c

not only be upregulated in cells undergoing apoptosis but also in proliferating cells.
study involved administering high doses of the hepatomitogen cyproterone acetate
(CPA) which results in the doubling of liver size within six days. During this period
growth, clusterin was found to be upregulated, before returning to background levels
once the maximum growth had been achieved (even though CPA treatment continued).
Withdrawal of CPA caused a decrease in liver weight resulting from cells dying by

apoptosis, which also correlated with high levels of clusterin mRNA expression (Bursch
etal, 1995).

There have also been several cases where clusterin upregulation is not detectable in
undergoing apoptosis. For example, Jomary et al (1995) found that clusterin is not

increased in apoptotic photoreceptor cells, while Garden et al. (1991) could not detec
clusterin expression in apoptotic cells from the central nervous system or nonneural

tissue. Similarly in the hair folicle which undergoes cycles of growth, regression and
rest, clusterin was shown only to be expressed during periods of growth (Seiberg and
Marthinuss, 1995). Furthermore, in apoptotic thymocytes clusterin was found to be
upregulated only in surviving cells and not dying ones (French et al, 1994b). It is
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apparent therefore that clusterin expression is not required for cell death to occur.

Similarly, clusterin expression does not cause cell death as the viability of transfect

cell lines which overexpress clustein was no different to the parental cell lines (Pila
etal, 1993; Sensibar et al, 1995; Humphreys etal, 1997).

The different effects clusterin has on cell death may relate to variant clusterin speci
that have recently been reported. Kimura and colleages (1996 and 1997) identified

alternative splicing variants of clusterin mRNA that were produced in various organs of

rats injected with cycloheximide or treated with heat. Clusterin variants had deletions

exon 5 resulting from alternative splicing, in which the deleted regions differed not o
between species but also between cell types of the same species (Kimura et al, 1997).
Similarly, clusterin mRNA variants were also found in prostate, liver and thymus in
response to androgen (Izawa, 1998) and two variants were detected in mouse testes (Lee
etal, 1993). However, as these independent studies employed rt-PCR which does not
correct for complex mRNA conformation structures such as hairpin loops it is possible

that these variants are artifacts of the rt-PCR procedure. Further studies will be requ
to confirm the presence of these alternative transcripts and to determine whether they
have different effects on cell death.
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1.4 CONCLUSION
Clusterin has been associated with many areas of research, including studies of cell

maturation and reproduction, cell death, complement regulation, and lipid recycling. It'

expression and interaction with various biological ligands indicates that either cluste
is a multifunctional protein or that it has a single unifying function.
The aims of this thesis were two fold:
i) To investigate the involvement of clusterin expression in cell death by
constructing transfected cell lines which inducibly or constitutively express
clusterin.
ii) To test the hypothesis that clusterin may have a chaperone-like action
(Introduced in chapter 5).

These aims were addressed by:
(i) Identifying agents which induce apoptosis in L929 cells.
(ii) Creating the following stably transfected L929 cell lines :(a) A cell line which can inducibly secrete human clusterin.
(b) A cell line which constitutively expresses high levels of human clusterin.
(c) Appropriate control cell lines:- a cell line that constitutively expresses high levels of green fluorescent
protein (GFP).
- cell lines transfected with the same plasmids as in (a) or (b) but lacking
the clusterin cDNA insert.

(iii) Using these transfectant cell lines to analyse whether human clusterin expression
provides protection against various forms of stress.
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The L929 cell line was chosen for this study because:- It is a murine derived cell line and therefore does not express human clusterin.
Transfection of L929 cells with human clusterin cDNA allowed specific
detection of over-expressed protein using human-specific monoclonal
antibodies.
- It is a hardy cell line that is easily transfected by electroporation.

(iv) Sequence analysis predicts that clusterin has three putative amphipathic ahelical regions known to be important for interactions with hydrophobic molecules. It
has also been demonstrated that clusterin has a high affinity for hydrophobic surfaces
it can be purified from ram rete testis fluid on the basis of it's strong hydrophobic

interaction with Affi-blue gel (Blaschuk et al, 1983). Other reports have also suggeste
that clusterin's association with complement protein C9, apolipoprotein A-I and cell
aggregation are due to hydrophobic interactions (Tschopp et al, 1993; Jenne et al,

1991; Fritz, 1995). During these studies, Michel et al (1997) reported that the cluster

promotor contains an element that specifically recognises the transcriptional activator
heat shock factor 1 (HSF 1). It was also demonstrated that this element can mediate
heat-shock-induced transcription (Michel etal, 1997) suggesting that expression of
clusterin and heat shock proteins may be co-regulated. Against this background it was
hypothesized that clusterin may have some small heat shock protein-like chaperone
activity. Therefore, several in vitro heat and reduction-mediated denaturing assays,
commonly used to identify heat shock proteins (Jakob et al, 1993; Horwitz, 1992), were
used to determine whether clusterin has any chaperone activity.
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CHAPTER

General Materials and Methods
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2.1 CELL CULTURE
2.1.1 Tissue Culture Reagents
DMEM:F-12 tissue culture medium was purchased from Gibco BRL (Melbourne,

Australia). Fetal bovine serum (FBS), trypsin/EDTA (1:250), and all other tissue cult
reagents were obtained from Trace Biosciences Pty Ltd (Sydney, Australia).

T a b l e 2.1 General recipes of T C products. Note: all items were filtered sterilised or
autoclaved and only opened in a laminar flow hood.
^_
Item

Recipe

pH

PBS

68.5 m M NaCl, 1.3 m M KC1, 0.74 m M KH 2 P0 4 , 4 m M Na 2 HP0 4

7.4

EDT A/PBS

5 m M E D T A in half strength PBS (diluted in R O water)

7.4

DMEM:F12

As manufacturers instructions + 2 g/1 N a H C 0 3 + 2.383 g/1 HEPES

7.2

Freeze mix

5 0 % (v/v) FCS, 1 0 % (v/v) D M S O , 4 0 % DMEM:F12

T a b l e 2.2 Preparations of various stock solutions offluorescentstains used in tissue
culture. Note: as these items were used for short incubation times they were not
sterilised.
Stain

Stock concentration

Dissolved in

Propidium iodide

1 mg/ml

R O water

7-amino-actinomycin D

5 mg/ml

DMSO

Acridine orange

1 mg/ml

DMSO

T a b l e 2.3 Preparations of various cytotoxic agents used in tissue culture.
Dissolved in
Stock concentration
Cytotoxic agent
TGFp

2 ug/ml

PBS

TNFa

0.5 mg/ml

PBS

Aetinomycin D

1-5 mg/ml

DMSO

Colchicine

2mM

DMSO

Staurosporine

ImM

DMSO

Azide

10% (w/v)

R O water

29

2.1.2 General methods
2.1.2.1 Maintenance
All cell lines were grown in DMEM:F12 growth media supplemented with
10% (v/v) foetal calf serum (FCS). Cells were incubated in a Forma Scientific
humidified incubator at 37°C, 5% C02 unless otherwise mentioned.

2.1.2.2 Freezing cells
Cells to be frozen were pelleted at 2000 rpm (Beckman TJ-6) for 5 minutes.
The pellet was resuspended in cold freeze mix (defined in section 2.1) and
aliquoted (1 ml) into cryovial tubes (Interpath, Sydney). Cryovials were
incubated at -80°C overnight in a cryogenic freeze container which lowered the
temperature at a rate of approximately 1°C per minute. Thereafter cryo vials
were permanently stored in liquid nitrogen until needed.

2.1.2.3 Thawing cells
Cryovials were quickly thawed in a 37°C water bath. The cellular suspension
was washed and pelleted in PBS at 2000 rpm (Beckman) for 5 minutes. The
pellet was resuspended in growth media and maintained in tissue culture flasks.
After thawing, cells were not used in experiments for approximately one week
to allow them time to recover from being frozen.

2.1.2.4 Passaging
Suspension cells: 95% of the growth media was poured off and collected if
needed. Warm fresh media was returned into the tissue culture flask.
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Adherent cells: Growth media was poured off and collected if needed. Enough
EDTA/PBS was put on to cover cells. Cells were incubated for 5 minutes at
37°C. Approximately 80% of the cells were then removed, using a pipette, by
vigorous passage of EDTA/PBS over the inner surface of the culture vessel.
The EDTA and cells were removed from the flask and replaced with fresh
growth medium.

2.1.3 Cell Lines used in this study
1929: Fibrosarcoma cell line; Murine.
HL60: Myeloid leukemia cells; Human.
HeLa: Cervix epithelial carcinoma cells; Human.
MCF-7: Breast cancer cells; Human.
G7: Murine hybridoma cell line received as a gift from Dr B Murphy (St
Vincents Hospital, Melbourne, Australia). Secretes monoclonal IgGi K
antibodies which specifically recognise human clusterin.
78E: Murine hybridoma cell line which secretes monoclonal IgGjK antibodies
which specifically recognise human clusterin (Wilson & EasterbrookSmith, 1993).
4ID: Murine hybridoma cell line which secretes monoclonal IgG^K antibodies
which specifically recognise human clusterin. 4ID was made by
conventional methods using immunoaffinity purified human serum
clusterin as antigen (Wilson M.R, unpublished).
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DNP-9:

Murine hybridoma cell line. Secretes monoclonal IgGi K antibodies

which recognise dinitrophenol groups (Wilson & Easterbrook-Smith,
1993).

2.2 ELECTROPHORESIS
2.2.1 SDS/PAGE Buffers
* Acrylamide/bisacrylamide stock solution 30% : 0.08 % (w/v) in milli Q water.

Table 2.4: Recipe for either 0.75mm or 1mm thick SDS-PAGE gels. All values are
ml unless otherwise specified.
Gel thickness
0.75 m m
1.0 m m
[Acrylamide] %

10%

12.5%

15%

10%

12.5%

15%

Acrylamide/bisacrylamide

3.3

4.13

4.95

4.95

6.2

7.43

0.75 M tris cl, p H 8.8

5.0

5.0

2.5

7.5

7.5

3.75

10% SDS

0.1

0.1

0.1

0.15

0.15

0.15

TEMED

0.007

0.007

0.007

0.01

0.01

0.01

1 % ammonium persulfate

0.5

0.5

0.5

0.75

0.75

0.75

H20

1.1

0.26

1.95

1.65

0.39

2.93

* Stacking gel:

Acrylamide/bisacrylamide

1.0 M tris CL,pH 6.8 0.42 ml
10% SDS 0.033 ml
H20 2.4 ml
TEMED 0.007 ml
1 % ammonium persulphate 0.17 ml

* 2x Sample Buffer: 0.5 M tris Cl
20% glycerol (v/v),
5% SDS (w/v),
0.005% bromophenol blue (w/v).
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(pH 6.8)

0.33 ml

* Running Buffer:

0.025 M tris

0.192 M glycine
0.1% SDS
pH8.3

* Coomassie blue stain: 0.25% (w/v) coomassie blue (R250)
500 ml Methanol
500 ml RO H20
100 ml Glacial AcCOOH

* Destain solution: 500 ml Methanol
500 ml RO H20
100 ml Glacial AcCOOH

2.2.2 SDS/PAGE Methods
2.2.2.1 Loading the acrylamide solution
The acrylamide solutions were set in either a "tall mighty small" (Pharmacia,
Melbourne, Australia) or Novex (Sydney, Australia) gel casting apparatus
sealed at the bottom by a 1% agar mix. While the separating gel was setting 1-2
ml of ethanol was placed on top to remove any air bubbles and to create a
horizontal interface for the stacking gel. When the separating gel had set the
ethanol was washed off with d^O, any remaining water was removed with
blotting paper.

The stacking gel was loaded with the appropriate toothed comb and after it had
polymerised the comb was removed and wells were washed and outlined on the
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glass with a marker pen to help position the samples. Gels that were not to be
used immediately were kept at 4°C in running buffer.

2.2.2.2 Sample preparation and electrophoresis of SDS PAGE gels
Samples were generally prepared in PBS + 0.02% azide to which a final equal
volume of sample buffer was added. Reduced samples had the addition of 50
mM P-mercaptoethanol. Samples were boiled for approximately 5 minutes
before being loaded into the wells.

After the samples were loaded, gels were electrophoresed at 130 V for
approximately 2 hours. The gel was quickly rinsed with RO water and then
gently removed from the ceramic backing plate.

2.2.2.3 Coomassie blue staining of SDS PAGE gels
SDS PAGE gels were placed in a plastic container followed by enough
Coomassie blue R250 stain to cover the gel. A typical 10% SDS PAGE gel was
stained for approximately 1 hour on a shaker at room temperature, while higher
percentage gels were stained for longer time periods.

Stained gels were then destained by adding the destain solution and left on a
shaker until the background was negligible. The destain solution was replaced
when a considerable amount of Coomassie blue had leached out of the gel. For
overnight destaining an equal volume of the destain solution and water was
used. Destained gels were dried using the Novex Gel drying kit as described by
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the manufacturer's instructions.

2.2.3 Western blotting
2.2.3.1 Semi-dry Transfer
SDS/PAGE gels were electrophoresed as described (section 2.2.2.2) without
the staining procedure. After electrophoresis gels were equilibrated in transfer
buffer (0.037% (w/v) SDS; 48 mM tris base; 29 mM glycine; 20% (v/v)
methanol) for at least 30 minutes at room temperature. Ten pieces of blotting
paper of identical size to the gel were also soaked in transfer buffer. Similarly,
one piece of nitrocellulose (Sartorius, Melbourne, Australia) or PVDF
(Millipore, Sydney, Australia) was cut to the exact size of the gel and soaked in
transfer buffer.

Five layers of blotting paper were placed onto the semi dry transfer apparatus
(Biorad, Hercules, CA, USA) followed by the nitrocellulose and then the gel

ve
Blotting paper (5 layers)
1 Gel
P V D F or nitrocellulose
Blotting paper (5 layers)
+ ve
F i g u r e 2.1: Arrangement for a semi-dry western transfer of proteins from
a gel onto a P V D F or nitrocellulose membrane. Five pieces of blotting paper
are layered followed by a sheet of P V D F or nitrocellulose membrane and then
the gel. Anotherfivelayers of blotting paper are then layered on top. All
components are cut to an equivalent size and are layered one piece at a time to
avoid trapping air bubbles.
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(Figure 2.1). Anotherfivelayers of blotting paper were then placed on top of

the gel. The transfer was run at 15 volts constant for approximately 30 min
(10% SDS PAGE gels) or 1 hour (15% SDS PAGE gels).

2.2.3.2 Immunolabelling western blots.
After proteins from SDS PAGE gels had been transfered to nitrocellulose or
PVDF membrane they were blocked with HDC for 1 hour at room temperature.

Membranes were incubated with the appropriate antibody, which was diluted i
HDC or in many cases consisted of TC sn from hybridoma cultures. In each

case, membranes were sealed in plastic bags, and then left on a shaker for 1
hour at room temperature.

The nitrocellulose strip(s) were then thoroughly washed in RO H2O before

being incubated in plastic bags with either sheep-anti-mouse Ig-HRP or shee
anti-mouse Ig-AP conjugated antibody at a dilution of 1:1000 in HDC for 1
hour at room temperature. The nitrocellulose strips were again thoroughly
washed in 0.5% (v/v) Triton X100 followed by RO H2O. Membranes labelled
with HRP were then developed using ECL (Pierce, Sydney), while membranes
labelled with AP were developed using ECF (Amersham, Sydney) as described
by the corresponding manufacturer's descriptions.
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2.2.4 Agarose gel electrophoresis reagents
* 6x Sample buffer: 0.25% (w/v) bromophenol blue
40% (w/v) sucrose
0.25% (w/v) xylene cyanol FF
Made in milliQ water, stored at 4°C

* Running buffer (50x): 242g/l Tris base;
57.1 ml/1 galacial acetic acid;
100 ml/1 0.5 M EDTA (pH 8.0).

2.2.5 Agarose gel electrophoresis
Agarose was dissolved in hot running buffer at the desired concentration. The hot
agarose solution was poured into the casting tray (BioRad, USA) and then the comb was
aligned and inserted. Once the agarose had set the comb was removed and the
electrophoresis chamber was filled with running buffer. Gels were electrophoresed at 70
volts until the dye front had migrated the appropriate distance down the gel.

2.3 Bacterial culture
2.3.1 General recipes
* 2YT media: 5 g/1 NaCl
16 g/1 Tryptone (Oxoid, Melbourne, Australia)
10 g/1 Yeast extract (Oxoid, Melbourne, Australia)
pH7.0 using5NNaOH
Sterilized by autoclaving
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* 2 Y T agar media:

Same as 2 Y T media + 15 g/1 of agar (Oxoid, Melbourne, Australia).

Sterilized by autoclaving

* Wash Buffer: 10% glycerol (v/v in RO water)
Sterilized by filtering or autoclaving

2.3.2 Freezing cells
Cells were pelleted and washed once in 10% glycerol. Cells were resuspended in 10%
glycerol before being stored indefinitely at -80°C.

2.3.3 Preparing electrocompetent DH5a cells
A fresh colony of DH5oc was innoculated in 5 ml of 2YT media and left to incubate
overnight at 37°C with shaking. The 5 ml culture was expanded to 250 ml by incubating
for 2-3 hours at 37°C until an OD550 of 0.8 was reached.

Cells were harvested at 4000 rpm for 10 minutes at 4°C and then resuspended in wash
buffer. Cells were pelleted once again and resuspended in 2 mL of wash buffer. 40 pi
aliquots were then aliquoted into sterilised Eppendorf tubes before being stored at
-80°C.
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2.3.4 Transformation of electrocompetent DH5 a cells
25 ng of plasmid DNA was mixed with a 40 ul aliquot of DH5a electrocompetent cells.
Cells were electroporated using a Biorad Gene Pulser with the following settings: 200
ohms, 25 uF, 2.5 kV.

Cells were left to recover for one hour in 2YT media at 37°C with no selection agent.
Cells were plated on petri dishes prepared with 2YT-agar +100 ug/ml ampicillin in
dilutions of 1/1, 1/10 and 1/100. Plates were incubated overnight at 37°C. Plate(s)
containing distinct colonies were stored at 4°C until needed.

2.3.5 Purification and analysis of plasmids from transformed bacteria
Transformed bacteria were streaked onto 2YT agarose plates containing the appropriate
selective agent and left to grow overnight at 37°C. The following morning plates were

analysed and typically 2-4 isolated colonies were selected and grown up in 5 ml liquid
2YT cultures. Plasmids were purified from transformed cultures using Qiagen miniprep columns following the manufacturer's instructions. Purified plasmid DNA was
then analysed by agarose gel electrophoresis to confirm its identity. Transformed
bacteria were frozen for later use.
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Producing stably transfected cell
lines that inducibly or
constitutively express h u m a n
clusterin.
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3.1 Introduction
Clusterin is found in most bodilyfluidswhere it presumably collects from the numerous
tissues/organs in which it is expressed. The expression of clusterin in healthy organs
appears to be restricted mainly to epithelial cells and in some cases highly specialized
cell types (Jordan-Starck et al, 1992). However in times of stress m a n y cells express
clusterin and the amount produced is significantly higher than is the case for nonstressed cells. For example, a seventeen-fold increase in clusterin m R N A occurs in
castrated rat prostate tissue (Bettuzzi et al, 1989). Similarly, clusterin expression is
increased four fold in tumours treated with toremifene (which induces apoptosis)
compared to control tumours (Huovinen et al, 1993), while in scrapie-infected brains of
hamsters clusterin expression is increased ten fold compared to non-infected brains
(Duguid et al, 1989). The timing of clusterin upregulation during cell death has led
some to believe that it is a cell death marker and predict that it m a y have a role in either
cell protection or cell death (Buttyan et al, 1989; Alitzky et al, 1992). However, there
are numerous reports that show cell death in the absence of clusterin expression. This
indicates that clusterin expression is not essential for cell death to occur (refer section
1.3; Jomary et al, 1995; Garden et al, 1991; Seiberg and Marthinuss, 1995).

In order to create transfected cell lines secreting clusterin, use was made of two diff
commercial expression systems. The Lac Switch expression system from Stratagene
(CA, U S A ) is comprised of two plasmids and allows controllable expression of any
desired protein for which c D N A is available (Figure 3.1). Protein expression is
controlled via the E.coli lactose operon in p O P R S VI. Repressor molecules transcribed
from p3'SS have a high affinity for the lactose operon which w h e n bound inhibit the
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Lac repressor proteins (LRP)
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Figure 3.1: The Lac Switch expression system produced by Stratagene (CA, USA).
Transfection with one plasmid, p3'SS, results in the endogenous production of lac repressor protein
which inhibits the lac promotor on pOPRSVI. The second plasmid, pOPRSVI, is introduced
containing a sequence coding for the desired protein, the expression of which is under the control of
lac operator sites. Once stably integrated into the genome of the transfected cells, the addition of
IPTG to the culture medium results in the inhibition of endogenous lac repressor molecules and thus
expression of the desired protein.
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transcription of the c D N A insert in p O P R S V I . Inducing agents such as I P T G interact
with repressor molecules to reduce their affinity for the lactose operon. The addition
an inducing agent therefore allows transcription of the cDNA insert to proceed (Figure
3.1).

The other expression system used was the p R c / C M V expression system (Invitrogen,
Leek, The Netherlands). This expression system provides extremely high levels of
protein expression due to the powerful cytomegalovirus promotor (Figure 3.2). This
system consists of only one plasmid and successful incorporation into the genome
results in constitutive expression of the inserted cDNA.

Ndel
485
Nrul
206

Noil

Pvul
4896

Bsml
3209

F i g u r e 3.2: The p R c / C M V expression system produced by Invitrogen (Leek, The Netherlands). This
system is comprised of only one plasmid and results in constitutive expression of the product coded by the
inserted c D N A .
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To create a negative control transfected cell line that expressed a non-relevant protein
the pEGFP-Nl expression system (Clonetech, CA, USA) was used. The pEGFP-Nl
expression system allows constitutive expression of the enhanced green fluorescent
protein (EGFP) in mammalian cells. The EGFP is derived from green fluorescent

protein (naturally produced by the bioluminescent jellyfish Aequorea victoria) and h

higher fluorescence intensity than the native protein. The CMV promotor that is pres
in the CMV/pRc expression system (Figure 3.3) is also present in the EGFP expression

system, providing high protein expression. This system was therefore used to act as a
negative control for the other expression systems encoding clusterin.
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Figure 3.3: The pEGFP-Nl expression system produced by Clonetech (CA, USA). This
system is comprised of only one plasmid and results in constitutive expression of EGFP.
Note this protein does not contain a secretion signal and therefore expressed protein
remains intracellular.
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3.2 Methods

3.2.1 Plasmid amplification and purification - The Lac Switch system plasmids (p'3
and pOPRSVI) were purchased from Stratagene (CA, USA). pRC-CMV was purchased
from Invitrogen (Leek, The Netherlands), pEGFP-Nl was purchased from Clontech
(CA, USA).

Plasmids were electroporated into DH5a cultures under conditions described in sect

2.3.4. Large cultures of successfully transformed bacteria were created and plasmi
were purified as described in section 2.3.5.

3.2.2 Electroporation of DNA into eukaryotic cells - Cells were grown to confluenc

and then washed twice in 50 ml of PBS to remove all calf serum. 5-10 ug of sterile

linearised plasmid was used per 0.5 - 1 x 106 cells. Plasmids were transfected int

by electroporation using a BioRad Gene Pulser (BioRad, Hercules, CA, USA) using th
following settings- 250 Volts; 96 uF.

The LacSwitch system plasmids, p3'SS and pOPRSVI (which contained full-length
clusterin cDNA previously prepared by Wilson, M.R., unpublished), were
electroporated into L929 cells and grown in the presence of 0.4 mg/ml hygromycin
(Calbiochem, Sydney, Australia) and 0.4 mg/ml Geneticin™ (Gibco Life Technology,
Melbourne). Cells were then cloned and screened as described below. As a control,

L929 cells were transfected with p3'SS, and pOPRSVI vector which contained the ful
length clusterin cDNA in reverse orientation.
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Full-length h u m a n clusterin c D N A had previously been ligated into the p R c / C M V
plasmid (Wilson M.R, unpublished). This plasmid was also electroporated into L929,
HeLa, and K562 cells under the same conditions as descibed above. Cells were cloned
(see below) and grown in media containing 0.4 mg/ml Geneticin™. As a control, cell
lines were also transfected with the pRc/CMV plasmid lacking an insert. Negative
control transfected cells that were resistant to Geneticin were selected at random.

The pEGFP-Nl plasmid was also electroporated into L929 cells under the same
conditions as described above. Cells were cloned and screened as described below and
were grown in media containing 0.4 mg/ml Geneticin.

3.2.3 Cloning of transfected cell lines - After transfection, cells were plated in 96
trays in DMEM:F12 containing 20% FCS and 20% FCM. Selective agents were added

two days after electroporation to kill cells that did not contain plasmid(s). When the
individual cultures had grown confluent they were screened by immuno-dot blotting TC

(refer section 3.2.4 below). Cells transfected with the pEGFP plasmid were screened fo
expression of EGFP by fluorescence microscopy.

Once positive colonies of cells had been identified they were cloned twice by limiting

dilution as described in (Davis et al, 1994). Briefly, cells were plated in 96 well tr

concentrations of either 1 cell per well or 0.5 cell per well. When colonies of cells
grown confluent they were screened before being cloned again or expanded for further
experimentation. Cells were not used for experimentation unless they had been cloned
twice.
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3.2.4 Screening of clusterin-expressing transfected cell lines - Immuno-dot blots; Cells

were grown to confluency in either 96 or 24 well trays and if required were induced to

express clusterin for 24 hours. 2 ul of TC sn from transfectant cells was adsorbed ont
nitrocellulose and left to dry. Nitrocellulose strips were then blocked with 1% HDC
followed by either G7 or DNP-9 TC sn. The secondary antibody was sheep-anti-mouseHRP antibody (Silenus laboratories, Melbourne, Australia) prepared at a dilution of
1:1000 in 1% HDC. All antibody and blocking steps were carried out for 1 hour on a
shaker at room temperature. Membranes were developed with ECL (Pierce, Sydney,
Australia) following the manufacturer's instructions.

Flow cytometry, fluorescence microscopy; L929 cells which were transfected with
pEGFP-Nl were trypsinized from culture vessels. 10,000 cells were analysed with a
flow cytometer (FACSort, Becton Dickinson, Sydney, Australia) and were compared to
wild type L929 cells to confirm EGFP expression. Transfected cells were also examined
through a Leitz DMJL inverted fluorescence microscope (Leica, Sydney Australia).
Photographs were taken through a Wild Photomat MPS45 camera system (Leica,
Sydney Australia).

3.2.5 Quantifying clusterin secretion by transfected cell lines- Immuno-dot blots wer
used to quantify clusterin secretion for different transfected cell lines. Cells were

innoculated into 24 well trays and left to adhere to the culture surface overnight. 3
of fresh culture media (+ 5 mM IPTG for L929 LS.clus) was then added to the cultures
and then left for 48 hours. TC sn were then collected and analysed by immuno-dot blot
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(as described above) and cells were trypsinized and counted using a haemocytometer.
Immuno-dot blots were analysed by densitometry (Biorad, Hercules, CA,. USA).

3.3 Results
3.3.1 Production ofL929 cell lines stably transfected with the Lac switch system
L929 cells transfected with the Lac Switch system containing human clusterin cDNA

has previously been described (Humphreys D., Honours thesis, 1994). In summary, cells

were transfected by electroporation and cloned twice by limiting dilution to ensure a
true clone was obtained. Immuno-dot blot analysis of TC sn probed with the G7 antihuman clusterin mAb identified clusterin secreting clones (Figure 3.4 A). Further
analysis of TC sn by western immunoblotting confirmed that secreted clusterin was
indistinguishable in size from clusterin purified from human serum (Figure 3.4 B).
These inducible clusterin-secreting cells were named L929-LS.clus(F), and the
corresponding controls which contain the clusterin cDNA in reverse orientation were
named L929-LS.clus(B). Examination by light microscopy did not reveal any
morphological differences between L929-LS.clus(F) cells induced to express clusterin
and either non-induced L929-LS.clus(F) cells or L929-LS.clus(B) cells.
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F i g u r e 3.4: (A) Dot blot analysis of T C sn from L929 LS.clus(F) clone showing that cells express
human clusterin when induced with IPTG. "x" indicates the position where media was dotted onto the
membrane. (B) Western immunoblot confirming that human clusterin is correctly processed in L929LS.clus(F) cells. Lane 1, 100 ng of pre purified clusterin purified from human serum; lane 2 and 3, T C sn
of L929-LS.clus(F) which had been induced for 24 hours. Lanes 1 and 2 were incubated with G 7 antibody
that only recognises human clusterin. Lane 3 was incubated with DNP-9, an isotype negative control
antibody. Arrows indicate the position of molecular weight markers. (Taken from D Humphreys Honours
Thesis, 1994).

3.3.2 Production ofL929 cell lines stably transfected with pRc/CMV.

The pRc.clusterin and pRc plasmids were linearised with Bgl II restric

before being electroporated into L929 cells. The selective agent Genet

was added to the growth medium two days after transfecting and plating

Transfected cells grew quickly and within 10 days there were enough ce
screening.

TC sn from individual wells containing transfected pRc.clus cells were screened by
immuno-dot blots probed with the G7 anti-human clusterin mAb. Initial
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performed on wells that contained viable cells. Clusterin-secreting cells were then

cloned (Figure 3.5 A). A total of thirteen colonies grew from the first round of clon

Analysis of the TC sn from each of these colonies revealed that they secreted differen
amounts of clusterin. The strongest clusterin secreting colony (E3) was cloned again.
The second round of cloning resulted in 12 colonies which each secreted a similar
amount of clusterin. Colony B3 was expanded and named L929-pRc.clus (Figure 3.5
A). Clusterin secreted from L929-pRc.clus was indistinguishable from purfied human
serum clusterin on western immunoblots and had a molecular mass of about 80 kDa
under non-reducing conditions and about 40 kDa under reducing conditions (Figure 3.5
B).

Similarly, pRc transfected L929 cells that did not secrete human clusterin were clone
twice by limiting dilution and one of these colonies of cells was expanded and named
L929-pRc. These cells were used as the control cell line for L929 pRc.clus cells.
Examination by light microscopy did not reveal any morphological differences between
L929-pRc.clus and L929-pRc cells.

The Lac Switch expression system uses the RSV promotor, which is weaker than the
cytomegalovirus promotor used by the pRc/CMV system. TC sn from L929-LS.clus(F)
and L929-pRc.clus cells were analysed to estimate the amount of clusterin produced by
each expression system. Initially, cells were grown in serum-free media in order to
maximise the amount of clusterin in the TC sn binding to the dot blot membrane.
However, when transfected cell lines were grown in serum-free media for 24 hours no
clusterin could be detected. Therefore immuno-dot blot comparisons was performed on
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F i g u r e 3.5; (A) The clone history of the L929-pRc.clus transfectants. Each rectangle
represents a plating of cells and the number enclosed represents the number of colonies that
grew in that plating. Bold underlined text represents the plate position of a colony which
was screened and selected for subsequent cloning. Arrows indicate cloning, generally two
rounds of cloning were performed on the selected colony. The text underneath each
rectangle represents the plate position of the parental colony and the concentration of the
plating, ie {1} = 1 cell/well; {0.5} = 0.5 cells/well (refer 3.2.3). (B) Analysis of L929pRc.clus T C sn by western immunoblotting demonstrates that cells secrete correctly
processed human clusterin. Lane 1 and 3, 100 ng purified serum clusterin; Lane 2 and 4,
L929 pRc.clus T C sn. Lanes 3 and 4 were electrophoresed under reducing conditions. Note
that the intensity of the reduced clusterin bands are considerably less than non-reduced
bands due to poor recognition by the G 7 anti-clusterin antibody. Arrows indicate the
position where molecular mass markers migrated to.
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transfected cells T C sn samples which contained 1 0 % F C S (Figure 3.6). T o compensate
for the amount of serum binding to the membrane, clusterin standards were also made
up in growth media containing 10% FCS. Densitometer analysis of the dot blots
estimated that L929-pRc.clus cells secreted about 0.2 pg of clusterin per cell over
hours while L929-LS.clus(F) cells secreted about 4 fg of clusterin per cell over 48

Therefore, L929-pRc.clus cells secrete human clusterin at a rate about 50x that of I
induced L929-LS.clus(F) cells.

(i)

(ii)

Sample 1 W

Sample 2 * §

Sample 3
Figure 3.6: Immuno-dot blots of triplicate TC sn samples obtained from (i) L929-pRc.clus cells or (ii)
induced L929-LS.clus cells after 48 hours growth. Clusterin standards were also dotted onto the same
membrane before probing with the anti-clusterin G 7 antibody (not shown). Densitometer analysis of these
dots indicated that L929-pRc.clus cells secreted approximately 50 x more human clusterin than L929LS.clus cells.
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3.3.3 Production ofHeLa

cell lines stably transfected withpRc/CMV.

The pRc/CMV plasmids were transfected into HeLa cells by electroporation. The
selective agent Geneticin (400 ug/ml) was added to the growth medium two days after

transfecting and plating of the HeLa cells. Transfected cells grew slowly because cells
did not grow in a monolayer, but rather they grew in clumps forming nodules. Cells
were therefore regularly trypsinized to maintain a monolayer of cells which enhanced
growth.

TC sn from individual wells containing transfected HeLa-pRc.clus cells were screened
by immuno-dot blots probing with the G7 mAb. Initial screening of the first round
clones indicated that 4 of the 96 wells contained cells which constitutively secreted

clusterin (Figure 3.7 A). Cells from one of these wells (Hll) was then cloned. After the
first round of cloning 6 of the 14 wells in one tray contained cells which secreted
clusterin. Each clone secreted different amounts of clusterin. The strongest secreting
clone (G7) was cloned for the second time. The second round of cloning isolated clones
which secreted a similar amount of clusterin (Figure 3.7 B). Cells growing in well E4
were expanded and named HeLa-pRc.clus (Figure 3.7 A). HeLa-pRc transfected cells
containing no clusterin cDNA were also created by electroporation and cloned twice by
limiting dilution.
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F i g u r e 3.71 (A) The clone history of the HeLa-pRc.clus transfectants. Each rectangle
represents a plating of cells and the number enclosed represents the number of colonies that grew
in that plating. Bold underlined text represents the plate position of a colony which was screened
and selected for subsequent cloning. Arrows indicate cloning, generally two rounds of cloning were
performed on the selected colony. The text underneath each rectangle represents the plate position
of the parental colony and the concentration of the plating, ie {1} = 1 cell/well; {0.5} = 0.5
cells/well (refer 3.2.3). (B) Analysis of HeLa-pRc.clus T C sn by immuno-dot blot demonstrating
that transfected cells secrete more h u m a n clusterin compared to H e L a W T cells, "x" represents the
positions where T C sn were dotted. Clusterin was detected with the G 7 m A b .

3.3.4 Production ofL929 cell lines stably transfected

withpEGFP-Nl.

pEGFP-Nl plasmid was purified from transformed DH5oc bacteria and then linearised
with Dra HI restriction enzyme. The pEGFP-Nl plasmid was transfected into L929 cells
by electroporation. The selective agent Geneticin (400 ug/ml) was added to the growth
medium two days after transfection and plating of the L929 cells. Electroporated cells
grew quickly and wells containing cells expressing EGFP were identified by
fluorescence microscopy within four days.

Transfected cells were cloned twice by limiting dilution (Figure 3.8 A), and the final
clone from well C2 was expanded and called L929-EGFP. These cells express high
levels of GFP protein which was easily visualised by fluoresence microscopy (Figure
3.8 B). Interestingly, there were variations in the level of EGFP production within
cultures of cloned cells. Flow cytometric analysis of the C2 clone shows a broad green
fluorescent peak which ranges from negligible fluorescence (ie same fluorescence as
L929 wild type cells) to approximately 10-100 fold brighter green fluorescence than

L929 wild type cells (Figure 3.8 C). The C2 cell line was maintained for long periods o

time (months), and throughout this time the cells did not lose their ability to produce
EGFP. The reason(s) for this wide cariation in the levl of expression of EGFP in

individual transfected cells is uncertain. Examination by light microscopy did not rev
any morphological differences between L929-EGFP and the parental L929 cell lines.
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F i g u r e 3 . 8 : (A) The clone history of the L929-EGFP transfectants. Each rectangle represents
a plating of cells and the number enclosed represents the number of colonies that grew in that
plating. Bold underlined text represents the plate position of a colony which was screened and
selected for subsequent cloning. Arrows indicate cloning, generally two rounds of cloning were
performed on the selected colony. The text underneath each rectangle represents the plate position
of the parental colony and the concentration of the plating, ie {1} = 1 cell/well; {0.5} = 0.5
cells/well (refer section 3.2.3). (B) Fluoromicrograph of L929-EGFP cells (x400). (C) Flow
cytometry analysis showing the fluorescence of L929-EGFP cells (thick, green line) versus the
fluorescence of wild type L929 cells (thin, black line). Most L929-EGFP cells have high green
fluorescence compared to L929 wild type cells due to the expression of E G F P .
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3.3.5 Production ofK562 cell lines stably transfected with

pRc/CMV.

The pRc.clus and pRc plasmids were transfected into K562 cells by electroporation. The
selective agent Geneticin (400 p.g/ml) was added to the growth medium two days after

transfecting and plating the K562 cells. Electroporation resulted in the death of a la

number of cells. Surviving cells grew very slowly. Dot blot analyses did not detect any
secreted clusterin in TC sn of electroporated K562 cells. This procedure was performed
many times without success. The reason(s) for the inability to produce clusterinsecreting transfected K562 cells are uncertain.

3.4 DISCUSSION:
This chapter described the transfection of L929 and HeLa cell lines with expression
systems containing human clusterin cDNA. The Lac Switch expression system and the
pRc/CMV expression systems were both trialled in L929 cells while the latter was only
used in HeLa cells. The Lac Switch expression system is comprised of two plasmids,
p3'SS and pOPRSVI, and allows controllable expression of inserted cDNA. Human
clusterin cDNA had previously been inserted into pOPRSVI in the two possible
orientations, foward (sense information allowing expression) and reverse (non-sense
information, no expression).

L929 cells were transfected by electroporation with either of the expression systems
before being cloned twice by limiting dilution. The final secondary clones secreted
human clusterin which had a molecular mass of 75 - 80 kDa under non-reducing
conditions and a molecular weight of 40 kDa under reducing conditions (ie
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indistinguishable from purified clusterin from h u m a n serum). This indicates that the
murine L929 cell line can secrete human clusterin that is glycosylated and
proteolytically processed.

Negative control cell lines were also made. In the case of the Lac Switch expression
system, the negative control consisted of transfected cells containing pOPRSVI in which

clusterin was present in the reverse orientation (called L929-LS.clus(B)). In the case o
the pRc/CMV expression system, the negative control consisted of transfected cells
containing pRc plasmid with no clusterin insert (called L929-pRc). These cells were
transfected by electroporation and as these cell lines could not be screened for protein
expression they were selected solely on the basis of their ability to grow in selective
agents. The morphology of the transfected L929 cell lines were identical to the parental
L929 cells.

L929-pRc.clus cells were expected to express more clusterin per cell than L929LS.clus(F) cells due to the powerful CMV promotor. Immuno-dot blot comparisons of
TC sn confirmed this. L929-pRc.clus cells secreted about 0.2 pg of clusterin per cell
over 48 hours while IPTG-induced L929-LS.clus(F) cells secreted about 4 fg of
clusterin per cell over 48 hours.

There are two previous reports of other transfected cells lines which over-express
clusterin (Pilarsky et al, 1993; Sensibar et al, 1995). Pilarsky et al. transfected baby
hamster kidney (BHK-21) cells with the vector pBEH in which canine clusterin cDNA

was inserted. The parental cell line was reported not to naturally express clusterin und
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normal culturing conditions. However, the question of whether these cells secreted
endogenous clusterin when stressed was not addressed. The transfected cell line

constitutively expressed high levels of canine clusterin (Pilarsky et al, 1993). Sensibar
et al. (1995) transfected LNCaP cells (a human prostatic cancerous cell line) with the
vector pBK/CMV in which mouse (SGP-2) clusterin cDNA was inserted. There was no
indication as to whether the parental LNCaP cells secreted endogenous clusterin under
normal culturing conditions or when cells were stressed. However the transfected cell
lines constitutively expressed high levels of mouse clusterin. The rate of clusterin
secretion by each of these transfectant cells was not determined. The expression of
clusterin by these transfected cell lines was found not to affect cell morphology or

viability indicating that the expression of clusterin did not cause cell death (Pilarsky
al, 1993; Sensibar etal, 1995).

The level of naturally produced clusterin mRNA in L929 cells is low under normal
culturing conditions (Kyprianou et al, 1991). However, the high level of human

clusterin expression did not appear to affect morphology or viability, as judged by ligh
microscopy. As found in other transfected cell types the high levels of clusterin
expression in L929 cells under normal culture conditions did not result in death. The

effect of clusterin expression on stress-induced cell death was also of interest and the
findings of this study are described in chapter 4.

The L929-EGFP transfectants were created to act as another negative control for the
clusterin-expressing cells. This cell line was created by electroporating the pEGFP-Nl
construct into L929 cells. This construct, like the pRc/CMV expression system,
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contained a C M V promotor. However the p E G F P - N l expression system differed from

those used to express clusterin in that the cDNA for EGFP contained no secretion signal
and thus when expressed the protein remained intracellular, which enabled quick
screening by flow cytometry and fluorescence microscopy.

The pRc/CMV expression system was also transfected into HeLa and K562 cell lines.
Clusterin was secreted at high levels by HeLa cell transfectants and these cells were
called HeLa-pRc.clus. The control cell line that contained the pRc/CMV expression
system without the cDNA insert was called HeLa-pRc. Unfortunately no K562
transfectants were produced. In each attempt cultures grew very slowly in the presence
of selective agents, and no clusterin was ever detected in TC sn. It is possible that
levels of clusterin expression cells are toxic in K562 cells.

In conclusion, various L929 cell lines were created that secreted different levels of
human clusterin. L929-LS.clus(F) cells expressed human clusterin only upon the
addition of IPTG while L929-pRc.clus cells constitutively expressed high levels of
clusterin. L929-pRc.clus cells secreted approximately 50x more clusterin than L929-

LS.clus(F) cells into the TC sn. The morphology and viability of each of these cell li

was not affected by human clusterin expression. These cells lines are useful tools for
analysis of clusterin's effects on cell death (Chapter 4).
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CHAFFER 4
M o d e of L929 cell death in
response to various cytotoxic
agents and effects of clusterin
overexpression.
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4.1 INTRODUCTION
4.1.1 The morphology of cell death

The inevitable death of cells within the body is a frequent event that can occur eithe
when cells come in contact with damaging external stimuli or as a planned event
whereby the body directly instructs cells to die. Necrosis is a term used to describe

uncontrolled cell death that occurs when cells are exposed to external noxious stimuli

Apoptosis describes cell death that results from a specific signal(s) directed to a ce
in turn activates a complex cascade of intracellular reactions. Apoptosis and necrosis
distinguished by morphological and biochemical criteria.

The distinguishing morphological characteristics of apoptosis include condensed,
fragmented cell nuclei, reduction of cell volume and cell membrane blebbing (Figure
4.1 A). The blebbing of the cell membrane leads to the formation of apoptotic bodies.
Apoptotic bodies hold fragments of the cells such as organelles, DNA, and cytoplasm
and allow for quick phagocytosis by other cells such as macrophages where they are
broken down and/or recycled (refer Savill et al, 1993). The formation of apoptotic

bodies partly explains how the cell decreases in size. The reduction of cell volume may
also results from a loss of water and ions (Cohen, 1993).

In contrast, the distinguishing morphological characteristics of necrosis include
pronounced swelling of the nucleus, mitochondria and cell membrane (Figure 4.1).
These characteristics result because the cell cannot maintain homeostasis. Eventually
the swelling of the cell results in the rupture of the outer cell membrane releasing

cellular contents into the surrounding tissue. Also released are noxious compounds tha
provoke inflammation of the local tissue.
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Figure 4.1: The typical morphological cascade of events that occur during
apoptosis and necrosis. (A) Apoptosis results in condensation of the cell volume
through the loss of water and ions. The nucleus also condenses and fragments. The
outer cell membrane begins to bleb, fragmenting the cell into apoptotic bodies.
Apoptotic bodies are thought to be recognised and phagocytosed by macrophages
or other cells. Throughout apoptosis the cell membrane integrity is retained. (B)
Necrosis is initiated from the exposure of a toxic insult that initially causes
reversible swelling of the cell. Continued presence of the insult results in
irreversible swelling of the cell and pronounced swelling of the mitochondria and
nucleus. Thisfinallyresults in cell rupture and total disintegration of the cell.
Figure modified from Boehringer internet catalogue
(http://biochem.roche.com/techserv/apoptosis/slide 1 .html).
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4.1.2 The molecular biology of apoptotic cell death
The molecular biology of apoptosis is complex cascade of events. Vaux and Strasser
(1996) suggest the categorization of these events into phases called the stimulus,
activation, effector, and post mortem phases. The stimulus phase describes the events
where the apoptotic signal is presented to the cell, which may be in the form of a drug,

toxin or the activation of cell surface receptor(s). The activation phase describes even
that detect the stimuli and transmit this signal through a cascade of reactions which in

turn activates the effector phase. The effector phase involves the activation of proteas
and other destructive events which initiate the physical death of the cell, while the
postmortem phase describes the events which cause the morphological features of
apoptosis as described above (section 4.1.1, Figure 4.1).

There are a wide variety of signals that are known to induce apoptosis in many different
cell types. However, signals that induce apoptosis in one cell type do not necessarily

induce apoptosis in another cell type and this indicates that the events that occur in th
stimulus and activation phases may be cell-type specific. On the other hand the events
that occur in the effector phase are thought to be similar between cell types (Vaux and
Strasser, 1996). The effector phase includes the activation of numerous cysteine
proteases that are mammalian homologues to ced-3 found in the nematode
Caenorhabditis elegans (Nicholson and Thornberry, 1997). These proteases are called

caspases and require specific cleavage of their tetrameric polypeptide chain that create
two active heterodimeric enzymes, each consisting of a small and large chain (Salvesen

and Dixit, 1997). Of the fourteen caspases that have been identified three (caspases 3, 2

10) appear to be essential for the effector phase in apoptosis (Nicholson and Thornberry,
1997). Caspases 6, 7, and 8 also appear to be involved in apoptosis and are thought to
promote various protein cascades, while the other caspases are involved in the

activation of proinflammatory cytokines (Salvesen and Dixit, 1997).

Mitochondria have also recently been identified as an important regulatory element of
apoptosis. Mitochondria of apoptotic cells have been shown to undergo a large
reduction in the mitochondrial membrane potential (Kroemer et al., 1997), which is
thought to result from a phenomenon called permeability transition (an increase in the
permeability of the inner mitochondrial membrane) (Zamzami et al, 1995).
Mitochondrial proteins have also been shown to be released from mitochondria into the
cytosol during apoptosis. Cytochrome c and apoptosis inducing factor (AIF) are two
such proteins and are important for the apoptotic pathway to proceed. AIF is capable of
inducing apoptosis in many cell types (Zamzami et al, 1996) and is thought to play a
key role in apoptosis as it can induce nuclear condensation and fragmentation in the
absence of other cytosolic components (Susan et al, 1996). Cytochrome c has been
shown to trigger the activation of caspase-3, which then triggered events required to
induce DNA fragmentation (Kluck et al, 1997a,b; Liu et al, 1996). It is unclear at

present whether the release of such proteins from the mitochondria is directly linked t
the reduction of mitochondrial membrane potential or permeability transition. However,
the events that lead to the disruption of mitochondrial membrane potential appear to be

linked to the effector phase, especially as this only occurs in cells that are committe
apoptotic cell death (Kroemer et al, 1997).

In contrast necrotic death does not involve any protein activation or regulatory events

This is because cells are exposed to situations that are intolerable and therefore unde
rapid death caused by the inactivation of basic cell functions.
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4.1.3 Biochemical properties of apoptotic cells
The changes that occur in the late stages of apoptosis (postmortem phase) are unique

and can be exploited to specifically identify apoptotic from healthy or necrotic cells

Biochemical characteristics of apoptotic cells that are not found in necrotic or healt

cells include an increase in cell membrane permeability, exposure of phosphatidylserin
(PS) on the outer surface of the cell membrane, mitochondrial depolarisation, and
internucleosomal fragmentation of chromosomal DNA (Gorman etal, 1994). Each of
these characteristics along with the changes in cell morphology are routinely used to
identify apoptotic cells. Unfortunately most studies only analyse one or possibly two
characteristics to determine apoptosis.

The membranes of apoptotic cells have been shown to be more permeable to small
molecules than healthy viable cells, but yet less permeable than membranes of dead
cells. This was demonstrated with the use of small fluorescent dyes which are

impermeable to healthy cells but freely pass into dead cells and stain apoptotic cells
an intermediate level (Schmid et al, 1994; Dive et al, 1992; Zamai et al, 1996;
Idziorek et al, 1995; Lyons et al, 1992). However, the reason for the increase in cell
membrane permeability during apoptosis are unclear. Structural changes to the outer
membrane such as the redistribution of PS to the outer leaflet of the membrane may
explain in part the increased permeability.

PS is a negatively charged phospholipid that is an important membrane component of

mammalian cells (Alberts, 1989). In healthy cells PS is confined to the inner leaflet o

the plasma membrane; however, during apoptosis, PS redistributes to the outer leaflet o

the plasma membrane (Martin et al, 1995). It has been proposed that PS acts as a ligand

that is recognized by macrophages and instucts them to remove the dying cell (Fadok et
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al, 1992a,b).

The nucleus is another organelle that undergoes dramatic changes in thefinalstages of
apoptosis. Chromosomal DNA of the nucleus is normally tightly wound about proteins
called histones (approximately 180 bp per histone) to form nucleosomes (Alberts,
1989). In apoptotic cells, exposed DNA that links nucleosomes together is cut by
activated endonucleases which results in mono and oligonucleosome fragments (Wyllie,
1980: Nature). DNA is initially cleaved into >700 and 200-250 kbp size fragments by a
Mg2+ dependent enzyme (Sun and Cohen, 1994; Oberhammer et al, 1993), before being
further degraded into multiples of 200 bp fragments. Analysis of DNA from apoptotic

cells was the initial technique used to identify apoptotic cells as electrophoresis o
fragmented DNA resolves a characteristic "DNA ladder" (Wyllie, 1980). The reason(s)
for the fragmentation of DNA is not clear but it may be a method by which the cell
makes sure no "readable" DNA escapes and transfects other cells. This would be
undesirable especially if the dying cell contained viral information, or if the DNA
induced an autoimmune response (Peitsch et al, 1994). The thorough fragmentation of

DNA is obviously irreversible and therefore the completion of this step guarantees ce
death. DNA laddering is now considered to be one of the hallmarks of apoptosis.

4.1.4 TNFa induced death in L929 cells

The high level of interest in the field of apoptosis has lead to identification of man
agents that cause apoptosis. TNFa, a cytokine secreted by many cell types, is capable

inducing apoptosis in several cell lines (Sarraf, 1994). It is also capable of causing

necrosis in tumours (hence its name) while not affecting "normal" cells in surrounding

tissues (Sarraf, 1994). Many studies use the L929 mouse fibrosarcoma cell line to test
the cytotoxic effects of TNFa (Flick et al, 1984; Levesque et al, 1995; Mishra et al,
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1995; Trost et al, 1994). Independent studies analysing the m o d e of cell death in L929
cells have reported TNFa to induce either necrosis (Schulze Osthoff et al, 1992;
Grooten et al, 1993) or apoptosis (Fady et al, 1995; Kyprianou et al, 1991).

TNFa interacts with cells through two cell surface receptors known as TNF-R1 and
TNF-R2. The high affinity type I (TNF-R1) receptor is 55 kD while the low affinity

type II receptor (TNF-R2) is 75 kD (Sarraf, 1994). The extracellular domains of these
receptors have three or four subdomains with a strong conserved pattern of cysteine

residues (Loetscher et al, 1990; Schall et al, 1990). Sequence analysis reveals that t

extracellular domains of the TNF receptors are most similar to the extracellular doma
of NGF-R and FAS, while their cytoplasmic domains show no homology to any known
protein (Schall et al, 1990; Loetscher et al, 1990).

As TNFa can bind up to three receptors it was proposed that receptor aggregation is

required to activate an intracellular signal (Song et al, 1994). This theory has been
supported by studies using transfected L929 cells that contain constructs for
chloramphenicol acetyltransferase (CAT), a well known cytosolic trimeric protein,
linked to TNF-R1. The inducible expression of CAT-TNF-R1 led to forcible
trimerisation of the TNF receptors which resulted in cell death, just as if TNFa had
been used (Fiers et al, 1996). Intracellular signalling resulting from the activation
TNF-R1 is initiated by the death domain protein called TRADD, which recruits other
recently identified proteins called RIP, TRAF2 and FADD/MORT1 (Kronke et al,
1996 and references therein). FADD/MORT1 recruits caspase-8 or caspase-10 to this
assembly where either is proteolytically activated (Boldin et al, 1996; Muzio et al,
1996; Vincenz and Dixit, 1997).
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One of the earliest events detected following the treatment of cells with T N F a is an

increase in protein phosphorylation (Van-Lint et al, 1992). The most prominant protein
that is phosphorylated is HSP25/27 (Mehlen et al, 1995). Van-Lint and colleagues
(1992) demonstrated that TNFa treatment of L929 cells results in the stimulation of
numerous serine and threonine protein kinases, which included two MAP kinases. The
stimulation of MAP kinases is thought to be important because they have not only been

shown to phosphorylate proteins in the cytosol but are responsible for the activation

various nuclear transcription factors (Fiers et al, 1996). For example, p38 MAP kinase
is activated in TNFa treated L929 cells and is responsible for the activation of an

unknown nuclear transcription factor required for interleukin-6 expression (Beyaert R
al, 1996). While the activation of various MAP kinases has been shown to be essential
for the activation of cell death, their activation alone does not necessarily result
death. One such example is Jun kinase, a member of the mitogen-activated protein
kinase (MAPK) family. This is activated in L929 cells following TNFa treatment
(Gardner and Johnson, 1996) and is essential for cell death to occur (Kronke et al,

1996). Co-treating cells with fibroblast growth factor-2 diminishes the cytotoxic effe

of TNFa but does not inhibit the activation of Jun kinase (Gardner and Johnson, 1996).

The TNF signalling cascade also involves lipids, as ceramide production is increased i
TNFa-treated L929 cells (Hayakawa et al, 1996; Jayadev et al, 1997). Ceramide is
produced from the sphingomyelin pathway and is a product of the hydrolysis of
sphingomeylin (Kronke et al, 1996). Activation of the sphingomeylin pathway involves
other unknown reactions which result in an increase of arachidonic acid (AA)
production and may require cytosolic phospholipase A2 (Jayadev et al, 1994; Jayadev
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et al, 1997). Research comparing the effects of T N F a treatment on wild type L929

cells to the TNFa resistant L929 cell line, C12, revealed that the production of AA
hence ceramide, are crucial to activate cell death (Jayadev et al, 1997).

Mitochondria have been proposed to be the first targets of TNFa damage (Hennet et al
1993; Schulze-Ostoff et al, 1993). In L929 cells, TNFa treatment has been shown to
generate reactive oxygen species (ROS) in the mitochondria (Schulze-Osthoff et al,

1992) which is dependent on the presence of glutamine (Goossens et al, 1996). It has

been suggested that ROI generated in TNFa-treated L929 cells are the cytotoxic agen
as the addition of antioxidants and iron chelators counteract the effects of TNFa

(Schulze-Osthoff et al, 1992; Goossens et al, 1995). ROI have also been implicated a
causing DNA damage in TNFa-treated L929 cells (Shoji et al, 1995).

The mode of death in L929 cells exposed to TNFa has previously been reported to be

either apoptotic (Fady et al, 1995; Kyprianou et al, 1991; Tomasovic et al, 1994) or
necrotic (Schulze Osthoff et al, 1992; Grooten etal, 1993; Schulze Osthoff et al,
1993; Goossens et al, 1996). These claims have been based on studies of DNA
fragmentation and general cell morphology. This chapter describes research which

analysed a variety of L929 cell characteristics to help distinguish the mode of TNFa
induced death. The parameters studied included changes in membrane permeability (7AAD), redistribution of PS to the cell surface, DNA fragmentation, and general cell

morphology. In addition, transfected L929 cells which secrete high levels of cluste
were also examined to determine whether clusterin expression had any effects on
TNFa-induced cell death.
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4.2 MATERIALS AND METHODS
4.2.1 Materials - Actinomycin D (Act D ) , 7-aminoactinomycin D (7-AAD), acridine
orange (AO), propidium iodide (PI), staurosporine, colchicine and azide were all
obtained from Sigma (St. Louis, MO, USA). Annexin V-FLUOR (FITC conjugate) was
obtained from Boehringer Mannheim (Sydney, Australia). Recombinant human TNFa

was a gift from Dr D Rathgen (Peptide Technology Ltd, Sydney, Australia). TGF(3 was

purchased from Sigma. All other general chemicals were purchased from Sigma or Ajax
Chemicals (Sydney, Australia).

4.2.2 Tissue culture - Cells were seeded into 24 well plates and left to aclimate f

least 16 hours before being treated. To induce death, cells were incubated with one
the following; 100 ng/ml of recombinant human TNFa, 100 ng/ml TNFa + 4 pg/ml Act
D, 2 uM colchicine, 1 uM staurosporine, or 0.6% (w/v) sodium azide. After various
durations, media containing non-adherent (floating) cells were removed while the
remaining adherent cells were incubated with trypsin/EDTA for 5 minutes at 37°C to

remove them from the plastic. Both populations of cells were pooled before staining

When testing for (i) the effects on cell survival of secreted proteins adsorbed to

culture vessel surface, or (ii) the expression of clusterin at the cell surface, adh
cells were removed from the plastic surface by removing the culture medium and
overlaying the cells with 0.5x PBS/EDTA (refer 2.1.1). After a 5-10 min incubation,
cells were removed by vigorous washing with 0.5x PBS/EDTA.

4.2.3 Flow cytometry - Flow cytometry data was collected using a Becton Dickinson
FACSort and analysed using CELLQuest software (Becton Dickinson, Sydney,
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Australia). For each flow cytometric analysis, data were acquired for 10,000 events.

4.2.3.1 Determining the rate of death in L929 cells caused by each cytotoxic
agent- Cells were seeded into 24 well tissue culture plates for 16 hours before
treatment. Cells were treated with each cytotoxic agent and at various time
points, remaining adherent cells were removed with trypsin and pooled with
non-adherent cells before being stained with 1 pg/ml PI in PBS for 10 minutes
and analysed by flow cytometry. Viable cells were identified by their lack of
staining with PI.

4.2.3.2 Membrane permeability of cells- The red fluorescing nuclear stain 7AAD was used to discriminate between dead, apoptotic and viable cells, as
described in (Schmid et al, 1994). To summarise, cells were washed in PBS
and then resuspended in a small volume (50 ul) of PBS containing 20 ug/ml of
7-AAD and incubated in the dark on ice for 20 minutes. Cells were then
resuspended in 100 - 500 ul of PBS before being analysed by flow cytometry.
In some cases experiments only required discrimination of viable and dead
cells. In these cases cells were stained with 1 ug/ml of PI for 5 minutes and
then immediately analysed by flow cytometry.

4.2.3.3 Phosphatidylserine exposure- The fluorescent FITC-labelled annexin
V protein (Boehringer, Sydney, Australia) was used to identify the presence of
PS on the outer cell membrane. Cells were washed in annexin V buffer (10
mM Hepes, 140 mM NaCl, 5 mM CaCl2) and then resuspended in a small
volume of annexin V buffer containing annexin V (according to the
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manufacturer's description) and 7 - A A D (1 ng/ml). Dead cells (cells which
were most permeable to 7-AAD) were electronically gated out from the
analysis.

4.2.3.4 Nuclear DNA content- Nuclear DNA content was assayed with

propidium iodide (PI) as described in (Nicoletti et al, 1991). Briefly cells we
washed and pelleted in PBS before being permeabilized with 0.3% Triton X100 (in PBS) overnight at 4°C. The following morning permeabilised cells
were stained with 1 ug/ml of PI before being analysed by flow cytometry.

4.2.3.5 Determining the level of intracellular clusterin- In one type of
experiment it was necessary to establish the level of intracellular clusterin

live versus dead cells in the same culture. This was done in the following way

For each test, 2.5 x 10^ cells were pelleted by centrifugation, resuspended in
ul of 20 ug/ml 7-AAD in PBS, and incubated on ice for 20 min. The cells were
then washed 3x with cold PBS and permeabilized by resuspension in 1 ml of
ice cold 50% (v/v) ethanol in PBS, followed by vortexing for 1 min and

incubation on ice for a further 4 min. The cells were then washed 3x with cold
PBS before incubating them with G7 MAb or a control MAb, followed by a
sheep-anti-mouse Ig-FITC (SaMIg-FITC) conjugate (Silenus Laboratories,
Melbourne, Australia). Dead cells were discriminated by their high red

fluorescence, while cells that in culture still had an intact cell membrane we
discriminated by their relatively low red fluorescence.
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4.2.3.6 Determining the amount of L929-pRc.clus cell surface clusterinCells were removed from TC flasks by constantly withdrawing and dispelling
large volumes of 0.5x PBS/EDTA over the culture vessel surface. Cells were
washed 3x with cold PBS. Cells were then incubated with G7 Mab or a control
Mab, followed by a SaMIg-FITC conjugate before being analysed by flow
cytometry.

4.2.4 Analysis of DNA fragmentation- To isolate DNA, 2-3 xlO6 cells were washed in
PBS before being lysed in 0.5 ml of 10 mM Tris, 6 mM EDTA, 0.5% SDS (w/v), pH

8.0, containing 300 p.g/ml of proteinase K (Bresatec, Adelaide). Lysates were incu
for 16 hours at 55 C before being subjected to two phenol:chloroform extractions
followed by one chloroform extraction (as described in Kyprianou et al, 1991). DNA

was precipitated from the extracts by adding two volumes of cold 100% ethanol, 1/1
volume of 3 M sodium acetate and 1/100 volume of 1 M magnesium chloride followed
by overnight incubation at -20°C. DNA was pelleted at 13,000 rpm in a bench top

microfuge before being washed in cold 80% (v/v) ethanol, air dried and then rediss
in 20-50 ul of 10 mM Tris, 1 mM EDTA, pH 8.0, and quantified by A2goContaminating RNA was removed by adding 2 ul of RNAse cocktail (Bresatec,

Adelaide, Australia) to each DNA sample and incubating for 1 h at 37 C. Purified D

was subjected to electrophoresis on 1.6% agarose gels and, after staining with eth
bromide (0.5 ug/ml), visualized with a Novaline gel documentation system (Novex,
Sydney).
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4.2.5 Microscopy- L929 cell morphology in response to various treatments was studied
using a Leitz Diavert white light inverted microscope (Leica, Germany). Cells were
observed in cultures without the aid of stains. For the examination of nuclear
morphology, cells were removed from flasks with trypsin before being stained with 5
pg/ml of acridine orange and then being washed twice with PBS. Micrographs and
fluorographs were taken on a Wild MPS45 photoautomat system through a Leitz DMIL
(Leica, Germany) inverted fluorescence microscope following the manufacturer's
instructions.

4.2.6 Preparation of cell ly sates, fluoro-imaging and dot blot assays- To prepare

cytoplasmic fractions (i.e. cytosol plus ER/Golgi), cells were lysed in TTX buffer (2
mM Tris HC1, pH 8.0, 100 mM NaCl, 0.2% Triton X-100) on ice for 15 min (Reddy et

al, 1996). The ly sates were centrifuged at 10,000 rpm in a microfuge for 5 min and t
supernatants mixed 1:1 with sample buffer (SB; 0.5 M Tris.Cl, 20% (v/v) glycerol, 5%
(w/v) sodium dodecyl sulfate, 0.005% bromophenol blue, pH 6.8) and electrophoresed
on 10% SDS polyacrylamide gels. Nuclear extracts were made as described in (Reddy
et al, 1996); briefly, cell were lysed as above and the total lysate overlayed on a
cushion of 10% sucrose in TTX buffer before centrifuging at 800 g for 10 min. The
pelleted nuclei were resuspended in SB and boiled for 5 min before loading on to 10%
SDS polyacrylamide gels and electrophoresis. Total cell extracts were prepared by

washing cells once in PBS, and then lysing them directly in SB and boiling them for 1
min before loading on to SDS polyacrylamide gels. Samples separated by SDS/PAGE
(refer 2.2.2) were electrophoretically transferred to nitrocellulose membrane as
described in section 2.2.3. Fluoro-imaging was performed using a Storm 840
fluoroimager (Molecular Dynamics, Sunyvale, CA, USA) and all data analyses carried
out using the ImageQuant^M software (Molecular Dynamics, Sunyvale, CA, USA).
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4.2.7 Electroporation ofproteins into L929 cells- L929 cells were prepared in
electroporation buffer (1.26 mM CaCl2, 5.37 mM KC1, 0.52 mM KH2P04, 0.64 MgCl2,
0.63 MgS04, 85.5 mM NaCl, 5.8 mM NaHC03, 0.50 mM NaH2P04, 12.5 mM Hepes)
as described by Glogaver and McCulloch (1992). Cells were electroporated in

electroporation buffer that contained 0.5 mg/ml of either BSA or clusterin, which h
had not been labelled with FITC. Electroporation was performed using a BioRad Gene

pulser (BioRad, Hercules, CA, USA) with the following settings: 200 or 400 volts, 9
uF. Thereafter, cells were trypsinized (with trypsin/EDTA mix from TRACE,
Melbourne, Australia) for various times (maximum 15 minutes) to establish how much
protein became incorporated into the cell rather than on or in the outer membrane.

viability (refer section 4.2.3.2) and the amount of protein incorporated into cell
then analysed by flow cytometry.
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4.3 RESULTS:
4.3.1 Rate ofL929 cell killing effected by different cytotoxic agents
There have been numerous reports describing agents capable of inducing apoptosis.

These agents do not necessarily cause apoptosis in all cell types as they often involve

specific ligand interactions. Therefore, several reported apoptotic inducers were teste
on L929 wild type cells and transfected cells to determine whether they induced
apoptosis. Table 4.1 lists the cytotoxic agents tested and the concentrations used.

Table 4.1 Cytotoxic agents at the concentrations used to test the mode of
death in L929 cells.
Cytotoxic Agent
TNFa

K n o w n Functions
Cytokine

Concentration
100 ng/ml
100 ng/ml

TNFa +
actinomycin D

Protein synthesis inhibitor

4 p.g/ml

Staurosporine

Protein kinase inhibitor

Colchicine

Disrupts microtubules

1 UM
2uM

Azide

Respiratory poison

0.6 % (w/v)

Of the agents tested, TNFa/Act D killed L929 cells most rapidly, killing > 9 0 % of cells
within 12 hours (Figure 4.2). The next most rapidly acting agent was staurosporine,
which killed >90% of cells within 18 hours (Figure 4.2). TNFa, colchicine and azide
were slower acting in that each agent required more than 48 hours to kill >90% of cells
(Figure 4.2).
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Figure 4.2: Comparing the viability of L929 cells over time when treated with various
cytotoxic agents. Viability determined on the basis of the ability of cells to exclude PI. Treatments
are as follows:- D 2 u M colchicine; O 100 ng/mL T N F ; O 100 ng/mL T N F + 4 pg/mL Act D;
• 1 u M staurosporine; A 0.6% Azide. All time points shown represent the mean for three
independent cultres of cells and error bars are the standard deviation of the mean. In some cases the
error was too small to be visable.

4.3.2 Effects of cytotoxic agents on cell size and cell membrane permeability

Particles differing in size can be identified by flow cytometry as populati

distinguished on the basis of the forward scatter signal. Classically, cells

necrosis initially increase in size before losing membrane integrity. In con
undergoing apoptosis shrink and maintain a smaller size than healthy cells.
differences can be detected by flow cytometry (Darzynkiewicz et al, 1992).

The D N A stain 7-AAD can be used to discriminate viable, apoptotic and dead cell

populations (Schmid et al, 1994). Flow cytometry was used to measure changes

size (forward scatter) and the extent of staining with 7-AAD (red fluoresce

cells treated with each of the cytotoxic agents. Analysis of TNFa-treated ce

with 20 ng/ml 7-AAD resolved three populations (Figure 4.3B). There was cons
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a small population of cells with a reduced size and an intermediate to high level of 7AAD staining, suggestive of apoptosis. This population was not fully resolved from the
dead cell population (Figure 4.3B). A similar pattern was found for L929 cells treated
with TNFa/Act D, although the proportion of cells with reduced volume and
intermediate staining with 7-AAD was less (Figure 4.3C). In contrast, analysis of
staurosporine-treated cells stained with 20 jig/ml 7-AAD discriminated only two
populations of cells, viable and dead (Figure 4.3D). This suggests that staurosporine

causes necrosis in L929 cells. A similar pattern was found for azide-treated cells whic
suggests it too causes necrosis; although there were some cells detected with
intermediate 7-AAD staining, most of these did not show a reduced forward scatter

signal relative to viable cells (Figure 4.3F). Analysis of L929 cells treated for perio
less than 36 h with colchicine and stained with 20 ug/ml 7-AAD resolved only two
populations, viable and dead. However, when the same analysis was performed with
cells exposed to colchicine for periods longer than 36 h, a large population of cells
reduced volume and intermediate staining with 7-AAD (and large amounts of cell
debris) was detected, suggestive of apoptosis (Figure 4.3E). All treatments produced
cell debri (visible by light microscopy) which was detected by flow cytometry as
particles with low forward scatter (indicated in Figure 4.3).

4.3.3 Effects of cyotoxic agents on exposure of PS at the cell surface
Annexin V is a protein that belongs to the family of annexins that bind calcium and
phospholipids. Annexin V has a high affinity for PS and has been used by many groups

to identify PS exposed on the outer surface of apoptotic cells (Martin et al, 1995; Fa
et al, 1992a and b; Vermes et al, 1995; Koopman et al, 1994). Treated and untreated
L929 cells were dual-stained with annexin V-FITC and 1 ug/ml 7-AAD and analysed
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by flow cytometry. Dead cells identified by 7 - A A D staining were electronically
excluded from the analysis. With the exception of azide, all treatments resulted in
significant binding of annexin V to intact L929 cells, indicating exposure of PS at the
cell surface (Figure 4.4).

4.3.4 Flow cytometric analysis of DNA fragmentation induced by cytotoxic agents
DNA fragmentation that occurs in the nucleus of cells can be identified by flow
cytometric analysis of permeabilized cells stained with the DNA intercalating fluor PI
(Nicoletti et al, 1991). Permeabilisation of cells with detergent-containing isotonic
buffer allows any small fragments of DNA to diffuse out from the cell. In preliminary
experiments, this technique was used to test what treatments elicited DNA
fragmentation in L929 cells.

Flow cytometric analysis of healthy untreated L929 cells identified two main
populations of cell nuclei which had similar but distinct levels of PI staining (Figure
A). The nuclei which stained most intensely with PI were from cells in the G2/M stage
of mitosis (as these cells are about to undergo cell division and contain twice the
amount of DNA), while the other main population of nuclei belonged to cells in the Gj
stage of mitosis. Nuclei from cells in the S phase were detected in the region between
these two populations (Nicoletti etal, 1991).

Treatment of L929 cells with each cytotoxic agent resulted in a population of nuclei
which had low PI stained nuclei (Figure 4.5 B-F). This indicates that all treatments
resulted in some form of DNA degradation. TNFa + Act D and staurosporine
treatments were by far the most potent inducers of DNA fragmentation, as
fragmentation was first detected at 6 hours. TNFa, azide and colchicine treatments

A

(A) TNF

(B) TNF + Act. D

. ..Mini

10J

1CT

i 11

j

.... . ..IIIIII^I
J

10q

1(T

(C) Staurosporine

nnmf

10

1(T

(D) Colchicine
o
T
O
CM
CO
O
T
<M
O
UO .

o
CO
mi

10u

101

10

i

i|

f

10"

10n

3

I. ' " " " ' I , '

10'

10^

I^IIIMI

I lllllllf

W

10q

(E) Azide

innni . i n

10*

10

Annexin-V Binding
F i g u r e 4.4: Flow cytometry histogram overlays showing binding of annexin-V-FITC to
untreated L929 cells (green line) versus L929 cells treated (orange line) with the agent indicated.
Dead cells (identified by their permeability to PI) were electronically excluded from histograms. The
treatments were A ) 100 ng/ml T N F a for 48 hours; B ) 100 ng/ml T N F a + 4 pg/ml actinomycin D for
4 hours; C ) 1 u M staurosporine for 7 hours; D ) 2 p M colchicine for 24 hours; E ) 0.6% (w/v) sodium
azide for 24 hours. The results shown are representative of many independent experiments.
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were slower inducers of D N A fragmentation, which wasfirstdetected at 36 hours. This
flow cytometric technique is limited in that the nature of the induced DNA
fragmentation cannot be determined. As both necrosis and apoptosis can result in DNA
degradation further analysis of DNA was required to help establish the mode of cell
death. Therefore DNA was extracted and analysed by agarose gel electrophoresis.

4.3.5 Gel electrophoretic analysis of DNA fragmentation induced by cytotoxic agents
Kyprianou et al. (1991) extracted intact DNA from untreated L929 cells and fragmented
DNA from TNFa treated L929 cells. Initial attempts to repeat this procedure only
yielded degraded DNA that appeared as a smear when analysed by agarose gel
electrophoresis. The smearing represents DNA that had become degraded. This is most
likely due to various DNases, which normally are tightly regulated, that have become
released upon lysis of the cell. Therefore to inhibit the affecting DNases different
buffers were prepared which contained varying concentrations of EDTA (Table 4.2), a
protease inhibitor. The different lysis buffers were used to extract DNA from healthy
untreated L929 cultures. The purified DNA was then analysed by agarose gel
electrophoresis (Figure 4.6 A). Lysis buffer C (which contained 25 mM EDTA_
resulted in a viscous DNA preparation which did not migrate into the gel as a single
band, but rather as a smear at the top of the gel (Figure 4.6 A lane 3). DNA purified
using the other lysis buffers appeared as a single major band which in each case
migrated a small distance into the gel (Figure 4.6 A lanes 1 and 2). Lysis Buffer B
(which contained 12 mM EDTA) resulted in the least amount of DNA smearing
indicating less DNase damage. This buffer was used for all further extractions of
genomic DNA from L929 cells.
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Table 4.2 Composition of different lysis buffers used to extract genomic D N A
from L929 cells.
Lysis Buffer

A
B

c

Concentration of E D T A
5mM
12 m M
25 m M

Components c o m m o n to all buffers
25 m M Tris
0.25% S D S
pH8.0

F i g u r e 4.6: 1.6% agarose gel electrophoresis of D N A extracted from L929 cells treated as follows:A ) D N A extracted from untreated L929 cells using buffer A (lane 1); buffer B (lane 2), buffer C (lane 3);
refer table 4.2. B ) Lane 1: untreated L929 cells; Lane 2: 1 p M staurosporine for 7 hours; Lane 3: 1 p M
staurosporine for 24 hours; Lane 4: 100 ng/ml T N F + 4 pg/ml actinomycin D for 7 hours; Lane 5: 100
ng/ml T N F + 4 pg/ml actinomycin D for 24 hours; Lane 6: D N A markers; C ) Lane 1 D N A markers; Lane
2: untreated cells; Lane 3: 100 ng/ml T N F for 48 hours; Lane 4: 2 p M colchicine for 48 hours; Lane 5:
untreated H L 6 0 cells; Lane 6: etoposide treated H L 6 0 cells (ie positive control for D N A laddering); Lane
7: 0.6% azide.
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Analysis of D N A extracted from L929 cells treated with staurosporine or TNFa/Act D
revealed DNA "ladders", a typical feature of apoptosis (Figure 4.6 B, lanes 2/3 & 4,

respectively). DNA laddering in staurospine treated cells was most apparent in cultures
that had been treated for between 7 and 24 hours. Treating cells with TNFa + act D for
periods longer than 16 hours resulted in extensive DNA degradation which on gel
electrophoresis appeared as a smear (Figure 4.6 B, lane 5). DNA laddering was not
detected in L929 cells treated with either TNFa, colchicine or azide at any time point
to 48 hours. However, L929 cells treated with these cytotoxic agents for 24 hours or
longer resulted in non-specific cleavage of DNA which when analysed by gel
electrophoresis appeared as a smear (Figure 4.6 C, lanes 3,4 and 7, respectively).

4.3.6 Effects of cytotoxic agents on nuclear and cell morphology
AO is a fluor that stains single and double stranded DNA as well as RNA. It is cell-

permeable and is a useful stain to visualise nuclear morphology. Nuclei of healthy cel

are large, intact and stain uniformly while apoptotic nuclei are generally small, compa

and fragmented. Nuclei of necrotic cells are generally larger than healthy cell nuclei
do not show condensation or fragmentation (Gorman et al, 1994). Following the
various treatments, cell morphology was examined by light microscopy. Cells were
trypsinized and pooled before staining with AO; nuclear morphology was analysed by
fluorescence microscopy.

Nuclei of untreated cells were large intact structures which stained heavily but
uniformly with AO (Figure 4.7 A). In untreated L929 cultures more than 95% of cells
remained attached to the culture vessel surface. Nuclei from TNFa-treated cells were
either (i) small and weakly stained, or (ii) normal size and brightly stained (Figure
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B). Rounded-up, detached cells were c o m m o n under these conditions and a very small
proportion of the adherent population showed extensive membrane blebbing (estimated
-1%) (Figure 4.7 B; no blebbing visible in the field shown). The appearance of nuclei in
TNFa/Act D-treated cells was similar to those of cells treated with TNFa alone,
although fewer large brightly stained nuclei were visible at corresponding time points
and some fragmented nuclei were detected (Figure 4.7 C). The addition of Act D greatly
enhanced the sensitivity of cells to TNFa and, between 5 and 7 hours after the initial
exposure, induced violent blebbing of the cell membrane (Figure 4.7 C). When removed
from culture vessel surfaces by treatment with trypsin, a fraction of cells treated with
TNFa or TNFa/Act D were observed to be smaller in size than untreated cells.

The AO-stained nuclei of staurosporine-treated L929 cells showed a variety of
morphologies, consisting of the following types: (i) brightly stained, condensed and

fragmented, (ii) condensed but dimly stained and (iii) brightly stained and intact (Figur
4.7 D). Staurosporine induced membrane blebbing within 1 hour of treatment (Figure
4.7 D) and after trypsinization many staurosporine-treated cells were noticably smaller

than untreated cells. Similarly, the AO-stained nuclei of colchicine-treated cells showed
a variety of morphologies, consisting of the following types: (i) condensed, lightly

stained nuclei, (ii) brightly stained, heavily fragmented nuclei, or (iii) brightly stain

intact nuclei (Figure 4.7 E). Following trypsinization, cells treated with colchicine for
periods of 48 hours or longer were noted to be smaller in size than untreated cells.

AO-staining of nuclei within azide-treated cells revealed two distinct morphologies: (i)
nuclei which only stained adjacent to the nuclear membrane and within one or more
small intra-nuclear patches and (ii) brightly, uniformly stained nuclei (Figure 4.7 F).
These nuclei were of equivalent size to non-treated cell nuclei. Following
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F i g u r e 4 . 7 : Light micrographs (top; magnification lOOx) and the corresponding fluorographs
(bottom; magnification 400x) of AO-stained L929 cells treated as indicated (note fields of view are not
coincident). (A) Untreated cells; (B) 100 ng/ml T N F ; (C) 100 ng/ml + 4 pg/ml Act D; (D) 1 p M
staurosporine; (E) 2 p M colchicine; (F) 0.6% azide. O n fluorographs, thin black arrows point to intact
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arrows indicate fragmented nuclei. O n light micrographs, the arrows indicate membrane blebbing.

trypsinization, L929 cells treated with azide were of similar size to untreated cells.
Interestingly, azide did induce some membrane blebbing (Figure 4.7 E).

4.3.7 Human clusterin expression does not affect TNF a induced cell death in L929LS transfectants.
There were were no differences in morphology detectable by light microscopy between
L929-LS.clus(F), L929-LS.clus(B) and L929 wild type cells. Similarly, when L929LS.clus cells were induced to secrete clusterin, no changes in cell viability or
morphology were apparent. The effects ofTNFa, TNFa/Act D and colchicine
treatments on L929-LS transfectants were then analysed. The mode of cell death in

transfected cells in response to the cytotoxic agents was similar to L929 wild type when
analysed by 7-AAD staining (Figure 4.8 vs 4.3) or light microscopy. The induction of
human clusterin expression in L929-LS.clus(F) cells did not provide any protection to
any of the cytotoxic agents when compared with non-induced L929-LS.clus(F) or L929LS.clus(B) cells (Figure 4.8 B & C). Previous kinetic studies on L929-LS transfectant

cells revealed that clusterin is first detected in the TC sn 6 hours after induction wit
mM IPTG (Humphreys, 1994). Even inducing clusterin expression in cells 12 hours
prior to treatment did not provide any protection against the cytotoxic agents.
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treatments were 100 ng/ml T N F a for 48 hours; 100 ng/ml T N F a + 4 pg/ml Act D; 2 p M colchicine. B )
Histograms showing average percent of viable cells (as determined in figure 4.3) in cultures exposed to
either 100 ng/ml T N F a or 100 ng/ml T N F a + Act D. The treatments are indicated by a corresponding
"x" in the table below the histogram. C ) Histograms showing average percent of viable cells (as
determined in figure 4.3) in cultures exposed to 2 p M colchicine. The treatments are indicated by a
corresponding "x" in the table below the histogram. For each histogram error bars represent standard
error of the mean and in some cases are too small to be visible.
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4.3.8 Mode of cell death in L929-pRc transfectants in response to staurosporine,
colchicine and azide.
All the cytotoxic agents listed in table 4.2 were tested on the L929-pRc transfectants.
Treatment of L929-pRc and L929-pRc.clus cells with staurosporine or colchicine
induced changes similar to those induced by these agents in wild type L929 and L929

Lac Switch transfectants (Figure 4.9 A vs Figure 4.3; refer section 4.3.2). Therefore it
was concluded that these agents also induce apoptosis in L929-pRc.clus and L929-pRc
cells. Azide-treated L929-pRc.clus cells stained with 20 ug/ml 7-AAD resolved three
populations in which the intermediate population was more apparent when compared to
the wild type L929 cells (Figure 4.9 A vs Figure 4.3 F). However, annexin V staining,
DNA analysis and light microscopy revealed that azide resulted in necrotic death as
found in wild type L929 cells. Clusterin expression in L929-pRc.clus cells did not
protect those cells, in comparison to L929-pRc cells, from the cytotoxic effects of
staurosporine, colchicine or azide (Figure 4.9).

4.3.9 Cytoprotective effects of clusterin expression in L929-pRc transfectants
L929-pRc or L929-pRc.clus cells treated with TNFa or TNFa + Act D resulted cell
death similar to that described for L929 wild type (section 4.3.2-6). The effects of
TNFa, and Act D in combination with TNFa, were tested on the survival of L929-pRc
and L929-pRc.clus cells. When non-clusterin secreting L929-pRc cells were exposed to
TNFa or TNFa + Act D, a greater proportion of cells were non-viable (as determined
by 20 ug/ml 7-AAD staining) relative to L929-pRc.clus cells treated with the same
agents (Fig 4.10 A and B). Interestingly, TNFa treatment of L929-pRc.clus cells

resulted in characteristics of cell shrinkage and intermediate staining with 7-AAD bein
more apparent in L929-pRc.clus cells than in control L929-pRc cells (e.g. Figure 4.10 A
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F i g u r e 4 . 9 : A ) Flow cytometry density plots of 7 - A A D uptake versus forward scatter in L929
pRc.clus and pRc cells treated with various cytotoxic agents indicated; B ) Histogram showing the
treatmentxontrol ratio (T/C ratio) for the percentage of viable L929-pRc (pRc) and L929-pRc.clus
(pRc.clus) cells in cultures exposed to the treatments indicated compared with control untreated cultures
(Calculated by dividing the % viable cells in treated cultures by the % viable in untreated cultures). In
each case, the table below the x-axis indicates the cell line and the conditions applied. The treatments
were 2 p M colchicine for 48 h, 1 p M staurosporine for 16 h and 0.6% (w/v) sodium azide for 24 h.
Viable cells were determined by 7 - A A D staining and flow cytometric analysis (see figure 4.3). Each
histogram represents the mean of three replicate measurements and the error bars shown represent S D of
the mean. In a number of cases the S D is too small to be visible. N o n e of the differences between L929pRc and L929-pRc.clus cells are statistically significant (p>0.05, Student's t-test).
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F i g u r e 4 . 1 0 : A ) F l o w cytometry density plots of 7 - A A D uptake versus forward scatter in L 9 2 9 pRc.clus and L929-pRc cells treated with 100 ng/ml TNFa or 100 ng/ml TNFa + 4 pg/ml Act. D. B)
Histogram showing average percent of viable cells after treatment as determined by flow cytometry
analysis of 7-AAD stained cultures (refer figure 4.3). The treatments are listed in the table below the
histogram and are indicated by an "x". Error bars are the standard deviation of the mean and in some
cases are too small to be visible.
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vs Figure 4.3).

The extent of D N A fragmentation in response to T N F a was also compared between
L929-pRc.clus and L929-pRc cells. DNA fragmentation was both analysed in cells by
flow cytometry or by extracting genomic DNA from cells, which was then analysed by
agarose gel electrophoresis. Both techniques confirmed that L929-pRc cells were more
sensitive to TNFa as L929-pRc.clus cells had significantly less DNA fragmentation
than L929-pRc cells (Figure 4.11 A and B respectively).

4.3.10 Overexpression of clusterin affects the sensitivity ofL929 cells to TGFp and

TNFa
It was previously reported that exposure of L929 cells to TGFp provides them with
protection against TNFa-mediated cytotoxicity (Chang, 1995). Clusterin has also been

reported to bind to the cytoplasmic domain of the TGF(3l receptor (Reddy et al, 1996).

Therefore, L929-pRc.clus cells were used to test whether the upregulated expression of
human clusterin would influence the effects of TGFp on TNFa-mediated cell death.
The pre-exposure of L929.pRc cells to TGFP was confirmed to protect cells from death
induced by subsequent exposure to TNFa (Figure 4.12 7 versus 3). In contrast, pre-

exposure of L929-pRc.clus cells to TGFp had no effect on the sensitivity of the cells
TNFa (Figure 4.12 8 versus 4). Furthermore, L929-pRc.clus cells show significant cell
death in response to TGFp, while L929-pRc cells did not die under the same conditions
(Figure 4.12 6 versus 5).
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F i g u r e 4 . 1 1 : A ) PI fluorescence of permeabilised L929-pRc.clus and L929-pRc cells which had
been left untreated or treated with 100 ng/ml T N F a for 48 hours. B ) 1.6% agarose gel electrophoresis of
D N A extracted from L929 cells treated as follows:- Lane 1: markers; Lane 2: L929-pRc.clus untreated
cells; Lane 3: L929-pRc.clus T N F a treated (100 ng/ml) cells; Lane 4: L929-pRc untreated cells; Lane 5:
L929-pRc T N F a treated (100 ng/ml) cells; Lane 6: H L 6 0 untreated cells; Lane 7 H L 6 0 cells treated with
etoposide (20 pg/ml). D N A from H L 6 0 cells confirmed that the D N A extinction method was capable of
extracting internucleosomally fragmented D N A . Thus T N F a treatment does not result in
internucleosomal D N A fragmentation but rather random D N A fragmentation in L929-pRc cells.
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F i g u r e 4 . 1 2 : Percentages of 7 - A A D stained cells defined by flow cytometric analysis as dead
(referfigure4.3) from cultures of L929-pRc (pRc) or L929-pRc.clus (pRc.clus) cells exposed to 2 ng/ml
of T G F P for 48 h and/or 100 ng/ml T N F a for 24 h. Cultures treated with both T G F P and T N F afirsthad
a 24 h incubation with T G F P followed by a 24 h incubation with both T G F P and T N F a . In each case,
the table below the x-axis indicates the cell line and the conditions applied (indicated by "x"). Each data
set represents the mean for triplicate cultures and the error bars shown represent S D of the mean in each
case. The result shown is representative of three independent experiments. There was no significant
difference in the proportion of dead cells in untreated pRc versus pRc.clus cultures (1 vs. 2; Student's ttest, p> 0.5). Whether exposed to T N F a alone, or to T G F P followed by T N F a , there was significantly
less cell death in pRc.clus versus pRc cells (4 vs. 3, p<0.001, and 8 vs. 7, p<0.05, respectively; Student's
t-tests). There were significantly more dead cells in cultures of pRc.clus cells exposed to T G F P relative
to pRc cultures treated the same w a y (6 vs. 5; p<0.005, Student's t-test). Following exposure to T N F a ,
there were significantly more dead cells in control pRc cultures relative to those that had been preexposed to T G F p (3 vs. 7; p<0.001, Student's t-test). Under the same conditions, there was no significant
difference between the level of dead cells in TNFa-treated pRc.clus cultures versus those that had been
pre-exposed to T G F P prior to treatment with T N F a (4 vs. 8; p>0.2, Student's t-test).
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4.3.11 Secreted or exogenous clusterin does not protect cells from

TNFa-mediated

cytotoxicity
The data in figure 4.10 (A, B) show that L929-pRc.clus cells are protected against
TNFa-mediated death. In order to establish the cellular site at which clusterin provides
this protective effect, L929-pRc cells were cultured in "conditioned" L929-pRc.clus TC
media containing secreted clusterin or media containing added exogenous clusterin and
then treated with TNFa. Neither "conditioned" TC sn from L929-pRc.clus cells nor
exogenous clusterin at 60 ug/ml affected the response of L929-pRc cells to TNFa
(Figure 4.13 A, B).

Treating L929 cells with TGFp results in the secretion of protein(s) that can become
bound to the surface of tissue culture vessels and provide protection against the
cytotoxic effects ofTNFa (Chang, 1995). To determine whether clusterin-secreting
cells also secreted protective proteins, L929-pRc cells were grown in culture vessels
where L929-pRc.clus cells has previously been cultured and gently removed. There was
no significant difference in viability following TNFa treatment of L929-pRc cells
grown on either new culture wells or culture wells in which L929-pRc or L929-pRc.clus
had previously been grown (Figure 4.13 C).

The cell surface was the only other possible extracellular site where clusterin may be
responsible for TNFa resistance. However, using flow cytometry, negligible clusterin
was found to be associated with the surface of L929-pRc.clus cells (Figure 4.13 D),
suggesting that cell surface-bound clusterin was not producing the effect. One

interpretation of these results is that they suggest that protection against TNFa-mediate
cell death is afforded by an intracellular action of clusterin protein.
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F i g u r e 4 . 1 3 : Influence of secreted molecules and added exogenous clusterin on the cytotoxic
effects o f T N F a on L929 cells. Histograms showing the average percentages calculated from triplicate
cultures of viable L929-pRc cells, defined by 7 - A A D staining and flow cytometric analysis (refer figure
4.3), from cell cultures exposed to a range of conditions. A ) W h e r e T N F a w a s applied, pRc cells were
exposed for 24 h to 100 ng/ml T N F a added to fresh culture m e d i u m or to culture supernatant removed
from other cell cultures (which had previously been incubated for 24 h). In each case, the table below the
x-axis indicates the conditions applied (indicated by "x"). There were no significant differences in the
percentages of viable cells in cultures exposed to the different culture media, with or without T N F a
(single factor A N O V A , 0.05<p<0.025). B. p R c cells were incubated with T N F a with or without the
addition of 60 pg/ml of purified exogenous h u m a n serum clusterin. In each case, the table below the xaxis indicates the conditions applied (indicated by "x"). The addition of exogenous clusterin had no
effect on the viability of the cells under any of the conditions tested (p>0.2, Student's t-test). In a number
of cases the S D is too small to be visible. C ) Viability of cultures treated with T N F a , where indicated,
after growing on surfaces which previously contained the indicated cell type (designated by "x") or fresh
cultures. D ) Flow cytometry histogram showing that no surface bound h u m a n clusterin is detectable on
L929-pRc.clus cells. Green line = L929-pRc.clus cells stained with G 7 , 78E, 4 1 D A b cocktail; black line
= L929-pRc.clus cells stained with an isotype control Ab.

98

4.3.12 Analysis of intracellular forms of clusterin in transfected L929 cells
Analysis of lysates of induced L929-LS.clus and L929-pRc.clus cells by SDS/PAGE
and immunoblotting revealed the presence in both cell types of two forms of clusterin
with apparent molecular masses, under non-reducing conditions, of about 80 kDa and
64 kDa (Figure 4.14 A). The 80 kDa form was also found in cell culture supernatants

and dissociated into two subunits under reducing conditions, indicating that it had been
appropriately cleaved at the Asp205 - Ser206 bond (Kirszbaum et al, 1989). The 64

kDa form was not found in cell culture supernatants and did not dissociate into subunits
on reduction.

Analyses were also performed on lysates prepared from L929 pRc.clus cells exposed for
48 hours to 100 ng/ml TNFa. Significantly more clusterin was found associated with all
cell fractions prepared from TNFa-treated L929-pRc.clus cells versus untreated control

cells (Figure 4.14 B; lanes 3, 5, 7 vs 2, 4, 6 respectively). The majority of this incre

appeared to be the 80 kDa form of clusterin associated with the nuclear fraction (lane 7
vs 6), however, there was also a noticable increase in both the 80 and 64 kDa clusterin
species present in the cytoplasmic fractions (lane 5 vs 4). The nuclear-associated
clusterin (Figure 4.14 B; lane 7) was physically indistinguishable from purified human
serum clusterin (Figure 4.14 B; lane 1), which is itself indistinguishable from cellsecreted clusterin (Figures 4.14 A; lane 3).

In addition, the cytoplasmic and total cell fractions prepared from TNFa-treated L929pRc.clus cells contained a form of clusterin which was detected on immunoblots that
was difficult to detect in fractions prepared from untreated L929-pRc.clus cells. This

novel form of clusterin is most clearly resolved under reducing conditions, where it can
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F i g u r e 4 . 1 4 : A ) Immunoblot of whole cell lysates and tissue culture supernatants from L929LS.clus cells and L929-pRc.clus which were grown in 5 ml of culture medium in 25 c m 2 flasks for 24
h. L929-LS.clus cells were grown in the presence of 5 m M I P T G to induce clusterin expression.
About 3 x IO 6 cells were recovered from each flask after the 24 h period. Cells were removed from the
flasks with trypsin/EDTA, washed, and then lysed in a volume of 1 ml as described in section 4.2.6.
Aliquots of cell lysates (40 pi) and culture supernatants (20 pi) were electrophoresed on a 1 0 % S D S polyacrylamide gel and then electrophoretically transferred to nitrocellulose membrane. Membranes
were probed with a cocktail of G 7 , 78E and 4 1 D M A b s (which only recognise human clusterin). Lane
1, whole cell lysate from L929-pRc.clus; lane 2, whole cell lysate from induced L929-LS.clus; Lane 3,
culture supernatant from L929-pRc.clus; Lane 4, culture supernatant from induced L929-LS.clus.
Lanes 1-4 were run under non-reducing conditions. Lanes 5-8 contain identical samples to those in
lanes 1-4 but were run under reducing conditions.
B) Immunoblot of various cell fractions prepared from L929-pRc.clus cells that had been exposed to
100 ng/ml T N F a for 48 h, or untreated controls. Cells were removed from the flasks with
trypsin/EDTA, washed, and then lysed as described in section 4.2.6. Fractions from about 1.5 x 10 6
cells were loaded onto each track. Samples were electrophoresed under non-reducing conditions on a
1 0 % SDS-polyacrylamide gel and then electrophoretically transferred to nitrocellulose membrane
Lane 1, 320 ng of purified human serum clusterin; Lane 2, total cell fraction, untreated controls; Lane
3, total cell fraction, TNFa-treated; Lane 4, cytoplasmic fraction, untreated controls; Lane 5,
cytoplasmic fraction, TNFa-treated; Lane 6, nuclear fraction, untreated controls; Lane 7, nuclear
fraction, TNFa-treated.
C) Same as B except samples were reduced with P-mercaptoethanol. Arrows indicate the position of
two clusterin bands at about 36 and 38.5 k D a in the total cell and cytoplasmic fractions prepared from
T N F a treated cells.
D) Immunoblot of whole cell lysates from L929-pRc.clus treated with various cytotoxic agents. Cells
were removed from the flasks with trypsin E D T A , washed and lysed as described in section 4.2.6.
Fractions from about 1.5 x IO6 cells were loaded onto each track. Samples were reduced with Pmercaptoethanol before being loaded onto S D S P A G E gels. After electrophoresis, proteins were
transferred onto nitrocellulose membrane and probed with the G 7 anti-human clusterin antibody. Lane
1 T N F a treated (48 hrs); Lane 2 colchicine treated (48 hrs); Lane 3 azide treated (48 hrs); Lane 4
staurosporine treated (16 hrs); Lane 5 T N F a + Act D treated(16 hrs); Lane 6 untreated (48 hrs).

B
12 3 4

1 2 3 4 5 6 7

5 6 7 8
98 >
CJ

VI
VI

64^

u

a 50M
o

S 36>

12
CS

64^VI
VI

3 4 5 6

7

D
KS

9 64->
CM

50 -W

U 50-*
=3
U
CD

1 2 3 4 5 6

3

o

I36
OJ

1 36->

100

be seen as a closely spaced pair of bands migrating at apparent sizes of about 36 and
38.5 kDa (Figure 4.14 C; lane 3 and 5, bands indicated with arrows). In the same
preparations, the normal processed form of clusterin is detected as a poorly resolved
pair of bands migrating at an apparent size of about 43-45 kDa. The 36/38.5 kDa form
of clusterin may also be present to a lesser extent in nuclear fractions prepared from
TNFa-treated L929-pRc.clus cells, although, by immunoblot analysis, this is difficult to
discern because of the large amounts of normal processed clusterin bound to dead cell

nuclei (Figure 4.14 C; lane 7). The 36/38.5 kDa clusterin is also detectable in lysates o
L929-pRc.clus cells exposed to staurosporine, colchicine, and to a much lesser extent
azide (Figure 4.14 D; lanes 4, 2, and 3 respectively). Like the constitutive form of
clusterin, the 36/38.5 kDa form has clearly been internally proteolytically cleaved.

Wilson et al (1995) has reported that when purified exogenous clusterin is added to
nutrient-deprived cultures of various cell types it readily binds to the nuclei of dead
cells. Therefore it was suspected that in TNFa-treated cultures of L929-pRc.clus cells,
cell-secreted clusterin was simply binding to the nuclei of dead cells once their cell
membrane was no longer intact. This hypothesis was tested by first staining L929pRc.clus cells, either untreated or treated with TNFa, briefly with 1 pLg/ml 7-AAD, and
then permeabilizing the membranes of the cells before detecting intracellular clusterin
with G7 MAb followed by SaMIg-FITC (refer section 4.2.3.5). Two colour flow
cytometric analysis then allowed the determination of the relative amounts of clusterin

associated with dead cells (discriminated as "strongly" stained with 7-AAD) versus cells
still possessing an intact cell membrane (discriminated as "weakly" stained with 7AAD) (Figure 4.15 A). This analysis confirmed that in TNFa-treated L929-pRc.clus
cultures, relative to cells with an intact cell membrane, dead cells had greater amounts
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F i g u r e 4 . 1 5 : A ) Flow cytometry overlay histograms showing the level of cell-associated clusterin
for ethanol-permeabilized L929-pRc.clus cells that had been exposed to T N F a for 48 hours. Dead cells
(that in culture lacked an intact cell membrane) were discriminated on the basis of high red fluorescence
(staining with 7 - A A D ; refer section 4.2.3.2). Cell-associated clusterin was detected as described in
section 4.2.3.5 and is represented by green fluorescence (dead cells - green line; cells that in culture had
an intact cell membrane - red line). The dotted line represents dead cells that were stained with D N P - 9
(an isotype-matched control antibody) then SaMIg-FrTC. B ) Flow cytometry overlay histograms
showing the level of clusterin-FITC (purple line) or B S A - F I T C (green line) that bound to permeabilized
L929 W T cells treated with T N F a . Black line represents unlabelled cells. C ) same as B except cells were
not treated with T N F a . Results shown are representative of three independent experiments
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of cell-associated clusterin. Inspection of the stained cells by fluorescence microscopy
indicated that clusterin was predominantly localized on the nuclei and cell membranes
of dead cells. Flow cytometry was also used to demonstrate that both clusterin-FTTC
and BSA-FITC bound at high levels to permeabilised wild type L929 cells which had
previously had been treated with TNFa (Figure 4.15 B) or left untreated (Figure 4.15
C).

4.3.13 The protection provided by clusterin expression is dependent upon the amount
of clusterin expressed.
The first round of cloning L929-pRc.clus cells produced several clones that expressed

different levels of clusterin. The highest expressing clone (E3) was chosen for a second
round of cloning and used for experimentation (refer Figure 3.5). To confirm that
resistance to TNFa seen in L929-pRc.clus cells was directly related to clusterin
expression, the cytotoxic effects of TNFa was tested on the first round clones. Clones
which expressed lower levels of clusterin as determined by immuno-dot blots were
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F i g u r e 4 . 1 6 : Viability of xlclones of L929-pRc.clus cells treated with 100 ng/ml of T N F a for 24
hours. Viability was determined using 7 - A A D staining (refer figure 4.3). Each clone secreted different
levels of clusterin. Clones are placed in order of the amount of clusterin secreted as determined by
immunodot-blot, with E 3 being the highest secreting clone and F8 being the weakest secreting clone.
Results shown are single determinations and are representative of two independent experiments

more sensitive to T N F a compared to clones which expressed higher levels of clusterin
(Figure 4.16).

4.3.14 The expression of TNF-receptors are not modified in L929-pRc.clus cells
The high expression of clusterin in L929-pRc.clus cells may indirectly affect the
expression of other proteins crucial to the TNF pathway thereby providing protection
against TNF. Two commercial antibodies specific for TNFR1 and TNFR2 were
purchased and the expression of these proteins on the surface of L929 cell lines was
analysed by flow cytometry. Both receptors were detected, expressed at a low level, on

the surface of each L929 cell line (Figure 4.17). This suggests that clusterin expressio
did not affect the expression of TNF receptors.

4.3.15 Introducing clusterin protein into the cytosol of intact L929 cells
The presence of clusterin in TC sn was shown not provide protection to TNFa (Figure
4.13 C). Therefore purified clusterin was electroporated into L929 cells to see whether
this provided protection against the cytotoxic effects of TNFa treatment. First,
conditions to electroporate proteins into L929 cells, while maintaining high viability,
were examined. Glogaver and McCulloch (1992) previously reported conditions they

found to be most favourable in the electroporation of proteins into fibroblasts. To avoi
using the finite stocks of clusterin initial experiments used BSA-FITC as a "tracer".

L929 cells prepared in electroporation buffer containing BSA-FITC were electroporated
at either 200 or 400 volts. Electroporation using these conditions resulted in high
mortality and many of the dead cells clumped together to form a large hydrophobic
mass. Approximately 30% of the cells that were returned to the culture were determined
to be dead. These cells were easily identified by their high level of staining with PI
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t I g u r e 4 . 1 7 : Flow cytometry histograms showing analyses of untreated A ) L929 W T ,
B ) L929-pRc.clus and C ) L929-pRc cell lines. Cells were labelled with antibodies that recognised
either TNF-R1 (green histogram), TNF-R2 (brown histogram) or an isotype control antibody
(black line) followed by sheep-anti-mouse-Ig-FITC secondary antibody.

(Figure 4.18 A ) . A similar amount of B S A - F I T C was incorporated into cells, as
determined by flow cytometry, from each electroporation setting relative to cells which
were electroporated with no protein (Figure 4.18). Immediately after electroporation
many cells were more permeable to PI than viable healthy cells (Figure 4.18).
Interestingly, the electroporation resulted in a linear distribution of cells that varied
membrane permeability and BSA-FITC incorporation (Figure 4.18 A). Cells with high
membrane permeability (high PI fluorescence, except dead cells as indicated in figure
4.18 A) tended to have incorporated more BSA-FITC (high green fluorescence) and
vice versa. The membrane integrity of these cells returned to levels similar to that of
untreated cells after 15 minutes (Figure 4.18 A).

Most of the protein incorporated into cells electroporated at 400 volts was destroyed by
trypsin treatment (Figure 4.18 A). This indicated that electroporation of L929 cells at
400 volts incorporates most of the protein into the outer membrane. Most of the protein
incorporated into cells electroporated at 200 volts was not destroyed by trypsin
treatment (Figure 4.18 A), indicating that under these conditions proteins were
internalised. As BSA-FITC was successfuly incorporated into cells this suggests that
clusterin protein can also be incorporated into cells. It was found that clusterin-FITC
was also incorporated into L929 cells by electroporation at 200 volts (data not shown).

L929 cells were electroporated with or without clusterin before comparing the cytotoxic
effects of TNFa. The electroporation of clusterin into cells did not alter cell viability
relative to cells electroporated with BSA or no protein (Figure 4.18 B). Surprisingly
clusterin incorporated into L929 cells did not provide any significant protection against
TNFa when compared with cells electroporated with no protein or BSA (Figure 4.18

B).
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F i g u r e 4 . 1 8 : A ) Density plots of L929 cells which had been electroporated at the indicated
voltage with B S A (labelled with FITC or unlabelled as indicated) and then either treated (15 minutes)
or not treated with trypsin. Density plots show green fluorescence (BSA-FITC uptake) versus PI
uptake. Cell that had a greater PI uptake than the blue line are dead. B ) Average viability of L929
cells which had been electroporated with clusterin or B S A at 200 volts and then treated with 100 ng/ml
o f T N F a for 24 hours. (Viability was determined by flow cytometric analysis of cells stained with PI;
refer section 4.2.3.2). Table below the histogram indicates (with "x") the protein electroporated into
cells (clusterin or B S A ) and whether cells were treated with T N F a . Error bars represent standard
deviation of the mean in each case. In some cases the standard deviation is too small to be seen.
Results shown are representative of three independent experiments.
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4.3.16 Effects ofTNFa

on other transfected cell lines

The CMV promotor which is responsible for the expression of EGFP in L929-EGFP
transfected cells is the same promotor which controls clusterin expression in L929pRc.clus cells (refer chapter 3). A comparison was made between the cytotoxic effects
ofTNFa on L929-EGFP cells, L929-pRc.clus cells, and L929-pRc cells. Suprisingly,
overexpression of EGFP provided a similar level of protection against TNFa
cytotoxicity as clusterin overexpression in L929-pRc.clus cells (Figure 4.19).

TNFa + cycloheximide is also reported to induce apoptosis in HeLa cells (White et al,
1992). HeLa-pRc.clus cells were therefore treated with TNFa + cycloheximide or
TNFa alone to determine if clusterin expression provided protection as seen in L929pRc.clus cells. HeLa transfected cells were not sensitive to TNFa alone, however the

addition of cycloheximide resulted in cell death. Surprisingly, HeLa-pRc.clus cells we
more sensitive to TNFa + cycloheximide treatment relative to HeLa-pRc cells (Figure
4.19).
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F i g u r e 4 . 1 9 : A ) Histogram showing average cell viability of L929-EGFP, L929pRc.clus and L929-pRc cells following treatment with 100 ng/ml T N F a for 48 hours. B )
Average cell viability of HeLa-pRc.clus and HeLa-pRc.clus transfectants treated with either
100 ng/ml T N F a alone or in combination with 10 pg/ml cycloheximide. The tables below
the histograms indicate (with an "x") treatments. In each case viability was determined by
flow cytometric analysis of cells stained with 7 - A A D (refer figure 4.3). Means were
calculated from values determined for three independent cultures and errors bars are
standard deviation of the mean. In some cases the standard deviation is too small to be
visible.

4.4 DISCUSSION

The L929 cell line is commonly used to test the cytotoxic effects of TNFa, a procedur
that was first described in 1985 (Aggarwal and Kohr, 1985). These tests typically
involve exposing L929 cells to TNFa and then staining them with coloured or
fluorescent compounds unable to penetrate intact cell membranes (eg Levesque et al,

1995). Loss of cell viability is quantified by measuring the fraction of all cells tha

stained with these compounds (ie those which have lost integrity of the cell membrane
The tests often involve the addition of Act D which sensitizes L929 cells to TNFa,
reducing the incubation times required (Ostrove and Gifford, 1979).

Initial reports demonstrated that TNFa induced oligonucleosomal DNA fragmentation

and condensed and fragmented nuclei in L929 cells, consistent with apoptotic cell dea
(Fady et al, 1995; Kyprianou et al, 1991; Tomasovic et al, 1994). However, other
studies of TNFa-treated L929 cells demonstrated swift structural degeneration of
mitochondria and the production and accumulation of ROS, suggesting a necrotic mode
of death (Schulze Osthoff et al, 1992; Grooten et al, 1993; Schulze Osthoff et al,

1993; Goossens et al, 1996). Interestingly, one of these studies reported that extende
treatment of L929 cells with TNFa produced apoptotic DNA fragmentation (although
this data was not shown; (Schulze Osthoff et al, 1992)). Research described in this
chapter examined the mode of death of L929 cells following exposure to various
cytotoxic agents including TNFa, TNFa/Act D, staurosporine, colchicine and azide.
The mode of cell death was investigated using the DNA stain 7-AAD to identify
"leaky" apoptotic membranes, annexin V-FITC to identify exposure of PS on the outer
surface of the cell membrane, the DNA/RNA stain acridine orange (AO) to visualise
nuclear morphology, agarose gel electrophoresis to analyse DNA fragmentation, and
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light microscopy to examine cellular morphology. PI staining of permeabilised cells has
been reported to allow detection of DNA fragmentation (Nicoletti et al, 1991).
However, this method did not discriminate apoptotic from necrotic cells as both modes
of death eventually resulted in the degradation of DNA (Gorman et al, 1994). Therefore
this measurement was not used in determining the mode of cell death. A review of the
literature reveals that 7-AAD and annexin V have not been used before in analyses of
L929 cell death.

4.4.1 Mode ofL929 cell death induced by TNFa
Flow cytometric analysis of TNFa-treated L929 cells stained with 20 pg/ml of 7-AAD
identified a population with reduced cell volume and cell membrane permeability
between that of healthy viable cells and dead cells (Figure 4.3B), characteristic of
apoptotic cells. Examination of untreated and TNFa-treated cells by light microscopy
indicated that TNFa induced cell shrinkage, supporting the flow cytometry results. The
redistribution of PS from the inner to the outer leaflet of the plasma membrane in
apoptotic cells is thought to constitute a phagocyte recruitment signal and facilitate

disposal of the cell corpse (Fadok et al, 1992 a and b). Annexin V bound to the surface
of TNFa-treated L929 cells (Figure 4.4A) indicating that these cells had externalised
PS, consistent with them undergoing apoptosis. However, extensive membrane
blebbing, common in apoptotic cells, was only detected in a small fraction (-1%) of
TNFa-treated L929 cells.

One of the hallmarks of apoptosis is the cleavage of DNA into fragments that are
multiples of 180-200 bp in length. DNA from TNFa-treated L929 cells was nonspecifically fragmented (detected as a broad smear by agarose gel electrophoresis;
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Figure 4.6C). Similar D N A degradation occurred in L929 cells treated with sodium

azide (a known inhibitor of the respiratory chain which results in necrosis in many ce

types; Fady et al, 1995; Lizard et al, 1995; Vaux et al, 1996) and during heat-induced
necrosis of L929 cells (Tomasovic et al, 1994). The nuclei of TNFa-treated L929 cells
were not fragmented (Figure 4.7B). Examination of TNFa-treated L929 cells stained

with AO identified two populations discriminated on the basis of differences in nuclea
morphology. One population consisted of cells with normal sized brightly stained
nuclei, while the second population, which appeared after 24 hours, had small weakly

stained nuclei (Figure 4.7B). The intensity of staining with AO gives an indication of
the amount of DNA present in the nucleus. Therefore, the small weakly stained nuclei
probably belong to cells that had undergone extensive degradation and lost DNA. This

pattern of DNA degradation without nuclear fragmentation is consistent with a necrotic
mode of cell death.

4.4.2 Relationship to other studies of the effects of TNF a on L929 cells
As previously mentioned, other studies have identified the mode of L929 cell death
induced by TNFa as either apoptotic or necrotic. There are a number of possible

explanations for the discrepancies between these earlier reports and between this repo
and those. Firstly, a number of these reports relied exclusively or largely on the
demonstration of DNA "laddering" to establish apoptosis. Furthermore, some of these
studies used recombinant murine TNFa to induce death while others used recombinant
human TNFa. It has been shown that although murine TNF-R1 binds with equal
affinity to mTNFa and hTNFa, the latter is bound with relatively poor affinity by
murine TNF-R2 (Lewis et al, 1991). Thus, differential recognition by murine TNF-R2
ofTNFa from different species may in part explain some of the reported discrepancies.

However, this cannot explain all discrepancies because it was reported that L929 cells
treated with human TNFa (i) showed clear evidence of classical oligonucleosomal
DNA fragmentation after only 12 hrs (Kyprianou et al, 1991), or (ii) showed extensive
non-specific fragmentation of DNA with evidence of limited oligonucleosomal
fragmentation only after 48 hrs of exposure (Sanchezalcazar et al, 1997). A possible
explanation for the differences between these latter published results might be the
different concentrations ofTNFa used ((Kyprianou et al, 1991)- 100 ng/ml;
(Sanchezalcazar et al, 1997)- 25 ng/ml).

It is interesting to note that much earlier studies reported both necrosis and apoptosis
occurring simultaneously in L929 cultures treated with TNFa (Mcquilkin and Earle,

1961; Russel et al, 1972). It was suggested that there are two distinct subpopulations o

cells within L929 cultures (Laster et al, 1988). It is therefore possible that over time,

a result of different culturing conditions between research groups, one or other of thes
subpopulations has become dominant, accounting for the contrasting results obtained by
different groups. Nevertheless, the research described in this chapter was performed on
L929 cells that were obtained from ATCC in 1996. When treated with TNFa these cells

exhibited features that could be regarded as typical of both necrosis and apoptosis. Thi
is not a unique finding as Simm et al. (1997) also found features of both necrosis and
apoptosis in serum-depleted fibroblasts.

4.4.3 Mode of death induced by TNFa/Act D
It was confirmed that Act D sensitized L929 cells to TNFa as the rate of death was
increased approximately five fold relative to treatment with TNFa alone (Figure 4.2).
Flow cytometric analysis of 7-AAD-stained TNFa/Act D-treated L929 cells
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discriminated two major populations of cells, viable and dead. A minor population of
cells was also identified that had a reduced volume and stained to an intermediate level
with 7-AAD (Figure 4.3C). As death induced by TNFa/Act D was very rapid it is

possible that the stage of intermediate cell membrane permeability is short lived in this
system. The mode of death in L929 cells exposed to this combination of agents was
apoptotic as cell shrinkage (Figure 4.3C and light microscope observations), membrane
blebbing (Figure 4.7C), exposure of PS at the cell surface (Figure 4.4B), nuclear
condensation/fragmentation (Figure 4.7C) and DNA laddering (Figure 4.6B) were all
detected.

4.4.4 Modes of death induced by staurosporine, colchicine and azide
Staurosporine and colchicine are cytotoxic agents which are commonly used to induce
apoptosis in a variety of cell types. The inhibitory effects of staurosporine on protein
kinases has recently been reported to sensitise L929 cells to the effects of TNFa
(Oconnell et al, 1997; Beyaert et al, 1993). Here it is shown that exposure of L929
cells to staurosporine induced cell shrinkage, extensive membrane blebbing (Figure
4.7D), exposure of PS at the cell surface (Figure 4.4 C), condensation and fragmention
of the nuclei (Figure 4.7D) and cleavage of DNA into oligonucleosomal fragments
(Figure 4.6B). Flow cytometric analysis of staurosporine-treated cells discriminated
only two populations, viable and dead (Figure 4.3C). Staurosporine-induced cell death
was very rapid (Figure 4.2). Thus, it is possible that in this system the stage of
intermediate cell membrane permeability is very short lived (or absent). Taken together,
these results indicate that staurosporine induces rapid apoptosis of L929 cells.

Colchicine is an agent that potently disrupts microtubule structure. Previous studies
have examined the effects of colchicine on L929 cells but these studies focussed on
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changes in microtubules and their effects on the structure of the cell (Moskalewski and
Thyberg, 1988; Kessel and Katow, 1984). Colchicine-treated L929 cells were found to
undergo a stage of intermediate staining with 7-AAD (Figure 4.3E), cell shrinkage
(Figure 4.3E), exposure of PS at the cell surface (Figure 4.4E), condensation of the
nucleus together with a unique pattern of nuclear fragmentation (Figure 4.7F; earlier
described in (Kessel and Katow, 1984)) and membrane blebbing (Figure 4.7F).

Surprisingly, colchicine treatment of L929 cells induced non-specific cleavage of L929
nuclear DNA (Figure 4.6A). However, it is known that not all cases of apoptosis
involve oligonucleosomal fragmentation of DNA (Schulze Osthoff et al, 1994; Zamai
et al, 1996; Nakamura et al, 1995; Fournal et al, 1995; Xu et al, 1996). Therefore, it
is concluded that colchicine induces a form of apoptosis in L929 cells which lacks
specific cleavage of nuclear DNA at internucleosomal sites.

Cell death induced by azide was relatively slow, taking more than 48 hrs for all cells
die, compared with approximately 12 hrs for cells treated with TNFa/Act D (Figure

4.2). Examination of untreated and azide-treated cells by light microscopy indicated t
azide did not induce cell shrinkage. Although a small fraction of azide-treated cells
stained to an intermediate level with 7-AAD, most of these were not reduced in size

compared to viable cells (Figure 4.3D). Azide did not induce exposure of PS at the cell
surface (Figure4.4D), nor did it induce condensation or fragmentation of the nucleus
(Figure 4.7E). Azide induced non-specific fragmentation of DNA in L929 cells (Figure
4.6A). These results are consistent with azide inducing necrosis of L929 cells,
consistent with its effects in many other cell types (Fady et al, 1995; Lizard et al,
1995; Vaux et al, 1996).
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4.4.5 Death of clusterin-secreting L929 transfectants in response to various cytotoxic
agents
The mode of cell death in clusterin-secreting L929 transfectants in response to the

various cytotoxic agents was similar to the parental cell line. The rate of cell death in
L929-LS.clus(F) and L929-LS.clus(B) transfectants treated with the various cytotoxic
agents was not altered when cells expressed clusterin. With the exception of TNFa a
similar pattern was observed in L929-pRc.clus cells when treated with the various
cytotoxic agents.

The overexpression of clusterin in L929-pRc.clus cells was found to provide them with
resistance to TNFa-mediated cytotoxicity, relative to control L929-pRc cells (Figure
4.10 and 4.11). Importantly, this protection was specific to TNFa, since L929-pRc and
L929-pRc.clus cells were equally susceptible to death mediated by colchicine,
staurosporine or azide (Figure 4.9). The level of clusterin expression appeared to
correlate with the level of protection against TNFa. L929-LS.clus cells, which express
approximately 50 times less clusterin than L929-pRc.clus cells (refer Figure 3.R.4),
were not protected from the cytotoxic effects of TNFa. Furthermore, comparing L929pRc.clus xl clones, the levels of resistance to TNFa appeared to relate to the amount of
clusterin expressed (Figure 4.16). Clearly, further research is required to analyse the
relationship between clusterin expression and TNFa toxicity in L929 cells. The Tet
off/on expression system (Clonetech, CA, USA), which only became available late in
this study, would be an ideal expression system for such a study as it allows "graded"
expression of a desired protein.

As a further control to determine whether protein expression was responsible for the
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protection against T N F a another transfectant cell line was created when the studies on
L929-pRc.clus were well advanced. The pEGFP-Nl expression system appeared ideal
as (i) it contained the same CMV promotor found in the CMV/pRc expression system,
and (ii) EGFP is not known to have any effects on mammalian cell metabolism. The
only non-ideal characteristic of the pEGFP-Nl expression system (for this application)
is that the expressed protein remains intracellular. Surprisingly, L929-EGFP cells had a
similar level of protection against TNFa cytotoxicity as L929-pRc.clus cells. As GFP is
a natural protein produced by Aequorea victoria (a bioluminescent species of jellyfish),
it was not expected to specifically interact with the TNF pathway. It is possible,
however, that the protective effect provided by EGFP expression may be non-specific.
For example, the high EGFP intracellular content may have "absorbed" the cytotoxic
effects of ROI that are responsible for TNFa cytotoxicity in L929 cells (Schulze
Osthoff et al, 1992; Goossens et al, 1995; refer section 4.1.4). Alternatively, as high
protein expression is common to both cell lines, it is possible that the expression of

either protein limits cell resources which in turn interferes with intracellular signalli
Future studies will be required to discriminate between these alternative possibilities.

However, clusterin overexpression may have a "real" effect on the TNFa and TGFP
signalling pathways by virtue of some non-specific chemical or physical property of

clusterin protein. It would be valuable to quantify the level of expression of endogenous
clusterin protein during exposure of L929 cells to TNFa. However, as murine-specific
anti-clusterin antibodies were not available, this was not possible. In support of the
contention that expression of clusterin can protect cells from TNFa-mediated
cytotoxicity, Sensibar et al have shown that anti-sense clusterin mRNA enhances
sensitivity of LNCaP cells to TNFa, and that similar protection is provided by
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overexpression of clusterin in the same cell type (Sensibar et al, 1995). Interestingly,
they showed that a transfected clone expressing low levels of clusterin was not
protected from TNFa, while a clone that expressed higher levels was given complete

protection, which agree with the results of this study. Unfortunately, the effects of ot
cytotoxic agents were not studied in the LNCaP system (Sensibar et al, 1995).

4.4.6 Cytoprotective effect of clusterin and its relationship to the TGFp pathway in
L929 cells

Using the two-hybrid system and other techniques, clusterin has recently been identified
as binding with the intracellular domains of TGFP receptors type I and II (Reddy et al,
1996). It has also been independently demonstrated that in L929 cells TGFpi induces
resistance to TNFa-mediated cytotoxicity (Chang, 1995). It was reported that the
exposure of L929 cells to TGFP induces phosphorylation of a variety of cellular
proteins and induces the secretion of proteins that bind to the extracellular matrix,
which can protect other L929 cells against TNFa cytotoxicity. Both of these induced
effects were implicated in protecting L929 cells from TNFa-mediated cytotoxicity
(Chang, 1995). These results were partly confirmed in that the exposure of L929 cells to
TGFp protected the cells from cytotoxicity associated with subsequent exposure to
TNFa (Figure 4.12). It was thought that the protective effects of clusterin expression
against TNFa cytotoxicity may be linked with the TGFP pathway. Therefore, L929pRc.clus cells were tested to determine whether the cytoprotective mechanism against
TNFa cytotoxicity was similar to that of L929 cells pre-treated with TGFp. It was
found that L929-pRc.clus transfectants did not secrete protein(s) capable of protecting
L929-pRc or L929 wild type cells against TNFa cytotoxicity (Figure 4.13 C).
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The high level of clusterin expression in L929-pRc.clus cells treated with T G F p alone
potentiated low levels of cell death. Pre-exposure of L929-pRc.clus cells to TGFp did
not alter the already high resistance to TNFa-mediated cytotoxicity (Figure 4.12). These

results indicate that the protective effects of clusterin overexpression and TGFp against
TNFa-mediated cell death are not additive and suggests that both clusterin and TGFp
may antagonise the TNFa-mediated cell death pathway via a common mechanism.

While the suggestion that high-level clusterin expression may potentiate the cytotoxicity
of TGFP on the one hand, yet on the other hand provide protection from TNFamediated cytotoxicity might at first appear paradoxical, the ability of a single type of
molecule to be involved in signalling for the opposing outcomes of cell death versus
survival is not unprecedented. Both Fas and TNFa induce cell death in tumour cells and
lymphocytes but can also enhance cell proliferation in these same systems (Ware et al,
1996). Furthermore it is known that TNFa induces resistance to its own cytotoxic effect
(Ware etal, 1996).

High protein expression is a common factor between L929-pEGFP and L929-pRc.clus
transfectant cells and may explain the resistance each has against the cytotoxic effects
of TNFa. For example during TNFa treatment the high level of protein expression in
these transfected cells may have resulted in the use of cell resources that are normally
required for full activation of the TNF pathway. However, it is possible that the human
clusterin protein expressed in L929-pRc.clus cells may specifically interact with
components of the TNF pathway. If clusterin is capable of specifically protecting L929
cells against TNFa cytotoxicity then the results described here suggest that it is most
likely to act intracellularly, since: (i) L929-pRc.clus cells did not secrete molecules

capable of protecting other L 9 2 9 cells against T N F a cytotoxicity (Figure 4.13 A ) ; (ii)
protection was not provided by the addition of exogenous clusterin (Figure 4.13 B); and

finally (iii) protection could not be ascribed to clusterin bound to the cell surface, s
no surface clusterin was detected by flow cytometry (Figure 4.13 D).

4.4.7 Analysis of secreted and intracellular forms of clusterin from L929-pRc.clus
transfectants
A truncated, non-glycosylated 43 kDa form of clusterin lacking the first 33 N-terminal
amino acids, and hence the hydrophobic signal peptide, has been reported in TGFPtreated HepG2 and CCL64 cells (Reddy et al, 1996). This shorter form of clusterin is
clearly translated on free ribosomes and is not translocated into the lumen of the
endoplasmic reticulum (Reddy et al, 1996). The intracellular form of clusterin could
therefore interact with the cytoplasmic domains of TGFp (or other) receptors. Analysis

of the forms of clusterin present in lysates of transfected L929 cells was performed as a

first step in examining the possibility that a cytosolic form of clusterin might interac
with cytoplasmic domains of receptors and hence influence the cellular response to
TNFa. When analysed under non-reducing conditions, cell lysates of L929-pRc.clus
and IPTG-induced L929-LS.clus cells contain two major species of clusterin, one is
similar to the secreted form with a molecular mass of about 80 kDa, and the other is an
uncleaved form of apparent molecular mass about 64 kDa (Figure 4.14).

Similar forms of clusterin, at 58 kDa and 70 kDa, were also present in lysates of HepG2
cells (Burkey et al, 1991). The 70 kDa form was shown to represent mature
glycosylated clusterin, processed via the endoplasmic reticulum and Golgi systems, and
internally cleaved to produce the two subunits. It has been suggested that this form is
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found within the cell inside Golgi and post-Golgi vesicle compartments. The 58 k D a
form has been shown to represent a non-glycosylated, uncleaved precursor form to the
70 kDa species (Burkey et al, 1991). Two forms of intracellular clusterin have also
been identified in MDCK cells: an uncleaved, incompletely glycosylated 65 kDa form
and a cleaved and fully glycosylated 80 kDa form (Urban et al, 1987). The two forms

of clusterin present in L929 cell lysates almost certainly correspond to the intracellul
forms described in untreated HepG2 and MDCK cells (Burkey et al, 1991; Urban et al,
1987). The recent demonstration of a novel 43 kDa truncated form of clusterin in
TGFp-treated HepG2 and CCL64 cells and the association of this form with the cell
nucleus (Reddy et al, 1996a), led to the examination of L929 cells to establish whether
exposure to TGFp or TNFa induced any changes in the level of synthesis of different
molecular forms of clusterin or their association with the nucleus.

In response to TNFa, L929-pRc.clus cells demonstrate an increased association of fully
processed clusterin, physically indistinguishable from cell-secreted clusterin, with the
nucleus (Figure 4.14). Flow cytometric analysis demonstrated that there is an increased
association of clusterin specifically with dead cells lacking an intact cell membrane
(Figure 4.15). This most probably results from secreted clusterin binding to dead cell
nuclei. The demonstration that BSA also binds to dead cell nuclei under these same
conditions and that clusterin and BSA bound to the nuclei of permeabilised untreated

cells indicates that the interaction of clusterin with the nucleus is in this case unlik
have physiological relevance (Figure 4.15).

An intracellular form of clusterin was also detected on immunoblots (following
SDS/PAGE under reducing conditions) as a pair of bands at about 36 and 38.5 kDa
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which was found in increased amounts in L929-pRc.clus cells treated with T N F a ,
TNFa + Act D, TGFp, azide, colchicine or staurosporine. These bands were unique as
the constitutively produced clusterin in either untreated or TNFa-treated L929-pRc.clus
cells appeared on the same immunoblots as a pair of poorly resolved bands at about 4345 kDa (Figure 4.14). The clusterin variant is clearly not the truncated 43 kDa
unprocessed form reported associated with nuclei in TGFp-treated HepG2 and CCL64
cells (Reddy etal, 1996). The TNFa-induced form of clusterin in L929-pRc.clus cells

is internally proteolytically cleaved and is not specifically associated with the nucleus
An exon-skip mechanism has been hypothesized to account for a truncated clusterin
mRNA in rat tissues treated with heat-shock or inhibitors of protein synthesis (Kimura
& Yamamoto, 1996). Therefore, the apparently smaller size of the clusterin subunits
induced by toxic agents could result from a variety of mechanisms, including
modifications to transcription (Kimura & Yamamoto, 1996) or translation (Reddy et al,
1996), additional proteolytic processing, or changes in glycosylation. The proportion of
clusterin detected as the 36/38.5 kDa form was increased in response to all of the toxic
agents tested. This indicates that this novel form may not be responsible for providing
protection from TNFa. However, it still remains a possibility.

4.4.8 Electroporation of clusterin into L929 cells does not provide protection from

TNFa
To confirm that clusterin was acting intracellularly in protecting L929 cells from TNFa
mediated death a method was established to introduce purified clusterin into intact L929
cells. Electroporation has previously been shown to succesfully incorporate exogenous
proteins into fibroblast cells (Glogauer and McCulloch, 1992). L929 cells were also
shown to incorporate exogenous proteins following this method. Surprisingly, the

incorporation of purified clusterin into L 9 2 9 cells did not provide any protection against
TNFa (Figure 4.18).

Electroporation is an invasive technique and may have inhibited clusterin from
protecting L929 wild type cells against TNFa. For example, clusterin or other proteins
may have leaked out from electroporated cells after a short period of time. An

alternative interpretation of this result is that it suggests that the protection gained i

clusterin-expressing cell lines is an artifact and is not specifically due to the expressi
of clusterin.

4.4.9 The effect of TNF on other transfected cell lines.
Another transfected cell line created late in this study was the HeLa-pRc.clus. TNFa
induces apoptosis in HeLa cells, an effect that can be augmented by the addition of
cycloheximide (White et al, 1992). The overexpression of clusterin in HeLa-pRc.clus
did not provide protection against TNFa cytotoxicity as seen in the L929 transfectants.
Instead, the cytotoxic effect of TNFa was enhanced by the overexpression of clusterin.
The differences seen in HeLa and L929 transfectants in response to TNFa may be
explained by different pathways being activated by TNFa. As HeLa and L929 originate
from different species this may mean that TNFa activates different pathways, hence
resulting in different outcomes.

123

4.4.10 Conclusion
The results presented in this chapter describe examinations of a variety of
morphological and biochemical parameters commonly used to discriminate between
apoptotic and necrotic cells. These studies determined the mode of death occurring in
L929 cells in response to treatment with TNFa and other cytotoxic agents. The
parameters examined included changes in membrane permeability (measured by
staining with 7-AAD) and exposure of PS at the cell surface (detected by binding of
annexin V-FITC). The literature reveals that these techniques have not been used before
in studies of L929 cell death. Features of both necrosis and apoptosis were detected in
L929 cells exposed to TNFa alone. The augmentation of the cytotoxicity of TNFa with
Act D induced classical apoptosis in L929 cells. This study also demonstrated for the
first time that staurosporine and colchicine both induce apoptosis of L929 cells.

There has been a clear association between increased clusterin expression and a wide

variety of instances of cellular "stress". It has been suggested that clusterin expressio

may be a general cellular response to a variety of noxious insults. The effect of cluster

expression in L929 cells treated with the various cytotoxic agents was also studied. The
overexpression of clusterin was shown to protect transfected L929 cells from death
mediated by TNFa but not from death induced by colchicine, staurosporine or azide.

The results also indicate that high level expression of clusterin potentiates the induct
of cell death in L929 cells by TGFp. The results are compatible with the suggestion that
clusterin and TGFp may act through a common mechanism to protect L929 cells from
TNFa cytotoxicity. The intracellular action of clusterin protein may be responsible for
the protection against TNFa cytotoxicity . However, this cannot be accounted for by

synthesis of a 43 k D a truncated form of clusterin reported in other systems, or a

cytokine-induced specific association of clusterin with the nucleus. Unexpectedly, hig
expression of EGFP also protects L929 cells against TNFa which raises the possibility
that in each case the effects measured are non-specific and only due to high levels of

protein expression. However, it remains possible that each protein specifically protec
cells from TNFa.

A subset of the results presented in this chapter have been published in the following
two journal papers:
Humphreys D., Hochgrebe T. T., Easterbrooksmith S. B., Tenniswood M. P. and
Wilson M . R. (1997) Effects O f Clusterin Overexpression O n TNF-Alpha- and T G F Beta-Mediated Death O f L929 Cells. Biochemistry 36, 15233-15243
Humphreys D.T., andWilson M.R. (1999) Modes of L929 cell death induced by TNFa
and other cytotoxic agents. Cytokine. In press.
These papers are attached in the appendix.

CHAPTER
Chaperone-like activity of
clusterin.
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5.1 INTRODUCTION
Clusterin has been shown to bind a wide array of biological molecules which include
immunoglobulins (Wilson and Easerbrook-Smith, 1992), lipids (Gelissen etal, 1998),
heparin (Pankhurst etal, 1998), glutathione-S-transferase (GST) (S B Easterbrook-Smith,
unpublished results), the surfaces of pathogenic isolates oi Staphylococcus aureus
(Partridge et al, 1996), terminal complement components C7, C8 and C9 (Tschopp et al,
1993), apolipoprotein A-I (Jenne et al, 1991), paraoxonase (Kelso et al, 1994), amyloid p
peptide (Oda et al, 1995), gp330 (Kounnas et al, 1995) and a protein secreted by

Streptococcus pyogenes (Akesson et al, 1996). Each description of a new clusterin binding

interaction has proposed that clusterin is involved with the specific biological functio

the binding partner. Consequently, functions proposed for clusterin are as diverse as its

reported binding partners (refer chapter 1). None of the previously proposed functions h
been established as genuine.

Sequence analysis predicts that clusterin has three putative amphipathic a-helical regio
type of secondary structure thought to be important in mediating interactions with
hydrophobic molecules (de Silva et al, 1990a; Tsuruta et al, 1990; Figure 1.1). Many of

the reported biological ligands of clusterin are largely or partly hydrophobic in charact
Therefore, the interactions of these molecules with clusterin may reflect a general
propensity of clusterin to bind to hydrophobic regions of molecules, regardless of their

biological function. In this context, the recent demonstration that a highly conserved 14

element (clusterin element or CLE), shared by all vertebrate clusterin proximal promoters

specifically recognizes the heat shock factor 1 (HSF1) transcription factor is of signif
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interest. This 14-bp element was shown to be capable of mediating heat-shock-induced
transcription (Michel et al, 1997). These authors suggested that this heat-responsive
element provides an explanation for the high sensitivity of clusterin expression to

environmental changes and proposed that clusterin may function as an extracellular heat
shock protein (Michel et al, 1997).

Heat shock proteins (HSP) are cytoprotective proteins that were first identified by th

upregulated expression in response to cellular stresses such as heat, hypoxia, and met
stress. HSP are categorised into five classes based on size, which include: HSP100,
HSP90, HSP70, HSP60 and the small HSP (sHSP). Each class of HSP contains proteins

that have high sequence homology to one another and all facilitate the folding of other

proteins. The upregulation of these proteins in times of stress are essential for cell

as they prevent cell death by inhibiting permanent denaturation of proteins. The abili
HSP to interact with the folding and unfolding of proteins led to the term molecular
chaperone.

The transcriptional activation of HSP upon heat shock results from the trimerisation of

proteins called heat shock factors (HSF) which bind to specific regions called heat sho
elements (HSE) located in the HSP promotor (Westwood et al, 1991). All HSP typically
have between three and six HSE in the upstream promotor sequence, which are inversely
repeated, and have a length of five base pairs (5' -nGAAn- 3') (Amin et al, 1988). The
CLE differs by only one base to three HSE inverted repeats (CLE: nTTCnnGAAnnCTCn;
triple HSF repeats: nTTCnnGAAnnTTCn). Mutation experiments that altered the central
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G A A motif in C L E reduced the heat shock induced transcriptional activity of the clusterin
promotor sequence (Michel et al, 1997). This indicates that the one copy of CLE in the

clusterin promotor is essential for heat induced transcription activity. If HSF is resp

for regulating clusterin expression via CLE in vivo then HSP70 proteins, one of the most

important classes of HSP that regulate the stress response in eukaryotic cells by bindin
and inactivating HSFs, may also regulate clusterin expression.

The members of the sHSP are less conserved than other HSP, but all have a conserved
domain refered to as the "a-crystallin domain" (Ehrnsperger et al, 1997; Leroux et al,
1997). The upregulated expression of sHSP provides thermotolerance to some cells. The
pattern of activation of sHSP is different to that of other HSP. For example, they are
upregulated at lower temperatures than other HSP and are the most highly expressed
proteins relative to other HSPs (Arrigo and Landry, 1994). During stress, sHSP localise

the nucleus (Collier and Schlesinger, 1986; Arrigo et al, 1988; Collier et al, 1988; No
et al, 1989; Rossi and Lindquist, 1989; Lavoie et al, 1993a). However sHSP are not

always upregulated in times of stress, for example, they are also upregulated in respon
various hormones (eg hsp27 estrogen (Fuqua et al, 1989)). The upregulated expression of

sHSP in response to stress is of the same order of magnitude as clusterin. Recently it w
shown that the upregulation of sHSP protected L929 cells from the cytotoxicity of

TNFa (Mehlen et al, 1995). The level of protection was similar to that measured in L929-

pRc.clus cells expressing clusterin (chapter 4). There is no substantial sequence homol
between clusterin and any known sHSP. However, there are three small regions of

sequence similarity between human clusterin and bovine a-crystallin (an archetypal sHSP

129

Figure 5.15). These regions correspond to h u m a n clusterin residues 203-210, 227-233 and

243-249 (numbered from the first translated residue; Figure 5.1). Interestingly, the last
these regions (K70 to V76 in aA-crystallin) corresponds to a part of the "a-crystallin
domain" which is the most conserved region in all sHSP.

bovine aA-crystallin
33

EYDLLPFL40

54

RTVLDSG60

70

KFVI FLD76

human clusterin
203TYHYLPFS

210 227

RSLMPFS

233 243

MFQPFLE249

Figure 5.1: Regions of sequence similarity between human clusterin and bovine aA-crystallin
(analysed using M a c Vector v4.14). Clusterin residues are numbered from the N-terminal amino acid of the
pre-pro-protein (ie prior to removal of the 22 amino acid signal peptide).

The function of clusterin expressed during cellular stress, like the sHSP, may be to act
chaperone-like manner and bind to hydrophobic regions of partly unfolded, stressed

proteins, thereby "solubilizing" them and protecting cells from the cytotoxic consequence
of protein precipitation. The aim of work described in this chapter was to test one part

this hypothesis by examining the ability of clusterin to protect a variety of proteins fr
stress-induced precipitation in vitro.
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5.2 MATERIALS AND METHODS:
5.2.1 Reagents- Bovine serum albumin (BSA), catalase, l-chloro-2, 4-dinitrobenzene,
glutathione (GSH), H202, iodoacetamide (IAA), a-lactalbumin and l-anilino-8naphthalene sulfonate (ANS) were all obtained from Sigma (St. Louis, MO, USA).
Dithiothreitol (DTT) was obtained from Boehringer Mannheim (Sydney, Australia). All
buffer salts were obtained from Ajax (Sydney, Australia). Glutathione-S-transferase
from Schistosoma japonicum was prepared by thrombin cleavage of recombinant Jun

leucine zipper-GST fusion protein and purified by GSH-agarose affinity chromatograph
as described by (Heuer et al, 1996).

5.2.2 Immunoaffinity purification ofclusterin5.2.2.1 Preparation of serum- Human serum packs were stored at -80°C. Serum
packs were quickly thawed in a 37°C water bath. 1 mM of phenylmethanesulfonl
fluoride and 5 mM of EDTA (protease inhibitors) was added to the serum. The
serum was filtered through a 7 cm glass fibre filter paper (GFC, Whatman, Crown
Scientific, Sydney).

5.2.2.2 Isolation of clusterin- PBS + 0.02% azide was passed through G7 anticlusterin monoclonal antibody column and a UV monitor until a baseline had
formed on the connected chart recorder (Figure 5.2). The UV monitor, which had
a 280 nm flow cell, was set at 0.5 absorbance units, the chart recorder 100 mV
and the flow rate was set at 0.5 ml/ minute. Serum was then passed through the
G7 column followed by washing with PBS + 0.02% azide until the base line was
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reached. 0.5% Triton X 1 0 0 in P B S + 0.02% azide was then passed through the
system to remove any bound apolipoprotein (Apolipoprotein A-I co-purifies with
clusterin purified from human serum; Jenne et al, 1991). PBS + 0.02% azide was
once again flushed through the column until the base line was reached. Clusterin
was then eluted from the column with 2 M guanidine hydrochloride (prepared in
PBS, pH 7.4).

Crude
Sample

Unbound material
or
purified sample

F i g u r e 5 . 2 : Immunoaffinity chromatography setup. Crude sample is pumped through the system at a rate
controlled by a peristalic pump. Clusterin is retained in the column while the remaining molecules pass out via
the U V monitor. After all crude material has been washed from the system the molecule of interest can be
eluted from the column and collected.

5.2.2.3 Secondary purification of Clusterin- Guanidine hydrochloride solutions
containing clusterin were dialysed against two 3 L volumes of PBS + 0.02 %
azide. Thereafter clusterin was passed through a Protein G column (Sigma,
Sydney) to remove contaminating IgG. Chart recorder settings and the flow rate
were the same as described for the G7 immunoaffinity column. The fraction
which passed through the Protein G column contained clusterin which was free of
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IgG. 2 M guanadine hydrochloride (pH 7.4) was used to elute off any Ig-clusterin
complexes. Thereafter PBS + 0.02 % azide was passed through the column until
the base line was reached.

5.2.2.4 Concentrating dilute stocks of clusterin- Each clusterin sample was then
concentrated in dialysis tubing where water + salts were absorbed from samples
by covering the dialysis tubing with dextran (7 million Daltons in size, ICN;
Sydney, Australia). The amount of clusterin present in a sample was calculated by
an absorbance reading at 280 nm. Every batch of purified clusterin was analysed
by SDS-PAGE electrophoresis (Refer 2.2.1)

5.2.3 Protein precipitation assays - Individual solutions of clusterin (10-200 pg/ml)

catalase (200 pg/ml) or GST (200 pg/ml), or mixtures of clusterin with catalase or GS
the same final concentrations, were prepared in 0.7 ml of 50 mM sodium phosphate
containing 0.1M NaCl and heated at 60°C. The light scattering of the solution at 360
was measured every 30 s for a total of 25 min in an automated seven chambered diode
array spectrophotometer (Hewlett Packard GMBH, Germany). Individual solutions of

clusterin (10-200 pg/ml), a-lactalbumin (2.5 mg/ml) or BSA (2.5 mg/ml), or mixtures o

clusterin with a-lactalbumin or BSA at the same final concentrations, were prepared i
ml of 50 mM sodium phosphate containing 0.1 M NaCl (or NaS04 or NaSCN where
indicated) and incubated at 37°C with or without 20 mM DTT. During this period
absorbance readings at 360 nm were acquired every 5 min for a total of 5 h in a
Spectramax 250 plate reader (Molecular Devices, Sunnyvale CA).
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5.2.4 Enzyme assays - Catalase was prepared at a concentration of 200 pg/ml in 0.1 M

sodium phosphate (pH 7.0) with or without clusterin (100 pg/ml). Mixtures were heat

37°C or 55°C for 30 min. 1.0 pi of the catalase/clusterin mixture was incubated wi

ml of H202 substrate solution (0.12% (v/v) H202 in 50 mM Na2HP04, pH 7) at 37°C for 5

min before the reaction was stopped with 150 pi of 4 M NaOH. The absorbance of H202

was measured at 250 nm on a Spectramax 250 plate reader. Enzyme activity was measur

as a decrease in absorbance. GST was prepared at a concentration of 200 pg/ml in 50

Na2HP04 (pH 7.0) with or without clusterin (100 pg/ml). Mixtures were heated at 37°
50°C for 30 min. GST was then diluted into substrate solution (1 mM GSH, 2 mM 1-

chloro-2,4-dinitrobenzene in 0.1 M phosphate solution pH 7.4) to a final concentra

4.5 pg/ml and incubated at 37°C for 5 min before measuring the absorbance at 350 nm
Enzyme activity was measured as an increase in absorbance, corresponding to the
appearance of l-S-glutathionyl-2,4-dinitrobenzene.

5.2.5 ELISA - GST and catalase, at 20 pg/ml in PBS (137 mM NaCl, 2.7 mM KC1, 1.5
mM KH2P04, 8 mM Na2HP04, pH 7.4) were adsorbed onto ELISA trays (Disposable

Products, Adelaide, Australia) for 1 h at 37°C. In some cases, after the coating st
trays were heated to 60°C for 30 min to partially denature the adsorbed proteins.
a-lactalbumin were applied to ELISA trays in PBS at concentrations between 1 and 5

mg/ml, with or without 20 mM DTT, and incubated overnight at 37°C. Plates were then
blocked with 1% (w/v) heat-denatured casein (HDC) prepared in PBS, pH 7.4 (ie 1%

HDC). Plate-bound, DTT-treated proteins were then incubated with 5 mM IAA for 1 h a
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37°C, in order to exclude the possibility of subsequent formation of disulfide bonds

between clusterin and the other proteins. Clusterin, initially at 10 pg/ml, was then s
diluted in binary steps across the ELISA tray, using 1% HDC as diluent, and incubated

37°C for 1 h. To minimize non-specific binding of clusterin to the ELISA plates, three

washes were then performed with 0.1% (v/v) Triton X-100 in PBS. A cocktail of G7, 78E
and 4ID anti-clusterin monoclonal antibodies was used to detect bound clusterin, and

DNP-9 was used as a isotype control. All antibodies were used in the form of unpurifie

hybridoma culture supernatants. Bound primary antibodies were detected with sheep-anti
mouse-Ig-HRP (Silenus, Sydney, Australia) using o-phenylenediamine dihydrochloride
(OPD; 2.5 mg/ml in 0.05 M citric acid, 0.1 M Na2HP04, pH 5.0, containing 0.03% (v/v)
H2O2) as substrate.

5.2.6 Size exclusion chromatography and native gel electrophoresis - Individual
solutions of clusterin (1 mg/ml), or GST, catalase, BSA or a-lactalbumin (each at 2

mg/ml), or mixtures of clusterin with one of the other proteins (at the same respectiv

concentrations) were left untreated or treated with heat (60°C for 30 min) or DTT (20

at 37°C for 5 h) and then centrifuged (1 min at 10,000 rpm in a benchtop microfuge) t

remove precipitated protein. Each solution was then analysed by loading 50 pi onto a 2

1 cm column of Sephacryl 300 (Pharmacia Biotech, Melbourne, Australia) equilibrated in
PBS containing 0.02% (w/v) azide. Separations were performed at a flow rate of 0.25
ml/min using a low pressure liquid chromatography system equipped with a 280 nm flow
cell (Econosystem; BioRad, Sydney, Australia). Aliquots (10-15 pg total protein) of
solutions prepared as above were also electrophoresed on 1% agarose gels. After
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electrophoresis gels were often stained with Coomassie blue for 30 minutes at room

temperature before being destained in destain solution overnight (refer section 2.2.1 a
2.2.2.3). In some cases, proteins were excised from gels to be further analysed by SDS

PAGE electrophoresis. Coomassie blue stained gels could not be used for this purpose as

the staining procedure precipitates proteins. Native proteins were removed from gels in

which duplicate samples had been loaded. After electrophoresis half the gel was stained

with Coomassie blue while the other half was stored at -20°C to stop proteins diffusing

of the gel. After the stained gel was destained (using destain, refer sections 2.2.1 an

2.2.2.3) the protein bands were identified and the corresponding section of the frozen

was excised. Excised gel pieces were boiled in Eppendorf tubes with the addition of SDS

and bromophenol blue (final concentrations of 0.01% (w/v) and 0.05% (w/v) respectively)
prior to loading onto polyacrylamide gels.

5.2.7 ANS fluorescence studies - Individual solutions of clusterin (100 pg/ml), or GST

catalase (each at 200 pg/ml), or mixtures of clusterin with one of the two other protein
the same respective final concentrations) were left untreated or heated at 60°C for 30

Individual solutions of clusterin (1.0 mg/ml) or BSA or a-lactalbumin (each at 2.5 mg/m

or mixtures of clusterin with one of the two other proteins (at the same respective fin

concentrations) were left untreated or were incubated with DTT (20 mM at 37°C for 5 h).

A total of 10-20 pg of protein was then loaded into wells of a black 96 well tray (Nunc

Denmark). At room temperature, ANS was progressively added to each well to give a final
concentration of up to 150 uM. After each addition of ANS, the fluorescence (390 nm
excitation/480 nm emission) of the wells was measured with a Biolumin 960 fluorescence
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plate reader (Molecular Dynamics, Melbourne, Australia). The fluorescence values

obtained were corrected by subtracting the fluorescence of equivalent amounts of ANS i
blank wells containing buffer alone. In some cases, possibly as a result of quenching
fluorescence of ANS in solution by protein, this correction produced small negative
fluorescence values.

5.2.8 Clusterin binding to DNA + DNA degradation assay- Genomic DNA was purified

from untreated L929 cells as described in section 4.2.4. RNA was purified from L929 ce

using the RNA isolation reagent (Integrated sciences, Sydney). 200 ng of DNA was dotte

onto nitrocellulose membrane and baked at 70°C for 1 hour. Membranes were then blocked
with 1% HDC for 1 hour. Membranes were then incubated in solutions of 1% HDC
containing 20 ug/ml of clusterin, before being washed with PBS with or without 0.1%
Triton X-100. Bound clusterin was detected with TC sn from G7 hybridoma cultures
followed by sheep-anti-mouse-HRP secondary antibody. Blots were developed with ECL
(Pierce, Sydney, Australia) following the manufacturer's instructions.

For the DNA degradation assay, tubes were set up containing DNA (3-10 ug), DNase (0-

15 ug), and either clusterin, BSA, gelatin or casein (100 ug/ml) in a total volume of
Tubes were incubated for 30 minutes at 37°C before samples were immediately
electrophoresed in 1% agarose gels.
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5.2.9 Studies of the effects of heat and H202 on cell viability- L929-pRc and L929-

pRc.clus cells were cultured in 24 well TC trays. For analysing the effect of heat on c

viability, cultures were prepared in 24 well TC trays and then incubated in fresh media
either 37°C, 41°C or 50°C for set periods of time. For analysing the effect of H2O2 on

viability, cultures were prepared in 24 well TC trays and then incubated in fresh media
containing 0.4 mM H202 for 24 hours. After either treatment cells were removed from TC
trays with trypsin and stained with PI before being analysed by flow cytometry (as
described in section 4.2.3.2).
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5.3 RESULTS
5.3.1 Purification of clusterin by immunoaffinity chromatography.
The G7 immunoaffinity column was equilibrated with PBS (Figure 5.3A pre-peak A)
before 50 ml of serum was passed through. Serum passage was detected by the UV
monitor as a large absorbance (Figure 5.3 A peak A). PBS followed serum through the

column until the baseline was reached. Apolipoprotein A-I and lipids were dissociated

from bound clusterin with 0.1% Triton X-100 (Figure 5.3 A peak B) before clusterin wa

finally eluted from the column with 2 M guanidine hydrochloride (Figure 5.3 A peak C)

Analysis of purified clusterin on SDS PAGE gels revealed a major protein species with

size of 80 kDa, which ran at 40 kDa under reducing conditions (Figure 5.3 B). Western

immunoblots using the human clusterin specific monoclonal antibody confirmed that thi
protein was clusterin (Figure 5.3 C). SDS PAGE analysis of purified clusterin also
revealed a minor protein species with a size of 200 kDa. This was thought to be
contaminating IgG, which clusterin binds to (Wilson and Easterbrook-Smith, 1992).

Clusterin stocks were therefore passed over a Protein G column to remove contaminatin
IgG. Clusterin which was free of IgG (as seen in figure 5.3 B) was used for further
experimentation.
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F i g u r e 5.3: A ) A trace of a chart recording which measured the absorbance of solutions
passed over a G 7 anti-clusterin immunoaffinity column. The U V monitor was blanked on PBS.
Peak A corresponds to serum being passed through the column followed by PBS. Peak B
corresponds to Triton X-100 being passed through the column followed by PBS. Peak C
corresponds to 2 M guanidine hydrocholride (pH 7.4) being passed through the column followed
by PBS. B ) 10 % S D S - P A G E electrophoresis of clusterin purified by immunoaffinity
chromatography. Lane: 1 Molecular weight markers; lane 2: 10 pg of clusterin; lane 3: 10 pg of
clusterin reduced with P-mercaptoethanol. C ) Immunoblot of an S D S P A G E gel which
electrophoresed purified clusterin samples. Lane 1: 1 pg clusterin; lane 2: 1 pg clusterin reduced
with P -mercaptoethanol. Clusterin was detected with a cocktail of G7,41D and 78E antibodies.

5.3.2 Clusterin protects proteins from stress-induced precipitation but does not protect
enzymes from heat-induced loss of function
Heating solutions containing GST or catalase at 60°C produced extensive protein

precipitation within 30 min (Figure 5.4 A, B). Likewise, reduction of solutions containi
BSA or a-lactalbumin with DTT resulted in extensive protein precipitation within 4 h

(Figure 5.4 C, D). In contrast, clusterin did not precipitate when heated at 60°C for 30

or when treated with DTT for 5 h (Figure 5.4 E). Similarly other proteins that were stab

at high temperatures did not prevent other proteins from precipitating (Figure 5.4 F). W
co-incubated with any of the proteins subjected to heat or DTT-mediated reduction,
clusterin potently inhibited protein precipitation (Figure 5.4 A-D).

To investigate whether clusterin is also capable of protecting enzymes from stress-induc
loss of function, the enzyme activity of GST and catalase was tested before and after

exposure to 60°C for 30 min in the presence or absence of clusterin. The enzyme activity
of GST was determined by an increase in absorbance at 350 nm which corresponded to the
conversion of l-chloro-2, 4-dinitrobenzene and glutathione to l-S-glutathionyl-2,4dinitrobenzene. Catalase is an enzyme found in peroxisomes and is responsible for
catalysing 2H202 into H20 and 02 (Alberts, 1989). A spectral scan showed that H202
absorbed light at wavelengths between 200 and 260 nm (Figure 5.5 A). Therefore the
enzyme activity of catalase was measured at 215 nm, where a decrease in absorbance

represented consumption of H2O2. The presence of clusterin (at sufficient concentration t
provide protection against precipitation; Figure 5.5 A,B) had no effect on the loss of
enzyme activity in either case (Figure 5.5 B,C). Overall, these results
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F i g u r e 5 . 5 : Enzyme activity of (A) G S T and (C) catalase following incubation at either
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below the x-axis indicates the conditions applied (indicated by an "x"). G S T activity was
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250 nm, representing the disappearance of H 2 0 2 which absorbs light at this wavelength. A )
spectral absorbance scan of H 2 0 2 between 190 and 300 nm. Further description of these activity
assays is provided in Experimental Procedures. Each histogram represents the mean of three
replicate measurements and the error bars shown correspond to standard errors (SE) of the mean.
In some cases, the S E are too small to be visible.

X

indicate that clusterin has potent heat- and reduction-stable chaperone-like properties that

are capable of protecting stressed proteins from precipitation but which cannot protect G
or catalase from heat-induced loss of enzyme activity.

5.3.3 Clusterin binds preferentially to stressed proteins

Clusterin did not bind significantly to any of the non-stressed proteins tested, with the

exception of GST (Figure 5.6). Binding of clusterin to unstressed GST had been previously
noted (S. Easterbrook-Smith, unpublished results). Clusterin showed significantly
increased binding to heat-stressed GST (Figure 5.6 A) and significant binding to DTTtreated BSA and a-lactalbumin (Figure 5.6 C, D). Thus, the ELISA results indicate that,
comparing untreated versus stressed GST, BSA and a-lactalbumin, clusterin binds

preferentially to the stressed form of each protein. In the ELISA configuration tested, t

was minimal binding of clusterin to either untreated or heat-stressed catalase (Figure 5.
B). However solution-phase denatured catalase was shown to inhibit the binding of
clusterin to plate-bound denatured GST, while solution-phase non denatured catalase did
not (Figure 5.6 B insert). This suggests that clusterin also preferentially binds to the
stressed form of catalase.

5.3.4 Clusterin interacts with stressed proteins to form a HMW complex
Chaperones such as the sHSP are known to form HMW complexes with partly unfolded
proteins under stress conditions (Rao et al, 1993; Carver et al, 1994). Experiments were
carried out to determine whether clusterin interacted with stressed proteins to form HMW
complexes. Size exclusion chromatography was used to analyse the following proteins or
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F i g u r e 5 . 6 : Results of E L I S A measuring the binding of solution-phase clusterin to native
(0) or denatured ( • and A ) adsorbed proteins: (A) G S T , heated at 60°C for 40 min to denature;
(B) catalase, heated at 60°C for 40 min to denature. Insert shows solution phase denatured catalase
inhibiting the binding of clusterin to denatured G S T which was adsorbed to the plate; (C) B S A ,
incubated with 20 m M D T T at 37°C for 5 h to denature; (D) a-lactalbumin, incubated with 20 m M
D T T at 37°C for 5 h to denature. Bound clusterin was detected with the G 7 (anti-clusterin)
monoclonal antibody (• , 0 ) and D N P - 9 (A) was used as an isotype control; refer Experimental
Procedures. The results shown are representative of three independent experiments. Each data point
represents the mean of three replicate measurements and the error bars shown are S E of the mean
in each case. In some cases, the S E are too small to be visible.

mixtures of proteins initially dissolved in P B S : clusterin alone, either untreated or heat- or

DTT-treated; GST or catalase, either alone or together with clusterin and either untreat

or heat-treated; BSA or a-lactalbumin, either alone or together with clusterin and eithe
untreated or DTT-treated.

The absorbance peak of clusterin was small in comparison to other proteins and there was
no significant difference between the elution profiles of untreated versus heat-treated

clusterin. Following treatment with DTT, there was a modest decrease in the proportion o

clusterin oligomers eluting at a position approaching that of the exclusion limit of the
column (Figure 5.7 C, D). The resolution of the Sephacryl S-300 column used is limited
the range < 100 kDa, however, there was no evidence of the appearance of 40 kDa species
(expected position indicated by dotted arrows, figure 5.7 C, D) which would indicate

physical dissociation of the a and p chains. Thus, disruption of the interchain disulfid

bonds by DTT resulted in partial dissociation of very large clusterin aggregates to form

monomers (80 kDa species) or lower order clusterin oligomers but did not appear to cause
substantial dissociation of the a and (3 chains.

In all cases, when clusterin was added to proteins undergoing heat- or DTT-mediated
stress, analysis of the mixtures by size exclusion chromatography indicated pronounced
formation of HMW complexes (Figure 5.7 A-D). The HMW complexes were not detected

in analyses of clusterin alone or any of the individual proteins, whether these molecule

were stressed or not. Nor were they detected in mixtures of clusterin and any of the oth
proteins in the absence of experimental stress (Figure 5.7 A-D). Next SDS PAGE
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F i g u r e 5 . 7 : Size exclusion chromatographic analyses of individual solutions of clusterin, G S T ,
catalase, B S A or a-lactalbumin, or mixtures of clusterin with one of the other proteins, either
untreated or treated with heat (60°C for 30 min) or D T T (20 m M at 37°C for 5 h). Specific treatments
are indicated adjacent to the individual plots. The results shown are representative of at least two
independent experiments. Dark arrows indicate the H M W species, dotted arrows indicate the
approximate elution position of a 4 0 k D a protein. Each analysis used 50 pg of each protein.
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electrophoresis was performed on H M W fractions collected from size exclusion
chromatography. In each case it was shown that these fractions contained both clusterin
and the stressed protein (Figure 5.8). The equivalent size exclusion chromatography
samples from untreated mixtures contain minimal amounts of protein (determined by UV

absorbance traces Figure 5.7). This suggests that clusterin was binding to stressed prot
and forming HMW complexes.

To confirm that clusterin was binding to stressed proteins in solution and forming HMW
complexes, samples were prepared as for size exclusion chromatography and analysed by
native agarose gel electrophoresis. The position of proteins was determined by staining
gels with Coomassie blue. The results were consistent with those obtained from size

exclusion chromatographic analyses. In all cases, when clusterin was present together wi

proteins undergoing heat- or DTT-mediated stress, a broad protein band was detected with
electrophoretic mobility distinct from that obtained by electrophoretic analysis of the
individual proteins in the mixture (Figure 5.9). Furthermore, the band of unique
electrophoretic mobility was only detected when the mixtures had been exposed to
experimental stress (Figure 5.9). It seems probable that these stress-induced complexes
correspond to the stress-induced HMW complexes detected by size exclusion

chromatography. Next areas of agarose gels where proteins migrated to were physically cu
out of the gel (e.g. areas defined in Figure 5.9) and analysed by SDS PAGE

electrophoresis. Agarose gel cutout sections, which corresponded to the distinct migrati

bands from protein mixtures which had been exposed to experimental stress, resolved into
two distinct bands by SDS PAGE electrophoresis (Figure 5.10). In each case these bands
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r l g U r e 5.8: S D S - P A G E gel analyses of H M W complexes which were collected by size
exclusion chromatography (refer fig 5.R.6 where samples collected from peaks indicated with
solid arrows). A ) 1 5 % S D S - P A G E gel. Lane 1: Molecular weight markers; Lane 2: 10 pg
catalase; Lane 3: 10 pg G S T ; Lane 4: 10 pg clusterin; Lane 5: H M W complex formed from
clusterin and catalase when heated at 60°C for 30 minutes; Lane 6: H M W complex formed from
clusterin and G S T when heated at 60°C for 30 minutes. B ) 12.5 % S D S P A G E gel. Lane 1:
Molecular weight markers; Lane 2: 10 pg BSA; Lane 3: 10 pg a-lactalbumin; Lane 4: 10 pg
clusterin; Lane 5: H M W complex formed from clusterin and B S A when treated with D T T ; Lane
6: H M W complex formed from clusterin and a-lactalbumin when treated with DTT.
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F i g u r e 5 . 9 : Native agarose gel electrophoresis of clusterin, G S T , catalase, B S A or alactalbumin, or mixtures of clusterin with one of the other proteins, either untreated or treated
with heat (60°C for 30 min) or D T T (20 m M at 37°C for 5 h). Individual proteins or protein
mixtures were treated prior to electrophoresis as indicated in the table below each image
(indicated with an "x"). Dotted rectangles represent regions which were excised and analysed
by S D S - P A G E , further described in figure 5.10.
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F i g u r e 5 . 1 0 : S D S P A G E electrophoresis of agarose gel sections containing clusterin, G S T ,
catalase, B S A , a-lactalbumin, or fractions of the broad migrating band occuring from mixtures of
clusterin with one of the other proteins when treated with heat (60°C for 30 min) or D T T (20 m M at
37°C for 5 h). The lanes contain protein bands excised from agarose gels following native gel
electrophoresis (see figure 5.9). A ) Lane 1: Makers; Lane 2: clusterin (clus-l); Lane 3: G S T (GST-1);
Lane 4-6 clusterin and G S T heated at 60 C for 30 mins (clus-GST-1, clus-GST-2, clus-GST-3
respectively). B ) as for A except Lane 3: catalase (cat-1); Lane 4-6 clusterin and catalase heated at 60 C
for 30 mins (clus-cat-1, clus-cat-2, clus-cat-3, respectively). C ) as for A except Lane 3: B S A (BSA-1);
Lane 4-6 clusterin and B S A treated with 2 0 m M D T T for 5 hours (clus-BSA-1, clus-BSA-2, clus-BSA-3
respectively). D ) as for A except Lane 3: a-lactalbumin (a-lact-1); Lane 4-6 clusterin and alactalbumin treated with 2 0 m M D T T for 5 hours (clus-a-lact -1, clus- a-lact -2, clus- a-lact -3
respectively). The results shown are representative of two independent experiments.
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corresponded to clusterin and the protein tested. Thus, results from both size exclusion

chromatography and native gel electrophoresis indicate that clusterin binds preferentia
to proteins undergoing stress to form a HMW complex.

5.3.5 ANS fluorescence measurements indicate that clusterin interacts with proteins tha
have stressed-induced exposed regions of hydrophobicity

To investigate the conformational state of clusterin and the proteins with which it int
under stress conditions, the binding of the hydrophobic probe, ANS, was monitored via
fluorescence spectroscopy. ANS binds to clustered, solvent-exposed hydrophobic regions
of proteins. For example, a large amount of ANS fluorescence is a characteristic of
intermediately structured molten globule states of proteins which have elements of

secondary structure present and an exposed hydrophobic core to which ANS binds (Ptitsyn
et al, 1990). Clusterin exhibited an increase in fluorescence of bound ANS at 60°C
compared to 25°C (Figure 5.11 A) suggesting that it exposes some additional regions of
hydrophobicity to solution at the higher temperature. At 25°C, the amount of ANS
fluorescence measured for GST was similar to that measured for clusterin. A mixture of

GST and clusterin at this temperature produced an ANS fluorescence that was significant
greater than the sum of the two individual values (p < 0.05). This result suggests that

is a conformational change in one or both of the proteins upon mixing at 25°C that expo

more hydrophobic surface. The implication from this result is that there is an interacti
between the two proteins under physiological conditions which is consistent with the
ELISA data (Figure 5.6 A).
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F i g u r e 5 . 1 1 : M a x i m u m A N S fluorescence measured for clusterin and (A) G S T or
catalase or (B) B S A or a-lactalbumin (see Experimental Procedures). Individual proteins or
protein mixtures were treated as indicated in the table below each plot (indicated with an "x").
The results shown are representative of three independent experiments. Each histogram
represents the mean of three replicate measurements and the error bars shown correspond to
standard errors (SE) of the mean. In some cases, the S E are too small to be visible. The
fluorescence values of blank wells containing an equivalent concentration of A N S in buffer
alone have been subtracted from the values shown, resulting in some cases in small negative
values (see Experimental Procedures).

A large increase in A N S fluorescence is observed for G S T upon heating to 60°C (Figure

5.11 A). This suggests that heating to 60°C induces a significant conformational change
GST which generates an increased solvent-exposed hydrophobic surface on the protein.
The ANS fluorescence of a HMW complex between clusterin and GST after heating at

60°C was approximately the sum of the values for the individual proteins at 60°C (Figure
5.11 A). Clearly, interactions between GST and clusterin did not reduce the total ANS

fluorescence. It has recently been shown that the subunits of a-crystallin, a sHSP, und
inter-molecular exchange even in the presence of bound substrate protein (Bova et al,
1997). It is possible that this type of dynamic interchange may also occur in the

interactions between clusterin and stressed proteins. It is therefore feasible that, as

of the dynamic nature of these interactions, ANS may have essentially unrestricted acces

to solvent-exposed regions of stressed proteins, despite binding interactions with clus
As clusterin undergoes only a relatively small change in its ANS fluorescence upon

heating (Figure 5.11 A), it is unlikely that the large amount of ANS fluorescence of the
HMW clusterin:GST complex arises from an alteration in exposed hydrophobicity of
clusterin at 60°C. More likely, this fluorescence is due to the increased exposed
hydrophobic surface on the bound GST molecules in the complex.

The pattern of change of ANS fluorescence for clusterin and a-lactalbumin, and mixtures
of these two proteins, with and without DTT-mediated stress was found to be similar to

that observed for corresponding treatments of clusterin and GST with heat-stress (Figure
5.11 B). The ANS fluorescence values of reduced clusterin and native a-lactalbumin were
small. a-Lactalbumin is known to adopt a molten globule conformation upon reduction
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(Kuwajima et al, 1990). Consistent with this, a large increase in A N S fluorescence was
observed following reduction of a-lactalbumin. The ANS fluorescence of the HMW
complex formed between clusterin and a-lactalbumin after reduction with DTT was

approximately the sum of the values for the reduced individual proteins (Figure 5.11 B

This pattern is consistent with the two proteins associating such that the majority of

ANS fluorescence arose from the partly unfolded, molten globule state of a-lactalbumin
(Figure 5.11 B).

Upon heating catalase to 60°C, there was only a slight increase in ANS fluorescence

(Figure 5.11 A). Accordingly, the addition of ANS to a solution of catalase and cluste

that had been heated at 60°C only led to a small increase in ANS fluorescence relative

an unheated control solution of the two proteins (Figure 5.11 A). The relative magnitu

this increase was much less than that observed for the heated solution of clusterin an
(Figure 5.11 A) suggesting that catalase does not display a large increase in exposed
hydrophobic surface upon partial unfolding and formation of the HMW complex with
clusterin.

Clusterin, BSA and mixtures of these two proteins, with or without reduction with DTT,

were also analysed for ANS binding (Figure 5.11 B). Native BSA exhibited a large amoun
of ANS fluorescence. Upon reduction of BSA, ANS fluorescence decreased to 48% of its

value in the native form (Figure 5.11 B). Reduced BSA is known to adopt a molten globu
conformation (Shin and Hirose, 1995). However, the data presented here indicate that

unlike most other proteins, the molten globule state of BSA has decreased, although st
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significant, exposed hydrophobicity compared to the native protein. The A N S fluorescence
of the HMW complex formed under reducing conditions between clusterin and BSA was

significantly greater than the sum of the fluorescences of the individual reduced prot
(Figure 5.11 B). This implies that there is also some alteration in the exposed
hydrophobicity of clusterin and/or the molten globule-state of BSA upon incorporation
the HMW complex.

5.3.6 Stress precipitation of proteins in solutions containing different salts confirm
proteins interact via hydrophobic interactions.

In solution salts effect the interaction between molecules and water. The Hofmeister s

predicts the strength of these interaction caused by different salts (Creighton, 1993).

of the stress sensitive proteins tested were prepared in solutions containing differen

from this series to confirm that proteins were precipitating as a result of hydrophobic
interactions. The Hofmeister series predicts the following order of salts that enhance

hydrophobic interactions in solution (listed from highest to lowest): SO4, Cl, PO4, fol

by SCN. In each case a greater rate of precipitation resulted when proteins were prepar
in SO4 (Figure 5.12). In extended stress treatments the precipitation of some proteins

prepared in this salt formed very large aggregations which decreased the amount of ligh

absorbed at 360nm (Figure 5.12, e.g. catalase after 20 minutes). Solutions containing S

resulted in limited precipitation of any protein when stressed with either heat or DTT.

Solutions containing Cl and P04 ions also resulted in the precipititaion of proteins wh

stressed. With the exception of catalase the stress treatment of all proteins prepared

resulted in faster precipitation compared to P04 (Figure 5.12). Catalase prepared in ei
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Cl or P 0 4 resulted in a similar rate of precipitation when heated (Figure 5.12 B). The rate

of precipitation of proteins prepared in Cl or P04 in each instance was less than p
prepared in S04 and greater than proteins prepared in SCN.
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F i g u r e 5.12: Protein precipitation as a function of salt. Absorbance at 360 nm, as a function of time
for (A) GST (200 pg/ml) heated at 60°C; (B) catalase (200 pg/ml) heated at 60°C; (C) BSA (750 pg
treated with 20 mM DTT at 37°C; (D) a-lactalbumin (750 ug/ml) treated with 20 mM DTT at 37°C. In
case proteins were prepared in either 0.1 M NaCl ( •), 0.1 M NaS04 ( o), 0.1 M NaSCN ( A ), or 0
NaP0 4 (a).
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5.3.7 Binding of clusterin to DNA

Clusterin was shown to accumulate in the nuclei of TNFa treated L929 cells (refer sec

4.3.12), and reportedly binds to nuclei of nutrient-deprived Hym2 or U937 cells (Wilso

al, 1995). Clusterin was therefore tested to see if it bound to DNA or RNA purified fr

wild type L929 cells. Clusterin bound to immobilised DNA but not RNA (Figure 5.13 A).

The binding interaction between clusterin and DNA is probably hydrophobic as clusteri
could be dissociated with the detergent Triton X-100 (Figure 5.13 A). Clusterin is

upregulated during apoptosis, a process that involves DNA degradation. Therefore, the

ability of clusterin to protect DNA from the restriction enzyme DNase I was examined.
the physiological concentration of 100 ug/ml, clusterin did not protect nor did it
significantly enhance the degradation of DNA caused by DNase I (Figure 5.13 B).

A B

F i g u r e 5 . 1 3 : A ) Dot blot in which either D N A or R N A which was dotted onto
nitrocellulose and then incubated with clusterin. Clusterin was detected with G 7 monoclonal
antibody. One membrane was washed with 0.1% triton X-100 in PBS. X mark the positions
where D N A or R N A was doted onto membranes. B) L929 genomic D N A which were
electrophoresed on a 1 % agarose gel. Lane 1: molecular weight markers; lane 2: 3 pg untreated
D N A . All other lanes were 3 pg of D N A treated with 50 pg/ml DNase I + either 100 pg/ml
clusterin (lane 3 and 4), B S A (lanes 5 and 6), gelatin (lane 7 and 8), or casein (lanes 9 and 10)
for 30 minutes at 37°C.
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5.3.8 Clusterin does not protect L929-pRc.clus cells against heat or H202.
The clusterin-expressing L929 transfected cell lines were tested to see whether the
expression of clusterin provided protection to those cells from heat or H202. Several
cultures of L929-pRc.clus and L929-pRc cells were compared following incubation at

either 37°C or 47°C. The rate of cell death, determined by PI staining (refer 4.2.3.2), w
not significantly different between the cell lines when cultured at high temperatures
(Figure 5.14). However, on occasions, L929-pRc.clus cells were found to be significantly

resistant to heat relative to L929-pRc cells. Unfortunately, this result could not be rel
reproduced.

The transfectants were also tested for their resistance to exposure to H2O2. Surprisingly

the rate of death due to H2O2 exposure was significantly greater (p < 0.05; students t-t
for L929-pRc.clus cells than for L929-pRc cells (Figure 5.14).

100^
80^J

604020-

Cell line
47°C
H2Q2

L929-pRc.clus

L929-pRc

F i g u r e 5.14: Average L929-pRc.clus and L929-pRc cell viability after treatment with either 0.4
m M H 2 0 2 or 47°C for 16 hours as indicated. All other cells were incubated at 37°C. Viability was
determined by staining cells with PI (refer section 4.2.3.2) and then analysing cells by flow
cytometry. Results shown is representative of three independent exeriments. Error bars are standard
deviation of the mean.
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5.4 DISCUSSION
5.4.1 Clusterin's ability to prevent protein precipitation by forming HMW complexes.

It was previously shown that clusterin reduced the aggregation of a synthetic amyloid (
peptide in aqueous solution (Oda et al, 1995). However the effects of clusterin on the

aggregation of stressed proteins has not been reported before. The results presented in

chapter demonstrate for the first time that clusterin has chaperone-like activity. Clus
potently protected GST and catalase from heat-induced precipitation and a-lactalbumin

and BSA from precipitation induced by reduction (Figure 5.4). Clusterin does not have a

affinity for these proteins, with the exception of GST, which suggests that it may also

capable of protecting many other proteins from stress-induced precipitation. This prope
of clusterin is therefore similar to that of sHSP which also are capable of preventing
protein precipitation caused by heat or reduction (Jakob et al, 1993; Horwitz 1992). In
some cases it has been demonstrated that some sHSP are capable of protecting enzymes

from heat-induced loss of catalytic activity. For example a recent report has demonstra

that a-crystallin not only protects catalase from heat-induced precipitation but also r

catalase enzyme activity (Hook et al, 1997). However, in the case of two enzymes tested,

GST and catalase, clusterin was unable to protect against heat-induced loss of activity
(Figure 5.5).

sHSP have been shown to protect proteins from various stresses by forming HMW
complexes (Carver et al, 1994). Clusterin also formed HMW complexes with each of the
four proteins tested upon heat or reducing treatment as determined by size exclusion
chromatography (Figure 5.7). The peak representing the HMW complex was at the
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position of the exclusion volume of the column indicating a mass greater than 1.5xl06 Da.
As this peak was absent in the analyses of solutions containing (i) unstressed protein

mixtures or (ii) individual proteins or clusterin, regardless of whether these proteins h
been stressed or not, this indicates that clusterin only formed HMW complexes with
stressed proteins.

SDS-PAGE analyses demonstrated the presence, in each case, of two proteins (clusterin
and the stressed protein) in the HMW fractions collected from size exclusion
chromatography (Figure 5.8). The formation of a complex between clusterin and stressed
proteins was also verified in each case by native gel electrophoresis and then subsequent
analysis by SDS PAGE (Figure 5.9 & 10). Results from size exclusion chromatography

and native gel electrophoresis clearly indicate that, in each case tested, like sHSP, clu
binds to the denatured protein to form HMW complexes.

5.4.2 Clusterin's attraction to hydrophobic surfaces.
No crystal structure is available for clusterin and very limited experimental data is

available concerning the secondary or tertiary structure of the protein. However, sequence

analysis indicates that clusterin has three putative amphipathic a-helical regions, secon

structures thought to be important in interactions with hydrophobic molecules (de Silva et
al, 1990a; refer Figure 1.1). In addition, sequence analysis predicts a number of short
regions of hydrophobicity outside those defined by the putative amphipathic a-helical

regions (Figure 5.15). Since clusterin is known to bind to a variety of native proteins wi
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hydrophobic domains, it is likely that clusterin exerts its chaperone-like activity by binding
to exposed hydrophobic regions of stressed proteins.

F i g u r e 5 . 1 5 : Predictions based on analysis of the sequence of h u m a n clusterin c D N A . The
hydrophobicity index (MacVector v4.14, H o p p - W o o d s scale) is plotted as a histogram display. Predicted
regions of amphipathic a-helices are represented by striped rectangles. Proteolytic cleavage sites for the
removal of the signal peptide and internal cleavage to produce the a- and P-chains are indicated by striped
and solid arrows, respectively. Asn residues that serve as attachment points for glycolsylation are marked
as solid circles.

The stress treatment of proteins prepared in salts which enhanced hydrophobic interactions

led to an increased rate of precipitation while the stress treatment of proteins prepared in

salts that diminishes hydrophobic interactions resulted in minimal protein precipitation. I
addition measurements of ANS fluorescence indicated that stress treatment of GST and oclactalbumin led to exposure of hydrophobic regions that were accessible to solvent and

therefore also clusterin (Figure 5.11). These results indicate that precipitation occurred d
to denatured proteins agglomerating together through interactions of hydrophobic surfaces
that became exposed to the solvent. It is therefore likely that clusterin prevents their
precipitation by non-specifically interacting with these newly exposed hydrophobic regions
caused by stress and thereby prevents the uncontrolled aggregation of proteins. There was
no significant difference of the ANS flourescence between stressed GST or a-lactalbumin
with clusterin and the sum of clusterin and the corresponding stressed protein. The
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similarity of theflourescencetherefore suggests that clusterin does not "umbrella" the

hydrophobic surface of the stressed protein as ANS still bound to the hydrophobic surface

Suprisingly there was a relatively small increase in ANS fluorescence associated with

heating of catalase indicating little exposure of hydrophobic surfaces to the solvent (Fi

5.11). Futhermore, clusterin did not bind to ELISA plate-bound denatured catalase (Figure
5.6). However as heat stressed catalase precipitates faster when prepared in salts that
enhanced hydrophobic interactions (Figure 5.12), this suggests that hydrophobic

interactions are responsible for the precipitation of this protein. Similarly, solution-p

denatured catalase inhibited the binding of clusterin to plate-bound denatured GST (Figur
5.6 insert), which suggests that clusterin bound to denatured catalase and formed HMW
complexes through hydrophobic interactions. In fact the ELISA format which showed that

clusterin had negligible affinity to bound denatured catalase may have been due to steric

constaints imposed by solid phase adsorption. Further work is therefore required to bette
define the nature of this interaction.

Native BSA had a high level of ANS flourescence that presumably is a consequence of
substantial exposed hydrophobic surface. This may serve the in vivo function of BSA in
transporting hydrophobic molecules in plasma. The 48% decrease in its ANS fluorescence
induced by reduction indicates that a major conformation change resulted (Figure 5.11).
This conformational change occurred due to the unfolding of the protein when cystein
bonds were broken from DTT treatment. The unfolding of BSA and a-lactalbumin was

shown to be very unstable as they both precipitated out of solution when treated with DTT
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(Figure 5.4). Precipitation of B S A (like catalase, G S T and a-lactalbumin) was due to

hydrophobic interactions. This is supported by the results of experiments testing the eff

of different salts on protein precipitation (Figure 5.12). Therefore, it is likely that cl
interacts with hydrophobic surfaces to prevent BSA from reduction-induced precipitation.

With the exception of GST, clusterin was shown not to bind to the native form of each of

the four proteins tested in this study by ELISA (Figure 5.6). Clusterin bound more strong
to heat-treated than to untreated GST and also bound significantly to reduced alactalbumin and BSA (Figure 5.6). Clusterin also bound strongly to reduced-denatured
BSA and a-lactalbumin but not heat-denatured catalase (Figure 5.6). However solutionphase heat-denatured catalase but not native solution-phase catalase prevented clusterin

from binding to plate-bound heat-denatured GST (Figure 5.6). This indicates that clusteri

has a higher affinity for denatured catalase than native catalase. Alltogether these ELISA

results suggest that clusterin is capable of non-selectively binding to denatured protein
is proposed that the binding of clusterin to denatured proteins results in the formation
HMW complexes that in turn prevents the denatured protein from precipitating.

5.4.3 The efficiency of clusterin binding.

Since many chaperones (and also clusterin) exist in solution as aggregates of an ill-defi
number of monomers, a convention that has been adopted when dealing with the

interactions between chaperones and other proteins is to define stoichiometry in relation

the individual subunits of the chaperone and the protein with which it interacts. For thes

calculations it was assumed that the molecular mass for intact clusterin was 80 kDa and t
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subunit mass 4 0 kDa. A n approximate subunit molar ratio ( S M R ) of clusterin:GST of
1.0:3.2 was the minimum required to virtually abolish reduction-induced precipitation
(Figure 5.4 A). Corresponding SMRs for the stabilizing effects of clusterin on the other

proteins tested were 1.0:1.3 (catalase), 1.0:2.3 (BSA), and 1.0:11 (a-lactalbumin) (Figu
5.4 B, C & D, respectively). In contrast, even at corresponding SMRs as high as 1.4:1.0,

control protein (ovalbumin) had only a small effect on the stress-induced precipitation o

any of the proteins tested (Figure 5.4 F). These SMR values indicate that clusterin is a

efficient chaperone. In comparison, the sHSPs are less efficient in their interactions w
stressed proteins; the available data suggest that sHSPs bind stressed proteins at a SMR
one or more subunits of sHSP to one partially folded protein (Farahbakhsh et al, 1995;
Lindner etal, 1998).

The SMRs of interaction of heat-stressed GST and catalase with clusterin are proportional

to the mass of the stressed protein (Table 5.1). A similar relationship was found for BSA
and a-lactalbumin, stressed by DTT-mediated reduction (Table 5.1). However, there is not

a simple uniform relationship (for all the proteins tested, regardless of the type of st
between mass and the SMR effecting inhibition of precipitation. Although the number of
data points is small (two per treatment) the close relationship between mass and the SMR
effecting inhibition of precipitation for GST and catalase and for BSA and a-lactalbumin
(Table 5.1) suggests that there may be a fundamental difference in the mechanism by

which clusterin exerts its chaperone-like action under conditions of stress induced by h

versus reduction. Despite this, regardless of the nature of the stress, the data indicate
steric constraints influence the interaction of stressed proteins with clusterin. When
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considering proteins stressed by heat, or those stressed by reduction, in each case clusterin

was able to interact with and stabilize a greater number of smaller versus larger stressed
protein molecules. This is consistent with the suggestion from the ANS studies that

stressed proteins bind to the external surface of clusterin. Interestingly, when a similar
comparison is made for the interaction of three reduced proteins (a-lactalbumin, BSA and
ovotransferrin) with the sHSP, a-crystallin, a close correlation is also observed between
the ratios of the molecular masses and SMR (Lindner et al, 1998).

Table 5.1: Relationship between molecular mass of proteins stressed by either heat or D T T mediated reduction versus the S M R of interaction between the stressed proteins and clusterin
effecting inhibition of protein precipitation.
Ratio of S M R
Ratio of Molecular M a s s
Comparison Between
Proteins
2.3
2.1
Catalase vs. G S T
B S A vs. a-lactalbumin

4.7

4.7

5.4.4 The effects of clusterin expression on cell stress
The upregulation of HSP25 and a-crystallin in L929 cells has been shown to provide
thermotolerance to those cells (Aoyama et al, 1993; Chretien and Landry, 1988).

Presumably this is due to an intracellular action whereby they prevent important regulator
enzymes and other proteins from becoming inactivated. However, the clusterin-expressing
L929 transfectants, L929-pRc.clus were not protected against either heat or H202 (Figure
5.13). Clusterin cDNA in the L929-pRc.clus cells contain the endogenous signal peptide

(chapter 3) which theoretically indicates that all the clusterin produced should be secret
Therefore clusterin produced in these cells could not protect enzymes and other

intracellular proteins from precipitating due to heat and H202 treatments. This also sugges
that the secreted clusterin, despite being present in low concentrations, was not capable
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protecting L 9 2 9 cells extracellularly from heat and H 2 0 2 treatments. Interestingly
preliminary work has shown that physiological concentration of clusterin have provided

limited protection to other cell lines in response to heat (S. Poon, Unpublished). It woul
be of interest to determine whether higher concentrations were also capable of protecting
L929 cells from the cytotoxic effects of heat and H202.

An intracellular form of clusterin has been reported (Reddy et al, 1996). Analysis of the

clusterin gene that codes for clusterin reveals contains two in frame ATG sites. Translati

of clusterin from the first ATG site would include the signal peptide while translation fr
the second site (located 33 bases downstream) would exclude the signal peptide, and would
result in a truncated intracellular form (Reddy et al, 1996). While no truncated form of
clusterin was detected by immunoblotting in the L929-pRc.clus cells under normal
culturing conditions (refer figure 4.14) it is still possible that small amounts of maybe

produced. It would be interesting to determine whether this intracellular clusterin form i

capable of protecting cells from various stresses likely to occur in physiological conditi
Creating transfectant cells lines that contain clusterin cDNA starting at the second ATG
site would help determine this. If such a study showed that clusterin did protect cells
intracellularly from stress would further support its role as a HSP. Additionally other

studies would also be required to determine if this intracellular form of clusterin really
exists.
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5.4.5 Conclusion

The results described in this chapter indicate that clusterin has a chaperone-like func
similar to that of the sHSP. Like clusterin, sHSP are known to bind to exposed
hydrophobic regions on stressed proteins to form HMW complexes (Carver et al, 1995).
The formation of these complexes "solubilizes" stressed proteins, preventing their
precipitation. It is also known that, generally, when acting alone, sHSP are unable to
protect enzymes from heat-induced loss of function (Carver et al, 1994; Horwitz, 1992).

All of these characteristics appear to be shared with clusterin. There are a variety of

additional similarities between the sHSP and clusterin which suggest that they may have
similar functional role in vivo:

(1) Heat shock factor 1 (HSF1) is a transcriptional activator of both the clusterin gen
sHSP genes (Michel et al, 1997).

(2) Both sHSPs and clusterin are involved in, and/or their expression is upregulated in
variety of instances of cell stress and disease states, for example, sHSPs in cataract,
neurodegenerative disorders such as Alzheimer's, Alexander and Creutzfeldt-Jakob

diseases and various cancers (Ehrnsperger et al, 1997) and clusterin in cataract (P. Wo

pers. commun.), retinitis pigmentosa, Alzheimer's and Pick's diseases, gliomas, epileptic

foci and many experimental models of stress (Silkensen et al, 1994; Jomary et al, 1993;
Jones etal, 1992; Clark and Groswold, 1997; Chapter 1).

(3) sHSPs and clusterin are highly resistant to stress-induced precipitation ((Horwitz,
1992), and results shown here).

(4) Both sHSPs and clusterin can protect cells from stresses ((Ehrnsperger et al, 1997);
refer chapter 4).
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(5) Both sHSPs and clusterin oligomerise in aqueous solution (oligomeric sHSPs perform
the chaperone function (Ehrnsperger et al, 1997; Leroux et al, 1997), refer chapter 1).

(6) The sHSP, HSP25, is often found as a disulfide-linked dimer, which aggregates to for
large oligomeric complexes (Zavialov et al, 1998). The oxidized and reduced forms of

HSP25 both have very similar chaperone ability (Zavialov et al, 1998). Likewise, cluster
forms disulfide-bonded dimers that behave very effectively as a chaperone under both
reducing and non-reducing conditions.
(7) The limited sequence homology between the a-crystallin domain (common to all
sHSP) and clusterin residues 243-249.

While much remains to be done to establish the mechanism by which clusterin protects

proteins from stress-induced precipitation, predicted structural features of the molecu

provide some clues. A yet to be defined sub-set of known hydrophobic regions of clusteri
sequence, possibly including one or more of the predicted amphipathic a-helices (Figure
5.15), are likely to be involved in binding to hydrophobic regions exposed on partly
unfolded, stressed proteins. The results clearly show that hydrophobic interactions are
important in the chaperone-like activity of clusterin. The structure of clusterin is

amphipathic, since it also possesses a number of strongly hydrophilic regions, includin

region at the extreme C-terminus of the molecule (Figure 5.15). It is interesting to not
sHSPs also have a hydrophilic C-terminal region, which plays an important role in their
chaperone action (Carver et al, 1992; Carver et al, 1995; Smulders et al, 1996).

Substantial additional hydrophilieity is provided to secreted clusterin by its extensive

glycosylation, which is complex and is attached to clusterin via six Asn residues (Kapro
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etal, 1997; Figure 7). Like the sHSPs, the amphipathicity of clusterin is very probably

critical in effecting solubilization of stressed proteins incorporated into HMW complexe
In this context, an obvious corollary is that at least some of the reported binding
interactions between clusterin and other (non-stressed) molecules with regions of
hydrophobicity may simply result from the amphipathic character of clusterin and
represent artifacts unrelated to any genuine biological function.

A subset of the results presented in this chapter have been published in the following
journal paper (a reprint is attached in the appendix):
Humphreys D.T., Carver J.A., Easterbrook-Smith S.B., Wilson M.R. (1999). Clusterin has
chaperone like activity similar to that of small heat shock proteins. J Biol Chem. 274,
6875-6881.
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CHAPTER 6
Summary and conclusion.
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This thesis has described research examining (i) the effect of clusterin expression on

cell death and (ii) the ability of clusterin to act as a chaperone. The aims of this proj
were to:

(i) Generate stable transfected L929 cell lines that inducibly or constitutively
secrete human clusterin.
(ii) Use the transfected cell lines to test what effects clusterin expression has on
apoptosis or necrosis.
(iii) Determine whether clusterin can act as a molecular chaperone.

6.1 Clusterin's propensity to bind to hydrophobic surfaces
Clusterin has been linked to numerous roles in the body due to its interaction with a
diverse array of ligands (refer section 1.2). These interactions indicate that clusterin
either has a multifunctional role in the body or that it has a common underlying
function. Here it has been shown that clusterin has chaperone-like activities similar to
that of small heat shock proteins. These results suggest that clusterin binds to
hydrophobic residues on denatured proteins and thereby inhibits protein precipitation
(chapter 5). It is also been shown that the upregulation of clusterin can protect L929pRc.clus cells from TNFa-mediated death (chapter 4). The propensity of clusterin to
bind to hydrophobic surfaces may explain how clusterin protects L929 cells from TNFa
mediated death as well as explain the wide array of proteins to which clusterin binds.

Clusterin's affinity for hydrophobic surfaces was first reported in 1983 by Blaschuk and
colleagues who demonstrated that (i) clusterin aggregated with itself to form dimers and

tetramers, (ii) it had a high affinity for the hydrophobic Affi-Gel blue matrix, and (ii
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aggregated Sertoli cells in vitro. F r o m these early findings clusterin was thought to
influence cell interactions in the testis or epididymis. On the basis of amino acid
sequence, computer analysis predicts three amphipathic a-helical regions in clusterin,

which also suggests that clusterin is likely to participate in hydrophobic interactions (
Silva et al, 1990a; Tsura et al, 1990). Research described in chapter 5 also suggested
that clusterin participates in hydrophobic interactions as it bound to heat- and DTTdenatured proteins to a significantly greater extent than to the corresponding native
proteins. Results presented here suggest that clusterin has sHSP-like chaperone activity
as it inhibits heat or DTT-induced precipitation of proteins. Like the sHSP, it appears
likely that clusterin binds to exposed hydrophobic regions of denatured proteins to form
a solubilized high molecular weight complex (chapter 5). The concentrations of
clusterin that protect stressed proteins from precipitation is within the range normally
found in some extracellular fluids in mammalian systems (e.g. 50-370 pg/ml in human
serum and 2.1-15.0 mg/ml in human seminal fluid; O'Bryan et al, 1990). This raises the
possibility that in these environments clusterin may act as a constitutively expressed
chaperone.

6.2 The association of clusterin expression with cell death
The numerous findings that clusterin is expressed in most tissues and is upregulated in
times of stress has generated a lot of interest and led to the suggestion that it either
provokes or prevents cell death. Three independently made transfected cell lines
expressing clusterin have each shown that its expression does not affect viability under
normal culturing conditions (Pilarsky et al, 1993; Sensibar et al, 1995; section 4.3.9).
Others have shown that clusterin is upregulated in proliferating tissue (Bursch et al,
1995; Seiberg and Marthinuss, 1995). These results indicate that clusterin expression
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does not cause cell death. However multiple lines of evidence suggest that clusterin acts

to protect cells from environmental stresses. For example, it was earlier reported that
inhibition of clusterin synthesis by treatment of LNCaP cells with an anti-sense
oligonucleotide enhanced the cytotoxicity ofTNFa and that overexpression of clusterin
in these cells protected them from TNFa-mediated death (Sensibar et al, 1995).
Furthermore, following the exposure of U937 cells to UV-B irradiation, in situ
hybridization detected clusterin mRNA in surviving cells but not in those that had
undergone apoptosis (a control mRNA was detected in both live and dead cells) (French
et al, 1994). Similarly, increased clusterin mRNA expression was not detected in
murine olfactory neurons induced to undergo apoptosis but was detected in surviving
glial cells that surounded the neurons (Michel et al, 1997). In addition, it has been
shown here that high clusterin expression in L929 cells protected them from TNFa

mediated death (Chapter 4). Therefore, it appears that clusterin expression is associ
with cell survival.

The upregulation of HSP27 and HSP25 also provides protection against TNFa mediated

death in L929 cells (Melhen et al, 1995; Park et al, 1998). In addition, the upregulate
expression of other sHSPs also protect cells from stresses by promoting cell viability
(Ehrnsperger et al, 1997). Therefore, by analogy with the HSP, the cytoprotective
effects of clusterin expression may be due to clusterin's chaperone-like activity.

TNFa reportedly induces cell death in L929 cells by stimulating the production of
reactive oxygen intermediates (ROIs) in the mitochondria (Schulze Osthoff et al, 1992;
Goossens et al, 1995). It was demonstrated that the expression of clusterin in L929pRc.clus cells protected them against TNFa through an intracellular mechanism as the

protection could not be passed onto control L929 cell lines though the addition of
exogenous clusterin or media from L929-pRc.clus cells (refer 4.3.11). As ROIs are

capable of denaturing and thus destroying proteins (Stadtman, 1992), it is possible tha

the protective action of clusterin was due to it binding to cytosolic damaged protein(s
and thereby inhibiting their precipitation. However, as clusterin contains a signal
peptide, this appears unlikely as it should be processed and then immediately secreted

from the cell. Despite this, an intracellular form of clusterin has been reported and w

postulated to result from the translation of a second in-frame ATG site located 33 base

downstream of the signal peptide (Reddy et al, 1996). The translation of such a product
may also occur in L929-pRc.clus cells, however further research will be required to

demonstrate this. Alternatively, clusterin may have interacted with denatured proteins
the secretory pathway. Here high concentrations of clusterin may act as a "lubricant"
damaged proteins by inhibiting their tendency to aggregating into large unmanageable
complexes, thereby escorting them along the secretory pathway to the surface of the
cell.

The protective effect of clusterin overexpression against TNFa may not be specific as
L929 cells expressing high levels of EGFP were also protected from TNFa (refer
section 4.3.16). This suggests that high level expression of any protein may provide
TNFa resistance to L929 cells. The protective effect of the overexpression of EGFP
could be an artifact caused by the accumulation of intracellular EGFP. For example,
EGFP may have "soaked up" the damaging effects of ROIs which would otherwise

have damaged important intracellular proteins. Therefore, another L929 transfected cel
line that secretes high levels of an unrelated protein will be required to determine
whether overexpression of protein provides protection against TNFa mediated cell

death in L929 cells. Until this cell line is created and tested, the possibilty that clusterin
expression protects L929 cells from TNFa cytoxocity cannot be excluded.

Clusterin expression did not protect L929 cells from staurosporine, colchicine, or azide

induced death (chapter 4). In these cases it is possible that cell death is not directly

caused by the denaturation of proteins, thus not allowing clusterin to interfere with th
process of cell death. For example, staurosporine and colchicine treatments resulted in
apoptosis (chapter 4) which involves many proteolytic cascades rather than denaturing
events. However, clusterin may play some role in apoptosis as it is commonly found to

be upregulated before the morphological characteristics become apparent (ie very early)
in apoptotic cells. Perhaps clusterin is secreted in such situations as a precautionary
measure in case cell lysis occurs. Lysis would result in release of noxious agents that
would damage proteins of the extracellular matrix and other neighbouring cells. The
release of clusterin expressed by the cell would therefore help protect near-neighbour
proteins from irreversible damage.

The L929 clusterin secreting transfected cells are not the ideal system to examine the

effects of clusterin expression on cell stress. One flaw in this system is that like ne
all cell types, L929 cells secrete endogenous clusterin during times of stress

(Kyrprianou et al, 1991). It is therefore possible that synthesis of endogenous clusteri
may mask the effects of overexpression of recombinant clusterin. A similar flaw exists
in the study of transfected LNCaP cells expressing clusterin and their sensitivity to
TNFa (Sensibar et al, 1995). Such a flaw would also exist if the transfected BHK-21
clusterin expressing cells described by Pilarsky et al, (1993) were used in similar
studies, as no measurements were reported for these cells of the levels of endogenous
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clusterin production in times of stress (Pilarsky et al., 1993). The ideal cell type would

be one in which clusterin expression has been knocked out. Transfecting such cell lines

with "graded" expression systems would allow the full effect of clusterin expression on

cell death to be established. Recently, clusterin knockout mice have been created which
will allow such cell lines to be created.

6.3 The site of clusterin action
The studies on L929-pRc.clus cells suggested that clusterin expression protected cells

from TNFa cytotoxicity via an intracellular site of action. However this site of action

appears unlikely as clusterin is normally a secreted product. Futhermore, there are onl

two reports describing intracellular forms of processed clusterin. Reddy et al, (1996b)
identified a truncated form of clusterin in LNCaP cells when treated with TGF p\ while

Mahon et al, (1999) recently reported that chicken clusterin is not a secreted product.
is concluded that the protection against TNFa cytotoxicity provided to L929-pRc.clus
cells by clusterin overexpression is most likely an artifact caused by high protein
expression. This is supported by the demonstration that L929-EGFP cells were also

protected from TNFa cytotoxicity. If clusterin is capable of protecting cells from othe
forms of stress it is predicted that the site of action will be extracellular.

6.4 The association of clusterin with lipid recycling

The proposal that clusterin is involved in lipid recycling due to its interactions with

various lipid complexes may also involve its chaperone-like function. It is likely that

clusterin binds to lipid complexes because of its affinity for hydrophobic surfaces. It
role in lipid recycling may be a general one as described by James (1995), whereby it
cleanses biological systems of hydrophobic harmful molecules. Here, clusterin has been

shown to be resistant to treatments that are damaging to other proteins (Chapter 5).
Clusterin may interact with such hydrophobic harmful molecules and possibly
neutralise them. The association of clusterin with paraoxonase is also fitting as
paraoxonase is thought to inactivate potent forms of lipids (Mackness et al, 1991;
Witztum and Steinberg, 1991).

6.5 The association of clusterin with complement

Clusterin's association with purified complement proteins, in particular with C5b-7, h
been deduced to be hydrophobic (Choi-Miura etal, 1993). Clusterin's hydrophobic
interactions with denatured proteins have been shown to be non-specific (chapter 5),
which may also include its interaction with complement. The proposed function of
clusterin regulating the formation of the MAC now appears to be dubious as in near

physiological conditions clusterin did not affect MAC formation (refer section 1.2.3).
Clusterin's co-localisation to regions of complement activation may now be explained
by it's chaperone-like activity. In these situations, clusterin may prevent proteins
extracellular matrix and on the surface of cells from being permanently damaged by
noxious compounds released from complement lysed cells. This in turn would help the
affected tissue recover from complement attack. The interaction between clusterin and
complement components may just be a means by which clusterin is recruited to affected

areas. In this scenario clusterin would most likely have to dissociate from complement
proteins before attending to proteins that are damaged on or near membranes of
unaffected cells to minimise any chance of complement-induced damage to those cells.
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6.6 Clusterin and Alzheimers disease
Clusterin has been shown to specifically interact with amyloid (3, one of the major
components of amyloid plaques that form in Alzheimer's diseased (AD) brains. It has
also been demonstrated that clusterin is capable of inhibiting the aggregation of the
amyloid p(M2) peptide in vitro (Oda et al, 1995). The ability of clusterin to inhibit
amyloidp(i.42) peptide from aggregating in vitro may involve similar mechanisms in
which clusterin prevented stressed proteins from precipitating (chapter 5). For example

this may result from a non-specific interaction that involves clusterin associating with
hydrophobic surfaces on the amyloid p(i.42) peptide. However, the association of
clusterin with amyloid P plaques in vivo indicates that it does not prevent their
formation, but novertheless clusterin may inhibit the plaque growth. The presence of
clusterin may be advantageous in affected areas of the brain afflicted with AD, as
components of these plaques have been implicated as being neurotoxic (Yankner et al,

1990; May et al, 1992a). However, more research in this area is required as one in vitro

study found that clusterin increased the neurotoxicity of amyloid p\i-42) peptide (Oda e
al, 1992).

The increased expression of clusterin in tissues affected with Alzheimer's disease may

also relate to the chaperone activity of clusterin. As described above, the production o
clusterin in stressed tissue may non-specifically protect cells from death by either
binding to and preventing irreversible protein denaturation of intracellular or
extracellular proteins.

6.7 Summary

The research described in this thesis has demonstrated that clusterin has chaperone-like
activity. The basis of this activity comes from its tendency to bind to hydrophobic
surfaces and protect proteins from stress induced precipitation. Clusterin also appears
have characteristics similar to the sHSP. For example the expression of either clusterin
(chapter 4) or sHSP in L929 cells both protect cells from the cytotoxic effects of TNFa.

The recent finding that clusterin expression can be controlled by HSF1 also indicate tha

clusterin has similar properties to the HSP. The fact that clusterin is generally a secr
product suggests that it may be an exracellular chaperone. No molecular chaperone has

been previously reported to act extracellularly and therefore this will require thorough
testing. The chaperone-like activity also suggest that many of clusterin's binding
partners throughout the body may actually be a non-specific interaction between
clusterin and these ligands. It is proposed that clusterin's chaperone-like activity is
utilised through interactions with these binding partners.

The findings of this thesis have now opened up exciting new avenues for clusterin
research. Some of the immediate questions that require addressing include determining
whether clusterin expression can protect cells from various forms of stress other than
TNFa treatment. It will also have to be determined how clusterin can protect cells from
stress. Answers to these questions will involve identifying the properties of clusterin
involved in mediating its interactions with party unfolded proteins and determining
whether clusterin has a specific cellular site of action.
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